Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Bladder Cancer, January 2020

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1167 articles:
HTML format


 

Single Articles

  1. NAITO T, Higuchi T, Shimada Y, Kakinuma C, et al
    An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.
    Oncol Lett. 2020;19:833-839.
    Abstract     Related articles   

  2. LU J, Xue Y, Shen F, Gu H, et al
    Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.
    J Int Med Res. 2019 Dec 29:300060519887267. doi: 10.1177/0300060519887267.
    Abstract     Related articles   

  3. XIONG Y, Yuan L, Xiong J, Xu H, et al
    An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis.
    J Cell Mol Med. 2019 Dec 28. doi: 10.1111/jcmm.14918.
    Abstract     Related articles   

  4. KUROKI H, Anraku T, Kazama A, Bilim V, et al
    9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.
    Sci Rep. 2019;9:19977.
    Abstract     Related articles   

  5. WANG J, Wang C
    Dietary fat intake and risk of bladder cancer: Evidence from a meta-analysis of observational studies.
    Cell Mol Biol (Noisy-le-grand). 2019;65:5-9.
    Abstract     Related articles   

  6. TATUM JL, Kalen JD, Jacobs PM, Ileva LV, et al
    A spontaneously metastatic model of bladder cancer: imaging characterization.
    J Transl Med. 2019;17:425.
    Abstract     Related articles   

  7. GIROUARD J, Belgorosky D, Hamelin-Morrissette J, Boulanger V, et al
    Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFalpha/NFKappaB and iNOS/NO pathways.
    Biochem Pharmacol. 2019 Dec 23:113778. doi: 10.1016/j.bcp.2019.113778.
    Abstract     Related articles   

  8. PU K, Huang J, Jiang Y, Li J, et al
    Renal-clearable Macromolecular Reporter for Near-infrared Fluorescence Imaging of Bladder Cancer.
    Angew Chem Int Ed Engl. 2019 Dec 25. doi: 10.1002/anie.201911859.
    Abstract     Related articles   

  9. AMOUROUX M, Salleron J, Huin-Schohn C, Ali S, et al
    Clinical evaluation of a device providing simultaneous white-light and fluorescence video streams as well as panoramic imaging during fluorescence assisted-transurethral resection of bladder cancer.
    J Opt Soc Am A Opt Image Sci Vis. 2019;36:C62-C68.
    Abstract     Related articles   

  10. YIN X, Zheng X, Liu M, Wang D, et al
    Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.
    Cell Biol Int. 2019 Dec 24. doi: 10.1002/cbin.11292.
    Abstract     Related articles   

  11. WU G, Wang F, Li K, Li S, et al
    Significance of TP53 mutation in bladder cancer disease progression and drug selection.
    PeerJ. 2019;7:e8261.
    Abstract     Related articles   

  12. GULLU AMURAN G
    Comment on "Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection".
    Dis Markers. 2019;2019:6432596.
    Abstract     Related articles   

  13. LYNCH KE, Viernes B, Khader K, DuVall SL, et al
    Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
    Womens Health Issues. 2019 Dec 21. pii: S1049-3867(19)30497.
    Abstract     Related articles   

  14. DOBOSZ P, Stempor PA, Roszik J, Herman A, et al
    Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
    Transl Oncol. 2019;13:193-200.
    Abstract     Related articles   

  15. MANCINI M, Righetto M, Baggio G
    Spotlight on gender-specific disparities in bladder cancer.
    Urologia. 2019 Dec 23:391560319887327. doi: 10.1177/0391560319887327.
    Abstract     Related articles   

  16. YU Q, Liu P, Han G, Xue X, et al
    CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
    Biosci Rep. 2019 Dec 23. pii: 221714. doi: 10.1042/BSR20191961.
    Abstract     Related articles   

  17. ZHANG Z, Yang L, Xie D, Wang Y, et al
    Illness perceptions are a potential predictor of psychological distress in patients with non-muscle-invasive bladder cancer: a 12-month prospective, longitudinal, observational study.
    Psychol Health Med. 2019 Dec 22:1-11. doi: 10.1080/13548506.2019.1707242.
    Abstract     Related articles   

  18. PLACZEK F, Cordero Bautista E, Kretschmer S, Wurster LM, et al
    Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopy.
    Analyst. 2019 Dec 23. doi: 10.1039/c9an01911.
    Abstract     Related articles   

  19. GUO Y, Jie X, Zhang A, Zhang W, et al
    Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
    Front Oncol. 2019;9:1315.
    Abstract     Related articles   

  20. ZHANG PB, Huang ZL, Xu YH, Huang J, et al
    Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.
    Cancer Cell Int. 2019;19:337.
    Abstract     Related articles   

  21. WORTEL K, Hovius MC, van Andel G, de Reijke TM, et al
    The feasibility and utility of cystoscopy-guided hydrogel marker placement in patients with muscle invasive bladder cancer.
    Pract Radiat Oncol. 2019 Dec 19. pii: S1879-8500(19)30370.
    Abstract     Related articles   

  22. BRUINS HM, Veskimae E, Hernandez V, Neuzillet Y, et al
    The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic B
    Eur Urol Oncol. 2019 Dec 19. pii: S2588-9311(19)30164.
    Abstract     Related articles   

  23. JERECZEK-FOSSA BA, Marvaso G
    Palliative radiation therapy in bladder cancer: a matter of dose, techniques and patients' selection.
    Ann Palliat Med. 2019;8:786-789.
    Abstract     Related articles   

  24. HERR H
    Urologic Principles Define the Standards for Successful Bladder Preservation in Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2019 Dec 18. pii: S2405-4569(19)30381.
    Abstract     Related articles   

  25. WANG YC, Wu J, Dai B, Shen YJ, et al
    Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes.
    World J Surg Oncol. 2019;17:225.
    Abstract     Related articles   

  26. KOUTROS S, Kogevinas M, Friesen MC, Stewart PA, et al
    Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes.
    Environ Int. 2019;135:105346.
    Abstract     Related articles   

  27. BOUBAKER NS, Spagnuolo M, Trabelsi N, Said R, et al
    miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters.
    Mol Biol Rep. 2019 Dec 20. pii: 10.1007/s11033-019-05228.
    Abstract     Related articles   

  28. LIN YH, Tsui KH, Chang KS, Hou CP, et al
    Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.
    Cancers (Basel). 2019;12.
    Abstract     Related articles   

  29. LI X, Ma H, Shu K, Wang L, et al
    Efficacy and safety of intra-arterial chemotherapy combined with intravesical chemotherapy for high-risk non-muscle invasive bladder cancer: A protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e18516.
    Abstract     Related articles   

  30. PATEL A, Elzweig J
    Mycobacterium bovis prosthetic joint infection following intravesical instillation of BCG for bladder cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  31. ERICSON KJ, Murthy PB, Bryk DJ, Ramkumar RR, et al
    Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.
    Clin Adv Hematol Oncol. 2019;17:697-707.
    Abstract     Related articles   

  32. HUANG Y, Luan T, Bao X, Fu S, et al
    A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer.
    Clin Lab. 2019;65.
    Abstract     Related articles   

  33. GE L, Chen Y, Yan C, Zhao P, et al
    Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management.
    Front Oncol. 2019;9:1296.
    Abstract     Related articles   

  34. GUO J, Zhao P, Liu Z, Li Z, et al
    MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis.
    Front Oncol. 2019;9:1242.
    Abstract     Related articles   

  35. MARTINEZ VG, Munera-Maravilla E, Bernardini A, Rubio C, et al
    Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.
    Front Genet. 2019;10:1125.
    Abstract     Related articles   

  36. CHEN M, Gao X, Huang D, Wang S, et al
    Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.
    Onco Targets Ther. 2019;12:10771-10786.
    Abstract     Related articles   

  37. LU JJ, Yang WM, Li F, Zhu W, et al
    Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity.
    Int J Nanomedicine. 2019;14:9731-9743.
    Abstract     Related articles   

  38. WU D, Zhang T, Wang J, Zhou J, et al
    Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  39. LIU SB, Zhou LB, Wang HF, Li G, et al
    Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway.
    Neoplasma. 2019 Dec 17. pii: 190206N108. doi: 10.4149/neo_2019_190206.
    Abstract     Related articles   

  40. WANG J, Xing H, Nikzad AA, Liu B, et al
    LncRNA MNX1-AS1 exerts oncogenic functions in bladder cancer by regulating miR-218-5p/RAB1A axis.
    J Pharmacol Exp Ther. 2019 Dec 16. pii: jpet.119.262949.
    Abstract     Related articles   

  41. RIBEIRO L, Rajendran S, Stenson K, Loftus I, et al
    Rare case of a proximal descending thoracic aorta mycotic aneurysm following intravesical BCG injections for the treatment of bladder cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  42. YANG Z, Chen J, Xie H, Liu T, et al
    Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
    Cancer Lett. 2019 Dec 13. pii: S0304-3835(19)30624.
    Abstract     Related articles   

  43. PICHLER R, Lindner AK, Comperat E, Obrist P, et al
    Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Am J Pathol. 2019 Dec 13. pii: S0002-9440(19)30855.
    Abstract     Related articles   

  44. WOJTCZYK-MIASKOWSKA A, Schlichtholz B
    Tobacco carcinogens and the methionine metabolism in human bladder cancer.
    Mutat Res. 2019;782:108281.
    Abstract     Related articles   

  45. LEI Q, Zhao L, Ye S, Sun Y, et al
    Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:4266-4272.
    Abstract     Related articles   

  46. YE ZY, Xu N, Chen SH, Lin YZ, et al
    [Analysis of influencing factors of ureteral anastomotic stenosis following urinary diversion after laparoscopic radical cystectomy].
    Zhonghua Yi Xue Za Zhi. 2019;99:3612-3616.
    Abstract     Related articles   

  47. ZHOU YJ, Wangyi YBN, Song Y, Yan YZ, et al
    [Study on the disease burden of cancer attributed to the dietary inorganic arsenic exposure in Chinese population in 2013].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:1247-1252.
    Abstract     Related articles   

  48. WU K, Fan J, Liang H, Yao Y, et al
    Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report.
    Medicine (Baltimore). 2019;98:e18000.
    Abstract     Related articles   

  49. SHANMUGAM PM
    Commentary: The shift to intra-arterial chemotherapy - Relevance in Indian context.
    Indian J Ophthalmol. 2019;67:2011-2012.
    Abstract     Related articles   

  50. DE LUCA R, Profita G, Vella M, Cicero G, et al
    Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.
    Oncology. 2019;97:341-347.
    Abstract     Related articles   

  51. ANFINAN N
    Cervical Cancer Staging in Saudi Arabia Clinicoradiological Correlation.
    Biomed Res Int. 2019;2019:8745828.
    Abstract     Related articles   

  52. YADAV D, Singh M, Gupta K, Kaur M, et al
    A report of orbital metastasis from a urinary bladder adenocarcinoma.
    Indian J Ophthalmol. 2019;67:1377-1380.
    Abstract     Related articles   

  53. KUO KL, Liu SH, Lin WC, Hsu FS, et al
    Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  54. YANG HY, Yang CC, Wu CY, Wang LJ, et al
    Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  55. ULLEN A
    Outside the box of immunotherapy - new hope for patients with advanced urothelial cancer.
    Acta Oncol. 2019;58:951-952.
    Abstract     Related articles   

  56. AL-MAGHRABI JA
    Overexpression of SIRT1 in urothelial carcinoma of the urinary bladder is associated with local recurrence and poor survival.
    Saudi Med J. 2019;40:541-547.
    Abstract     Related articles   

  57. BLACKMUR JP, Melquiot N, Robertson KE, Teahan S, et al
    Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  58. MANDELKOW T, Blessin NC, Lueerss E, Pott L, et al
    Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder.
    Dis Markers. 2019;2019:2532518.
    Abstract     Related articles   

  59. AKHTAR M, Al-Bozom IA, Ben Gashir M, Taha NM, et al
    Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
    Adv Anat Pathol. 2019;26:251-256.
    Abstract     Related articles   

  60. AL-MAGHRABI B, Gomaa W, Abdelwahed M, Al-Maghrabi J, et al
    Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis.
    Anal Cell Pathol (Amst). 2019;2019:5026939.
    Abstract     Related articles   

  61. DE BROT S, Grau-Roma L, Stirling-Stainsby C, Dettwiler M, et al
    A Fibromyxoid Stromal Response is Associated with Muscle Invasion in Canine Urothelial Carcinoma.
    J Comp Pathol. 2019;169:35-46.
    Abstract     Related articles   

  62. NAGAI T, Okamura T, Tanaka Y, Moritoki Y, et al
    Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guerin Therapy
    Asian Pac J Cancer Prev. 2019;20:1389-1392.
    Abstract     Related articles   

  63. ARSHAD Z, Zaidi SZ
    Urothelial carcinoma in children, case report with review of literature.
    J Pak Med Assoc. 2019;69:720-721.
    Abstract     Related articles   

  64. GONDKAR K, Patel K, Krishnappa S, Patil A, et al
    E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
    Cancer Biomark. 2019;25:223-232.
    Abstract     Related articles   

  65. MAURIZI P, Capozza MA, Triarico S, Perrotta ML, et al
    Relapsed papillary urothelial neoplasm of low malignant potential (PUNLMP) of the young age: a case report and a review of the literature.
    BMC Urol. 2019;19:36.
    Abstract     Related articles   

  66. KUANG S, Li H, Feng J, Xu S, et al
    Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
    Cancer Biomark. 2019;25:203-212.
    Abstract     Related articles   

  67. HUANG H, Yan B, Shang M, Liu L, et al
    Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution.
    BMC Urol. 2019;19:28.
    Abstract     Related articles   

  68. OEDORF K, Skaaheim Haug E, Liedberg F, Jarvinen R, et al
    Perioperative management of radical cystectomy in the Nordic countries.
    Scand J Urol. 2019;53:51-55.
    Abstract     Related articles   

  69. ZHAO P
    Urine cytology of metastatic breast lobular carcinoma.
    Diagn Cytopathol. 2019;47:738-739.
    Abstract     Related articles   

  70. BARCHETTI G, Simone G, Ceravolo I, Salvo V, et al
    Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Eur Radiol. 2019;29:5498-5506.
    Abstract     Related articles   

  71. ADAMS EJ, Amerine LB
    Process improvement strategy to prepare and administer bacillus Calmette-Guerin vaccine in compliance with United States Pharmacopeia chapter 800 standards.
    Am J Health Syst Pharm. 2019;76:613-616.
    Abstract     Related articles   

  72. DE PALMA G, Di Lorenzo VF, Krol S, Paradiso AV, et al
    Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract.
    Int J Biol Markers. 2019;34:101-107.
    Abstract     Related articles   

  73. SHELEKHOVA KV, Krykow KA, Mescherjakov IA, Mitin NP, et al
    Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Int J Surg Pathol. 2019;27:483-491.
    Abstract     Related articles   

  74. DEGBOE A, Ivanescu C, Rohay JM, Turner RR, et al
    Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
    Support Care Cancer. 2019;27:4189-4198.
    Abstract     Related articles   

  75. MIYAKE M, Furuya H, Onishi S, Hokutan K, et al
    Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth.
    Theranostics. 2019;9:853-867.
    Abstract     Related articles   

  76. CIMADAMORE A, Palagonia E, Piccinni P, Misericordia M, et al
    Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer.
    Urologia. 2019;86:35-38.
    Abstract     Related articles   

  77. UGATA K, Imamachi N, Hashimoto A, Saito Y, et al
    Anesthetic Management in an Adult Patient With Costello Syndrome: A Case Report.
    A A Pract. 2019;13:41-43.
    Abstract     Related articles   

  78. KADHIM A, McKenzie LK, Bryant HE, Twyman LJ, et al
    Synthesis and Aggregation of a Porphyrin-Cored Hyperbranched Polyglycidol and Its Application as a Macromolecular Photosensitizer for Photodynamic Therapy.
    Mol Pharm. 2019;16:1132-1139.
    Abstract     Related articles   

  79. ANAGNOSTOPOULOS I, Lagou S, Papatheodoridi M, Marinos L, et al
    A rare case of bone marrow BCG-itis responding to second-line anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2019;23:119-120.
    Abstract     Related articles   

  80. MALMSTROM PU, Skaaheim Haug E, Bostrom PJ, Gudjonsson S, et al
    Progress towards a Nordic standard for the investigation of hematuria: 2019.
    Scand J Urol. 2019;53:1-6.
    Abstract     Related articles   

  81. LIANG X, Hu X, Hu Y, Zeng W, et al
    Recovery and functionality of cryopreserved peripheral blood mononuclear cells using five different xeno-free cryoprotective solutions.
    Cryobiology. 2019;86:25-32.
    Abstract     Related articles   

  82. ZHOU Z, Zhao S, Lu Y, Wu J, et al
    Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors.
    World J Urol. 2019;37:1075-1084.
    Abstract     Related articles   

  83. WANG D, Sule N
    Mucinous Cystadenoma of the Urachus and Review of Current Classification of Urachal Mucinous Cystic Neoplasms.
    Arch Pathol Lab Med. 2019;143:258-263.
    Abstract     Related articles   

  84. SHIM JS, Seo HK, Ku JH, Jeong BC, et al
    Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea.
    Cancer Res Treat. 2019;51:1064-1072.
    Abstract     Related articles   

  85. TAN X, Broses LJ, Zhou M, Day KC, et al
    Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice.
    Lab Chip. 2020 Jan 10. doi: 10.1039/c9lc01006.
    Abstract     Related articles   

  86. AKAND M, Muilwijk T, Cornelissen J, Van Bruwaene S, et al
    Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System.
    Front Oncol. 2019;9:1402.
    Abstract     Related articles   

  87. BATISTA R, Vinagre J, Prazeres H, Sampaio C, et al
    Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
    Front Genet. 2019;10:1237.
    Abstract     Related articles   

  88. WANG K, Lu H, Qu H, Xie Q, et al
    miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.
    Onco Targets Ther. 2019;12:11453-11464.
    Abstract     Related articles   

  89. LIU W, Tian J, Zhang S, Yang E, et al
    The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Minerva Urol Nefrol. 2020 Jan 7. pii: S0393-2249.19.03648.
    Abstract     Related articles   

  90. GAO X, Zhang S
    [Research progress in mechanisms for drug-resistance and recurrence in bladder cancer].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:1287-1293.
    Abstract     Related articles   

  91. WANG Y, Zhu W, Chen X, Wei G, et al
    Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
    J Transl Med. 2020;18:17.
    Abstract     Related articles   

  92. WEI S, Gao J, Zhang M, Dou Z, et al
    Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer.
    Biomed Pharmacother. 2020;122:109473.
    Abstract     Related articles   

  93. DANFORTH KN, Luong TQ, Yi DK, Yamamoto A, et al
    Disparities in Stage at Diagnosis in an Equal-access Integrated Delivery System: A Retrospective Cohort Study of 7244 Patients With Bladder Cancer.
    Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30271.
    Abstract     Related articles   

  94. MACLEOD LC, Fam MM, Yabes JG, Hale NE, et al
    Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Dec 14. pii: S1558-7673(19)30384.
    Abstract     Related articles   

  95. SHEN Y, Lu Q, Ye H, Deng Z, et al
    Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study.
    Medicine (Baltimore). 2020;99:e18725.
    Abstract     Related articles   

  96. SCHMIDT S, Kunath F, Coles B, Draeger DL, et al
    Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Cochrane Database Syst Rev. 2020;1:CD011935.
    Abstract     Related articles   

  97. LEI T, Zhou S, Meng Q, Zhang M, et al
    STAT3 signaling pathway in drug-resistant bladder cancer cell line.
    J Biol Regul Homeost Agents. 2019;33:1347-1357.
    Abstract     Related articles   

  98. AGREDA CASTANEDA F, Raventos Busquets CX, Morote Robles J
    Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder Cancer.
    Clin Genitourin Cancer. 2019 Dec 4. pii: S1558-7673(19)30352.
    Abstract     Related articles   

  99. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.
    Biomark Cancer. 2019;11:1179299X19897255.
    Abstract     Related articles   

  100. FURUYA H, Chan OTM, Hokutan K, Tsukikawa Y, et al
    Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma.
    Diagnostics (Basel). 2019;10.
    Abstract     Related articles   

  101. DILER SB, Polat F, Bingol G
    The MNS16A VNTR polymorphism of the TERT gene in bladder cancer.
    Turk J Urol. 2019;46:44-49.
    Abstract     Related articles   

  102. FERNANDEZ-CONEJO G, de la Pena E, Hernandez V, Guijarro A, et al
    The value of tumour weight as a predictive factor for recurrence and progression in non-muscle invasive bladder cancer.
    Scand J Urol. 2020 Jan 6:1-6. doi: 10.1080/21681805.2019.1708968.
    Abstract     Related articles   

  103. TANG Z, Gillatt D, Rowe E, Koupparis A, et al
    IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.
    Oncotarget. 2019;10:7043-7057.
    Abstract     Related articles   

  104. ZHANG D, Yao L, Yu S, Cheng Y, et al
    Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis.
    World J Surg Oncol. 2020;18:4.
    Abstract     Related articles   

  105. CHEN Y, Zhang W, Kadier A, Zhang H, et al
    MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer.
    J Clin Lab Anal. 2020 Jan 3:e23193. doi: 10.1002/jcla.23193.
    Abstract     Related articles   

  106. AYDIN AM, Baydar DE, Hazir B, Babaoglu B, et al
    Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.
    World J Urol. 2020 Jan 3. pii: 10.1007/s00345-019-03065.
    Abstract     Related articles   

  107. DAI R, Zhou Y, Chen Z, Zou Z, et al
    Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
    J Cell Biochem. 2020 Jan 3. doi: 10.1002/jcb.29626.
    Abstract     Related articles   

  108. LIU Y, Lin F, Chen Y, Wang R, et al
    Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway.
    J Cancer. 2020;11:488-499.
    Abstract     Related articles   

  109. ZHANG Z, Mao W, Wang L, Liu M, et al
    Depletion of CDC5L inhibits bladder cancer tumorigenesis.
    J Cancer. 2020;11:353-363.
    Abstract     Related articles   

  110. TIAN J, Fan J, Xu J, Ren T, et al
    circ-FNTA accelerates proliferation and invasion of bladder cancer.
    Oncol Lett. 2020;19:1017-1023.
    Abstract     Related articles   

  111. GUSZCZ T, Szymanska B, Kozlowski R, Lukaszewski Z, et al
    Plasma aromatase as a sensitive and selective potential biomarker of bladder cancer and its role in tumorigenesis.
    Oncol Lett. 2020;19:562-568.
    Abstract     Related articles   

  112. PIAO XM, Jeong P, Yan C, Kim YH, et al
    A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer.
    Oncol Lett. 2020;19:476-486.
    Abstract     Related articles   

  113. GAN D, He W, Yin H, Gou X, et al
    beta-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway.
    Oncol Lett. 2020;19:291-300.
    Abstract     Related articles   

  114. ZHANG R, Wang J, Jia E, Zhang J, et al
    lncRNA BCAR4 sponges miR3703p to promote bladder cancer progression via Wnt signaling.
    Int J Mol Med. 2019 Dec 27. doi: 10.3892/ijmm.2019.4444.
    Abstract     Related articles   

  115. CHEN MK, Chen ZJ, Xiao KH, Qin ZK, et al
    Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
    Jpn J Clin Oncol. 2020 Jan 2. pii: 5688862. doi: 10.1093.
    Abstract     Related articles   

  116. ZHAO D, Peng Q, Wang L, Li C, et al
    Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients.
    J Cancer. 2020;11:108-120.
    Abstract     Related articles   

  117. LIAO C, Long Z, Zhang X, Cheng J, et al
    LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
    Int J Biol Sci. 2020;16:1-11.
    Abstract     Related articles   

  118. FAN J, Liu Y, Liu L, Huang Y, et al
    A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy.
    ACS Synth Biol. 2020 Jan 10. doi: 10.1021/acssynbio.9b00349.
    Abstract     Related articles   

  119. KIMURA S, Iwata T, Abufaraj M, Janisch F, et al
    Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2019 Dec 5. pii: S1558-7673(19)30358.
    Abstract     Related articles   

  120. REIS H, Mairinger F, Ting S, Nagy N, et al
    [Urachal Cancer: an update of current molecular findings].
    Pathologe. 2019;40.
    Abstract     Related articles   

  121. LEE D, Zimmern P
    Management of Pelvic Organ Prolapse After Radical Cystectomy.
    Curr Urol Rep. 2019;20:71.
    Abstract     Related articles   

  122. ROPERTO S, De Falco F, Perillo A, Catoi C, et al
    Mitophagy mediated by BNIP3 and BNIP3L/NIX in urothelial cells of the urinary bladder of cattle harbouring bovine papillomavirus infection.
    Vet Microbiol. 2019;236:108396.
    Abstract     Related articles   

  123. KAUR S, Gupta A, Gulwani HV
    A clinicopathological and immunohistochemical study of non-urothelial bladder tumours.
    Indian J Cancer. 2019;56:254-260.
    Abstract     Related articles   

  124. HUTTERER GC
    Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  125. KANEHIRA K, Yano Y, Hasumi H, Fukuhara H, et al
    Fluorescence Enhancement Effect of TiO2 Nanoparticles and Application for Photodynamic Diagnosis.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  126. RAZAFIMAHEFA J, Gosset C, Mongiat-Artus P, Andriamampionona TF, et al
    Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
    Diagn Pathol. 2019;14:75.
    Abstract     Related articles   

  127. KRATIRAS Z, Spapis V, Koniaris E, Kozyrakis D, et al
    Malignant solitary fibrous tumor of urinary bladder: A rare clinical entity.
    Arch Ital Urol Androl. 2019;91.
    Abstract     Related articles   

  128. PARMAR KM, Sharma G, Rai T
    Urinary bladder mass with emphysematous cystitis: double whammy.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  129. FA'AK F, Vanegas D, Osei KM
    A Case Report of Atezolizumab Induced Tumor Lysis Syndrome.
    Am J Case Rep. 2019;20:785-789.
    Abstract     Related articles   

  130. HAMLIN AN, Chadwick LE, Fox-Alvarez SA, Hostnik ET, et al
    Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
    Vet Radiol Ultrasound. 2019;60:552-559.
    Abstract     Related articles   

  131. KUMARI K, Pradeep I, Kakkar A, Dinda AK, et al
    BK polyomavirus and urothelial carcinoma: Experience at a tertiary care centre in India with review of literature.
    Ann Diagn Pathol. 2019;40:77-80.
    Abstract     Related articles   

  132. HOSSEINI A, Ebbing J, Collins J
    Clinical outcomes of robot-assisted radical cystectomy and continent urinary diversion.
    Scand J Urol. 2019;53.
    Abstract     Related articles   

  133. SANGUEDOLCE F, Russo D, Calo B, Cindolo L, et al
    Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.
    Pathol Res Pract. 2019;215:152413.
    Abstract     Related articles   

  134. ZHU D, Singh S, Chen X, Zheng Z, et al
    The landscape of chimeric RNAs in bladder urothelial carcinoma.
    Int J Biochem Cell Biol. 2019;110:50-58.
    Abstract     Related articles   

  135. PALANGI A, Shakhssalim N, Parvin M, Bayat S, et al
    Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.
    Clin Transl Oncol. 2019;21:1240-1249.
    Abstract     Related articles   

  136. LIN G, Ye H, Wang J, Chen S, et al
    Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Nephron. 2019;141:256-264.
    Abstract     Related articles   

  137. WANG G, McKenney JK
    Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging Update.
    Arch Pathol Lab Med. 2019;143:571-577.
    Abstract     Related articles   

  138. HELLMAN JB, Traynis I, Lin LK
    Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia.
    Orbit. 2019;38:244-247.
    Abstract     Related articles   

  139. KONG VC, Taylor A, Chung P, Craig T, et al
    Comparison of 3 image-guided adaptive strategies for bladder locoregional radiotherapy.
    Med Dosim. 2019;44:111-116.
    Abstract     Related articles   

  140. JAWORSKI D, Szylberg L, Gzil A, Stawinski P, et al
    Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
    Ann Diagn Pathol. 2019;40:182-188.
    Abstract     Related articles   

  141. SOLIMAN MM, Cornman-Homonoff J, Schiffman MH
    Incidental sonographic detection of bladder cancer in a woman with large uterine fibroids: significance and lessons learned.
    Clin Imaging. 2020;61:1-3.
    Abstract     Related articles   

  142. SIRACUSANO S, Rizzetto R, Porcaro AB
    Bladder cancer genomics.
    Urologia. 2020 Jan 16:391560319899011. doi: 10.1177/0391560319899011.
    Abstract     Related articles   

  143. WALKER AK, Na J, Browning L, Humayun-Zakaria N, et al
    MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation.
    Bladder Cancer. 2019;5:147-157.
    Abstract     Related articles   

  144. BATISTA R, Vinagre N, Meireles S, Vinagre J, et al
    Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  145. CAO Y, Tian T, Li W, Xu H, et al
    Long non-coding RNA in bladder cancer.
    Clin Chim Acta. 2020 Jan 12. pii: S0009-8981(20)30017.
    Abstract     Related articles   

  146. BERMUDEZ-ORIA A, Rodriguez-Gutierrez G, Rubio-Senent F, Sanchez-Carbayo M, et al
    Antiproliferative Activity of the Olive Extract Rich in Polyphenols and Modified Pectin on Bladder Cancer Cells.
    J Med Food. 2020 Jan 15. doi: 10.1089/jmf.2019.0136.
    Abstract     Related articles   

  147. EVLAMPIDOU I, Font-Ribera L, Rojas-Rueda D, Gracia-Lavedan E, et al
    Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union.
    Environ Health Perspect. 2020;128:17001.
    Abstract     Related articles   

  148. OU Z, Li K, Yang T, Dai Y, et al
    Detection of bladder cancer using urinary cell-free DNA and cellular DNA.
    Clin Transl Med. 2020;9:4.
    Abstract     Related articles   

  149. MEZHEYEUSKI A, Segersten U, Leiss LW, Malmstrom PU, et al
    Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.
    Sci Rep. 2020;10:281.
    Abstract     Related articles   

  150. MOUSTAKAS G, Kampantais S, Nikolaidou A, Vakalopoulos I, et al
    HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.
    J Int Med Res. 2020;48:300060519895847.
    Abstract     Related articles   

  151. CHEN M, Zhang S, Wen X, Cao H, et al
    Prognostic value of CLIC3 mRNA overexpression in bladder cancer.
    PeerJ. 2020;8:e8348.
    Abstract     Related articles   

  152. AL-MAGHRABI JA, Qureshi IA, Khabaz MN
    Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer.
    Int J Clin Exp Pathol. 2019;12:3049-3057.
    Abstract     Related articles   

  153. PAN J, Xie X, Li H, Li Z, et al
    Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence.
    Int J Clin Exp Pathol. 2019;12:2951-2958.
    Abstract     Related articles   

  154. CHEN X, Li S, Yu Z, Tan W, et al
    Yes-associated protein 1 promotes bladder cancer invasion by regulating epithelial-mesenchymal transition.
    Int J Clin Exp Pathol. 2019;12:1070-1077.
    Abstract     Related articles   

  155. YANG K, Tang H, Ding M, Guo Y, et al
    Expression of miR-195 and MEK1 in patients with bladder cancer and their relationship to prognosis.
    Int J Clin Exp Pathol. 2019;12:843-850.
    Abstract     Related articles   

  156. ZHAO W, Li W, Jin X, Niu T, et al
    Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy.
    Int J Clin Exp Pathol. 2019;12:549-558.
    Abstract     Related articles   

  157. CHEN H, Xu L, Wang L
    Expression of miR-182 and Foxo3a in patients with bladder cancer correlate with prognosis.
    Int J Clin Exp Pathol. 2019;12:4193-4203.
    Abstract     Related articles   

  158. SOGA N, Furusawa J, Ogura Y
    Long-Term Management of Incidental Bladder Cancer Detected in Patients Undergoing Prostatectomy for Prostate Cancer.
    Curr Urol. 2019;13:145-149.
    Abstract     Related articles   

  159. MITA K, Kobatake K, Ohara S, Kato M, et al
    [Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging].
    Hinyokika Kiyo. 2019;65:501-506.
    Abstract     Related articles   

  160. BOTHIG R, Tiburtius C, Fiebag K, Kowald B, et al
    Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database.
    World J Urol. 2020 Jan 13. pii: 10.1007/s00345-020-03077.
    Abstract     Related articles   

  161. WOOLBRIGHT BL, Pilbeam CC, Taylor JA 3rd
    Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.
    Prostaglandins Other Lipid Mediat. 2020 Jan 10:106409.
    Abstract     Related articles   

  162. WU Z, Wang M, Liu Q, Liu Y, et al
    Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
    Int J Med Sci. 2020;17:89-96.
    Abstract     Related articles   

  163. PICH J
    Perioperative nutrition for the treatment of bladder cancer by radical cystectomy: A Cochrane review summary.
    Int J Nurs Stud. 2019 Dec 19:103505. doi: 10.1016/j.ijnurstu.2019.103505.
    Abstract     Related articles   

  164. MATSUOKA Y, Taoka R, Xia Z, Sugimoto M, et al
    Hyperthermic therapy using warm sterile water enhances cytocidal effects on bladder cancer cells.
    Scand J Urol. 2020 Jan 13:1-5. doi: 10.1080/21681805.2019.1708967.
    Abstract     Related articles   

  165. YU EYW, Dai Y, Wesselius A, van Osch F, et al
    Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study.
    Eur J Epidemiol. 2020 Jan 11. pii: 10.1007/s10654-019-00597.
    Abstract     Related articles   

  166. MURAKAMI Y, Kobayashi T, Naruse Y, Goto T, et al
    [Metastatic Brain Tumor from Urachal Cancer:A Case Report].
    No Shinkei Geka. 2019;47:1269-1274.
    Abstract     Related articles   

  167. KHOO ACH, Tang WH
    Renal Pelvis Urothelial Carcinoma With Bowel Metastases.
    Clin Nucl Med. 2019;44:983-984.
    Abstract     Related articles   

  168. LIU C, Tate T, Batourina E, Truschel ST, et al
    Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells.
    Nat Commun. 2019;10:4589.
    Abstract     Related articles   

  169. MUNOZ MOYA JE, Alfaro Aguirre MO, Leiva Silva M, Kakarieka Weisskopf E, et al
    [Inflammatory myofibroblastic tumor: Variable presentation of the same pathology].
    Rev Chil Pediatr. 2019;90:328-335.
    Abstract     Related articles   

  170. SEKIGUCHI K, Hashimoto R, Noda Y, Tachibana H, et al
    Diaphragm involvement in immune checkpoint inhibitor-related myositis.
    Muscle Nerve. 2019;60:E23-E25.
    Abstract     Related articles   

  171. WANG T, Ding Y, Yang Y, Wang Z, et al
    Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Biomed Pharmacother. 2019;115:108899.
    Abstract     Related articles   

  172. TRANKENSCHUH W, Biesdorf AS, Papadimas N, Samara S, et al
    Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.
    Int J Surg Pathol. 2019;27:684-692.
    Abstract     Related articles   

  173. HAN L, Gallan A, Paner GP
    Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion.
    Am J Surg Pathol. 2019;43:475-479.
    Abstract     Related articles   

  174. DUNCAN C, Joon DL, Lawrentschuk N, Jenkins T, et al
    Fiducial markers: can the urologist do better?
    World J Urol. 2019;37:1281-1287.
    Abstract     Related articles   

  175. AYATI M, Amini E, Shahrokhi Damavand R, Nowroozi MR, et al
    Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Urol J. 2019;16:152-156.
    Abstract     Related articles   

  176. LIU Z, Yan H, Yang Y, Wei L, et al
    Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
    Biomed Pharmacother. 2020;124:109830.
    Abstract     Related articles   

  177. YING Y, Li J, Xie H, Yan H, et al
    CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
    Cell Prolif. 2020 Jan 23:e12751. doi: 10.1111/cpr.12751.
    Abstract     Related articles   

  178. XU S, Tan S, Wu T, Gu J, et al
    The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer.
    Lasers Med Sci. 2020 Jan 22. pii: 10.1007/s10103-020-02960.
    Abstract     Related articles   

  179. LIU T, Lu Q, Liu J, Xie S, et al
    Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating NP63 by sponging miR-762.
    Cell Death Dis. 2020;11:47.
    Abstract     Related articles   

  180. XIE Y, Xu P, Wang M, Zheng Y, et al
    Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  181. LI T, Jiang D, Wu K
    p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
    Cancer Sci. 2020 Jan 22. doi: 10.1111/cas.14321.
    Abstract     Related articles   

  182. HUDOLIN T, Kastelan Z, El-Saleh A, Bakula M, et al
    Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer.
    Oncol Lett. 2020;19:1291-1297.
    Abstract     Related articles   

  183. FU L, Zhang J, Li L, Yang Y, et al
    Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
    Oncol Lett. 2020;19:1165-1174.
    Abstract     Related articles   

  184. ABUFARAJ M, Shariat S, Moschini M, Rohrer F, et al
    The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II.
    Int J Epidemiol. 2020 Jan 21. pii: 5713010. doi: 10.1093.
    Abstract     Related articles   

  185. ABUGOMAA A, Elbadawy M, Yamawaki H, Usui T, et al
    Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  186. GUERRERO ORRIACH JL, Raigon Ponferrada A, Malo Manso A, Herrera Imbroda B, et al
    Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia.
    Oncology. 2020 Jan 21:1-7. doi: 10.1159/000504807.
    Abstract     Related articles   

  187. HAMAD J, McCloskey H, Milowsky MI, Royce T, et al
    Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  188. ROSENBLATT R, Lorentzi G, Bahar M, Asad D, et al
    Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
    Scand J Urol. 2020 Jan 21:1-6. doi: 10.1080/21681805.2020.1716067.
    Abstract     Related articles   

  189. ZHANG L, Xia HB, Zhao CY, Shi L, et al
    Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Eur Rev Med Pharmacol Sci. 2020;24:86-96.
    Abstract     Related articles   

  190. WANG F, Wu H, Fan M, Yu R, et al
    Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells.
    FASEB J. 2020 Jan 19. doi: 10.1096/fj.201902626.
    Abstract     Related articles   

  191. WANG T, Luo R, Li W, Yan H, et al
    Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21.
    J Cancer. 2020;11:1115-1124.
    Abstract     Related articles   

  192. CHEN C, Huang H, Zhao Y, Liu H, et al
    Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer.
    J Cancer. 2020;11:1082-1093.
    Abstract     Related articles   

  193. CAJIPE M, Wang H, Elshabrawy A, Kaushik D, et al
    Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only.
    Urol Oncol. 2020 Jan 16. pii: S1078-1439(19)30506.
    Abstract     Related articles   

  194. SCHULZ GB, Grimm T, Buchner A, Jokisch F, et al
    Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30312.
    Abstract     Related articles   

  195. MIYATA H, Osawa T, Abe T, Kikuchi H, et al
    The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2020 Jan 19. pii: 5709020. doi: 10.1093.
    Abstract     Related articles   

  196. AFONSO J, Santos LL, Longatto-Filho A, Baltazar F, et al
    Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
    Nat Rev Urol. 2020 Jan 17. pii: 10.1038/s41585-019-0263.
    Abstract     Related articles   

  197. MATULEWICZ RS, Rademaker A, Meeks JJ
    A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.
    Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30497.
    Abstract     Related articles   

  198. OZAYDIN S, Atas E, Karadurmus N, Emirzeoglu L, et al
    Outcomes of bladder preservation therapy on survival in patients with muscle-invasive bladder cancer.
    Arch Esp Urol. 2020;73:41-46.
    Abstract     Related articles   

  199. YU X, Wang R, Han C, Wang Z, et al
    A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis.
    J Cancer. 2020;11:781-787.
    Abstract     Related articles   

  200. HIRABAYASHI N, Nishizawa O, Kobayashi N, Ikeyama M, et al
    [Inverted Variant of Urothelial Carcinoma of the Urinary Bladder : A Case Report].
    Hinyokika Kiyo. 2019;65:463-467.
    Abstract     Related articles   

  201. KANNO T, Inoue T, Ito K, Kono Y, et al
    [The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort].
    Hinyokika Kiyo. 2019;65:439-444.
    Abstract     Related articles   

  202. SIKIC D, Richterstetter M, Wullich B, Apel H, et al
    [Renal transplantation in urinary diversions].
    Urologe A. 2020;59:27-31.
    Abstract     Related articles   

  203. GARRIDO-ABAD P, Martin LG, Zarra KV, Menendez AD, et al
    Metastatic non-muscle invasive bladder can-cer with cervical lymph node metastasis.
    Int Braz J Urol. 2019;45:1270-1274.
    Abstract     Related articles   

  204. KORKES F, Palou J
    High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients.
    Int Braz J Urol. 2019;45:1090-1093.
    Abstract     Related articles   

  205. THOMA C
    PD-L1 and BCG response prediction.
    Nat Rev Urol. 2020;17:8.
    Abstract     Related articles   

  206. MORALES J, Malles A, Kimble M, Rodriguez de la Vega P, et al
    Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?
    Int J Environ Res Public Health. 2019;16.
    Abstract     Related articles   

  207. PIERANTONI F, Maruzzo M, Gardi M, Bezzon E, et al
    Immunotherapy and urothelial carcinoma: An overview and future prospectives.
    Crit Rev Oncol Hematol. 2019;143:46-55.
    Abstract     Related articles   

  208. EL HUSSEIN S, Colanta A, Khader SN
    Revisiting cercariform cells: Small cell carcinoma masquerading as cercariform cells.
    Diagn Cytopathol. 2019;47:1072-1075.
    Abstract     Related articles   

  209. FINOTELLO R, Schiavo L, Ressel L, Frohmader A, et al
    Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
    J Comp Pathol. 2019;170:1-9.
    Abstract     Related articles   

  210. AKHTAR M, Al-Bozom IA, Ben Gashir M, Taha NM, et al
    Urothelial Carcinoma In Situ (CIS): New Insights.
    Adv Anat Pathol. 2019;26:313-319.
    Abstract     Related articles   

  211. YORITA K
    Clinical evaluation of ureteral pseudodiverticulosis.
    Abdom Radiol (NY). 2019;44:2676.
    Abstract     Related articles   

  212. MORGAN MA, Zafar HM, Papanicolaou N, Ramchandani P, et al
    Reply to letter to the editor: "clinical evaluation of ureteral pseudodiverticulosis".
    Abdom Radiol (NY). 2019;44:2677.
    Abstract     Related articles   

  213. PROSKOKOV AA, Darenkov SP, Agabekian AA, Trofimchuk AD, et al
    [Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer].
    Urologiia. 2020;:120-124.
    Abstract     Related articles   

  214. RIPAMONTI E, Azoulay L, Abrahamowicz M, Platt RW, et al
    Pioglitazone and bladder cancer: improving research methods.
    Diabet Med. 2020 Jan 29. doi: 10.1111/dme.14248.
    Abstract     Related articles   

  215. IIDA K, Naiki T, Naiki-Ito A, Suzuki S, et al
    Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway.
    Cancer Sci. 2020 Jan 29. doi: 10.1111/cas.14334.
    Abstract     Related articles   

  216. ELAMIN AA, Klunkelfuss S, Kampfer S, Oehlmann W, et al
    A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection.
    Front Oncol. 2020;9:1484.
    Abstract     Related articles   

  217. ALAVI A, Izadpanahi MH, Haghshenas L, Faridizad R, et al
    Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer.
    Int J Physiol Pathophysiol Pharmacol. 2019;11:289-292.
    Abstract     Related articles   

  218. HOURIGAN SK, Zhu W, S W Wong W, Clemency NC, et al
    Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
    BMC Urol. 2020;20:5.
    Abstract     Related articles   

  219. WU W, Jing Y, Xu Q, Hao J, et al
    MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway.
    Panminerva Med. 2020 Jan 24. pii: S0031-0808.19.03818.
    Abstract     Related articles   

  220. MANDELLI GE, Missale F, Bresciani D, Gatta LB, et al
    Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  221. ZHANG C, Berndt-Paetz M, Neuhaus J
    Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  222. MAINWARING A, Bullock N, Ellul T, Hughes O, et al
    THE TOP 100 MOST CITED MANUSCRIPTS IN BLADDER CANCER: A BIBLIOMETRIC ANALYSIS (Review article).
    Int J Surg. 2020 Jan 25. pii: S1743-9191(20)30138.
    Abstract     Related articles   

  223. JORGENSEN KR, Jensen JB
    Human papillomavirus and urinary bladder cancer revisited.
    APMIS. 2020 Jan 28. doi: 10.1111/apm.13016.
    Abstract     Related articles   

  224. FUKUSHIMA H, Moriyama S, Waseda Y, Fukuda S, et al
    Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2020 Jan 24. pii: S2405-4569(20)30022.
    Abstract     Related articles   

  225. GAKIS G
    Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
    Eur Urol Focus. 2020 Jan 24. pii: S2405-4569(20)30023.
    Abstract     Related articles   

  226. HORWICH A, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
    Ann Oncol. 2019;30:1697-1727.
    Abstract     Related articles   

  227. MURTHY V
    International consensus for advanced bladder cancer: an opportunity between the lines.
    Ann Oncol. 2019;30:1688-1690.
    Abstract     Related articles   

  228. HAN YH, Sun GL, Wan Y, Xiong H, et al
    Structural maintenance of chromosomes 2 is identified as an oncogene in bladder cancer in vitro and in vivo.
    Neoplasma. 2020 Jan 27. pii: 190510N419. doi: 10.4149/neo_2020_190510.
    Abstract     Related articles   

  229. KAPOOR K, Datta C, Pal DK
    Immunocytochemical detection of minichromosome maintenance protein 2 as a potential urinary-based marker of bladder cancer: A prospective observational study.
    Indian J Urol. 2020;36:32-36.
    Abstract     Related articles   

  230. AWADALLA A, Abol-Enein H, Gabr MM, Hamam ET, et al
    Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells.
    Urol Oncol. 2020 Jan 23. pii: S1078-1439(19)30489.
    Abstract     Related articles   

  231. AU S, Keyes M, Black P, Villamil CF, et al
    Clinical and pathological characteristics of bladder cancer in post brachytherapy patients.
    Pathol Res Pract. 2020 Jan 10:152822. doi: 10.1016/j.prp.2020.152822.
    Abstract     Related articles   

  232. LORENCIN I, Andelic N, Spanjol J, Car Z, et al
    Using multi-layer perceptron with Laplacian edge detector for bladder cancer diagnosis.
    Artif Intell Med. 2020;102:101746.
    Abstract     Related articles   

  233. LOFFEL LM, Furrer MA, Favre A, Engel D, et al
    Intra-operative norepinephrine administration and cancer-related outcomes following radical cystectomy for bladder cancer: A cohort study.
    Eur J Anaesthesiol. 2020 Jan 23. doi: 10.1097/EJA.0000000000001155.
    Abstract     Related articles   

  234. CHEHROUDI AC, Black P
    Emerging intravesical therapies for the management of bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward.
    Can Urol Assoc J. 2020 Jan 20. pii: cuaj.6101. doi: 10.5489/cuaj.6101.
    Abstract     Related articles   

  235. TRENTI E, Pycha S, Mian C, Schwienbacher C, et al
    Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
    Cancer Cytopathol. 2020 Jan 24. doi: 10.1002/cncy.22246.
    Abstract     Related articles   

  236. D'ANDREA D, Soria F, Zehetmayer S, Stangl-Kremser J, et al
    Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.
    Scand J Urol. 2020 Jan 24:1-6. doi: 10.1080/21681805.2019.1711160.
    Abstract     Related articles   

  237. TAARNHOJ GA, Johansen C, Pappot H
    Correction to: Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
    Health Qual Life Outcomes. 2020;18:15.
    Abstract     Related articles   

  238. YAMADA S, Osawa T, Abe T, Takada N, et al
    [The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder].
    Hinyokika Kiyo. 2019;65:495-499.
    Abstract     Related articles   

  239. SCHROEDER SR, Albuquerque K
    Clear Cell Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;105:690-691.
    Abstract     Related articles   

  240. LANG K, Kahveci S, Bonberg N, Wichert K, et al
    TGFBI Protein Is Increased in the Urine of Patients with High-Grade Urothelial Carcinomas, and Promotes Cell Proliferation and Migration.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  241. MINNULLINA L, Pudova D, Shagimardanova E, Shigapova L, et al
    Comparative Genome Analysis of Uropathogenic Morganella morganii Strains.
    Front Cell Infect Microbiol. 2019;9:167.
    Abstract     Related articles   

  242. FLIPPOT R, Beinse G, Boileve A, Vibert J, et al
    Long non-coding RNAs in genitourinary malignancies: a whole new world.
    Nat Rev Urol. 2019;16:484-504.
    Abstract     Related articles   

  243. ALLISON DB, VandenBussche CJ
    A Review of Urine Ancillary Tests in the Era of the Paris System.
    Acta Cytol. 2020;64.
    Abstract     Related articles   

  244. SALTAOURAS G, Lightowler H, Coe S, Brett J, et al
    Availability and quality assessment of online nutrition information materials for pelvic cancer patients in the UK.
    Eur J Cancer Care (Engl). 2019;28:e13039.
    Abstract     Related articles   

  245. LYON TD, Boorjian SA, Shah PH, Tarrell R, et al
    Comprehensive characterization of perioperative reoperation following radical cystectomy.
    Urol Oncol. 2019;37:292.
    Abstract     Related articles   

  246. HIZLI F, Argun G, Guney I, Guven O, et al
    Retraction Note: Obturator nerve block transurethral surgery for bladder cancer: comparison of inguinal and intravesical approaches: prospective randomized trial.
    Ir J Med Sci. 2020 Feb 7. pii: 10.1007/s11845-020-02194.
    Abstract     Related articles   

  247. WANG C, Hamacher A, Petzsch P, Kohrer K, et al
    Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  248. JUE JS, Koru-Sengul T, Miao F, Velasquez MC, et al
    Neoadjuvant vs adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis.
    Minerva Urol Nefrol. 2020 Jan 30. pii: S0393-2249.19.03657.
    Abstract     Related articles   

  249. CLAPS F, Pavan N, Umari P, Rizzo M, et al
    Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer.
    Minerva Urol Nefrol. 2020 Jan 30. pii: S0393-2249.20.03646.
    Abstract     Related articles   

  250. FURUYA H, Hayashi K, Shimizu Y, Kim N, et al
    Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model.
    J Transl Med. 2020;18:57.
    Abstract     Related articles   

  251. BATISTA R, Lima L, Vinagre J, Pinto V, et al
    TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  252. TIMOTEO F, Korkes F, Baccaglini W, Glina S, et al
    Bladder cancer trends and mortality in the brazilian public health system.
    Int Braz J Urol. 2020;46:224-233.
    Abstract     Related articles   

  253. FAVORITO LA
    Bladder Cancer highlighted.
    Int Braz J Urol. 2020;46:150-151.
    Abstract     Related articles   

  254. ZHOU L, Liang X, Zhang K
    Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
    Aging Male. 2020 Feb 5:1-12. doi: 10.1080/13685538.2020.1718637.
    Abstract     Related articles   

  255. BOTHIG R, Schops W, Zellner M, Fiebag K, et al
    [Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association].
    Urologe A. 2020 Feb 4. pii: 10.1007/s00120-020-01124.
    Abstract     Related articles   

  256. SU Y, Feng W, Shi J, Chen L, et al
    circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-beta2/smad3 pathway.
    Mol Cancer. 2020;19:23.
    Abstract     Related articles   

  257. ZHAN Y, Chen Z, He S, Gong Y, et al
    Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
    Mol Cancer. 2020;19:25.
    Abstract     Related articles   

  258. HAO L, Pang K, Pang H, Zhang J, et al
    Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  259. DENG M, Cao X, Guo L, Cao H, et al
    Graphene quantum dots: efficient mechanosynthesis, white-light and broad linear excitation-dependent photoluminescence and growth inhibition of bladder cancer cells.
    Dalton Trans. 2020 Feb 4. doi: 10.1039/c9dt04575.
    Abstract     Related articles   

  260. ROLEVICH A, Minich A, Vasilevich V, Zhegalik A, et al
    Efficacy of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer and quality of surgery: post-hoc analysis of small a, Cyrillic prospective randomized study.
    Cent European J Urol. 2019;72:351-356.
    Abstract     Related articles   

  261. LU HC, Yao JQ, Yang X, Han J, et al
    Identification of a potentially functional circRNA-miRNA-mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer.
    Cancer Cell Int. 2020;20:31.
    Abstract     Related articles   

  262. YUCETAS U, Aglamis E, Ates HA, Behzatoglu K, et al
    Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?
    Urol Ann. 2020;12:25-30.
    Abstract     Related articles   

  263. ASHRAFIZADEH M, Yaribeygi H, Sahebkar A
    Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways.
    Anticancer Agents Med Chem. 2020 Feb 3. pii: ACAMC-EPUB-104182.
    Abstract     Related articles   

  264. MASTUO T, Miyata Y, Yuno T, Mukae Y, et al
    Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer.
    Molecules. 2020;25.
    Abstract     Related articles   

  265. IM SW, Sung CO, Kim KS, Cho NH, et al
    Genomic Landscape of Young-Onset Bladder Cancer and Its Prognostic Implications on Adult Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  266. VAN HENSBERGEN M, van Osch FHM, Jochems S, James ND, et al
    Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme.
    Eur J Cancer Prev. 2020;29:110-118.
    Abstract     Related articles   

  267. ZHU G, Pei L, Li Y, Gou X, et al
    EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  268. LI G, Wang S, Deng D, Xiao Z, et al
    Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation.
    ACS Nano. 2020 Feb 7. doi: 10.1021/acsnano.9b06689.
    Abstract     Related articles   

  269. JIANG DM, Chung P, Kulkarni GS, Sridhar SS, et al
    Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
    Curr Oncol Rep. 2020;22:14.
    Abstract     Related articles   

  270. WANG G, Huang Y, Yang F, Tian X, et al
    High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  271. LI C, Gao L, Zhang J, Yang X, et al
    The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Lasers Med Sci. 2020 Jan 31. pii: 10.1007/s10103-020-02972.
    Abstract     Related articles   

  272. PEREIRA PMR, Roberts S, Figueira F, Tome JPC, et al
    PET/CT imaging with a (18)F-labeled galactodendritic unit in a galectin-1 overexpressing orthotopic bladder cancer model.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.236430. doi: 10.2967/jnumed.119.236430.
    Abstract     Related articles   

  273. MAO S, Wu Y, Wang R, Guo Y, et al
    Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study.
    Ann Palliat Med. 2020;9:8-18.
    Abstract     Related articles   

  274. ROFI E, Del Re M, Arrigoni E, Rizzo M, et al
    Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.
    Crit Rev Oncol Hematol. 2019;144:102812.
    Abstract     Related articles   

  275. AN HW, Li LL, Wang Y, Wang Z, et al
    A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging.
    Nat Commun. 2019;10:4861.
    Abstract     Related articles   

  276. IDE H, Inoue S, Mizushima T, Kashiwagi E, et al
    Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
    Mol Carcinog. 2019;58:2297-2305.
    Abstract     Related articles   

  277. SOMA O, Hatakeyama S, Okamoto T, Fujita N, et al
    Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
    Med Oncol. 2019;36:88.
    Abstract     Related articles   

  278. SAHU KK, Pandey D, Mishra AK, O'Shea J, et al
    Mystery of neck lump: an uncommon presentation of urachal cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  279. GLASER AP, Procissi D, Yu Y, Meeks JJ, et al
    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors.
    J Vis Exp. 2019;.
    Abstract     Related articles   

  280. SWAMI U, Grivas P, Agarwal N
    The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.
    Oncologist. 2019;24:580-583.
    Abstract     Related articles   

  281. PANAHI MH
    Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors".
    World J Urol. 2020;38:513.
    Abstract     Related articles   

  282. DYRSKJOT L
    Large-scale genomic comparison of UTUC and bladder tumours.
    Nat Rev Urol. 2019;16:149-150.
    Abstract     Related articles   

  283. FURRER MA, Huesler J, Fellmann A, Burkhard FC, et al
    The Comprehensive Complication Index CCI: A proposed modification to optimize short-term complication reporting after cystectomy and urinary diversion.
    Urol Oncol. 2019;37:291.
    Abstract     Related articles   

  284. TSAY MD, Hsieh MJ, Wang SS, Wang WC, et al
    Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
    Urol Oncol. 2019;37:293.
    Abstract     Related articles   

  285. LEVI LI, Schlemmer F, de Castro N, Brun O, et al
    Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter?
    Med Mal Infect. 2019;49:350-355.
    Abstract     Related articles   

  286. KADAM PD, Han HC, Kwok JL
    An uncommon case of mucosa-associated lymphoid tissue (MALT) tumor of the bladder.
    Int Urogynecol J. 2019;30:1017-1018.
    Abstract     Related articles   

  287. PHAM TM, Kubo T, Fujino Y, Fujimoto N, et al
    Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980-2010.
    J Epidemiol. 2019;29:464-470.
    Abstract     Related articles   

  288. PAVLIC K, Pohar Perme M
    Using pseudo-observations for estimation in relative survival.
    Biostatistics. 2019;20:384-399.
    Abstract     Related articles   

  289. MOTTET N, Ribal MJ, Boyle H, De Santis M, et al
    Management of bladder cancer in older patients: Position paper of a SIOG Task Force.
    J Geriatr Oncol. 2020 Feb 10. pii: S1879-4068(19)30481.
    Abstract     Related articles   

  290. D'ANDREA D, Black PC, Zargar H, Zargar-Shoshtari K, et al
    Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
    Urol Oncol. 2020 Feb 11. pii: S1078-1439(20)30011.
    Abstract     Related articles   

  291. EFILOGLU O, Basok BI, Turan T, Toprak T, et al
    Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks
    Turk J Urol. 2020 Feb 7:1-7. doi: 10.5152/tud.2020.19186.
    Abstract     Related articles   

  292. CELEN S, Kaygisiz O, Vuruskan H, Yavascaoglu I, et al
    Laparoscopic versus open radical cystectomy in the treatment of locally advanced T3 and T4 bladder cancer: Perioperative and Mid-term oncological outcomes.
    Turk J Urol. 2020 Jan 17:1-6. doi: 10.5152/tud.2020.19077.
    Abstract     Related articles   

  293. CHEN J, Li Y, Li Z, Cao L, et al
    LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling.
    J Biochem Mol Toxicol. 2020 Feb 13:e22452. doi: 10.1002/jbt.22452.
    Abstract     Related articles   

  294. CHEN J, Sun Y, Ou Z, Yeh S, et al
    Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.
    EMBO Rep. 2020 Feb 13:e48467. doi: 10.15252/embr.201948467.
    Abstract     Related articles   

  295. XU Y, Wu G, Li J, Li J, et al
    Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.
    Biomed Res Int. 2020;2020:8283401.
    Abstract     Related articles   

  296. WANG K, Ma L, Tang J, Yu Q, et al
    LncRNA00518 promotes cell proliferation through regulating miR-101 in bladder cancer.
    J Cancer. 2020;11:1468-1477.
    Abstract     Related articles   

  297. WANG X, Ding Y, Wang J, Wu Y, et al
    Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network.
    Front Genet. 2020;10:1398.
    Abstract     Related articles   

  298. WANG Y, Du L, Yang X, Li J, et al
    A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  299. KOYA M, Osborne S, Chemasle C, Porten S, et al
    An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer.
    BMC Urol. 2020;20:12.
    Abstract     Related articles   

  300. ROSE M, Bringezu S, Godfrey L, Fiedler D, et al
    ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  301. HINDUPUR SV, Schmid SC, Koch JA, Youssef A, et al
    STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  302. BALLAS L, Wei O, Daneshmand S, Schuckman A, et al
    Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature.
    Clin Genitourin Cancer. 2020 Jan 7. pii: S1558-7673(19)30389.
    Abstract     Related articles   

  303. PLOUVIER SD, Bonnal JL, Machuron F, Colin P, et al
    Impact of age on bladder cancer management practices: a general population study.
    Acta Oncol. 2020 Feb 11:1-5. doi: 10.1080/0284186X.2020.1723164.
    Abstract     Related articles   

  304. WONG R, Rosser CJ
    UroSEEK gene panel for bladder cancer surveillance.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  305. CLINTON TN, Wiseman M, Walasek A, Pietzak E, et al
    Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  306. SOLANKI AA, Liauw SL
    The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  307. VALES-GOMEZ M
    Bacillus Calmette Guerin in bladder cancer: is more immune stimulation better?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  308. DESAI NB, Bagrodia A
    The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  309. BOTTERO M, Ali E, Demofonti C, Lancia A, et al
    High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  310. FANKHAUSER CD, Mostafid H
    The inflammatory potential of diet and bladder cancer risk: results from a prospective cohort study.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  311. NASELLI A, Guarneri A
    Bladder cancer under staging: still unavoidable?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  312. MOTTERLE G, Karnes RJ
    Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  313. REIS LO
    Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  314. MAGEE DE, Kulkarni GS
    Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  315. KNAPP DW, Dhawan D, Ramos-Vara JA, Ratliff TL, et al
    Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.
    Front Oncol. 2020;9:1493.
    Abstract     Related articles   

  316. SCHULZ A, Gorodetska I, Behrendt R, Fuessel S, et al
    Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.
    Front Oncol. 2020;9:1461.
    Abstract     Related articles   

  317. BOU KHEIR G, Aoun F, Roumeguere T
    CD47 targeted near-infrared photo-immunotherapy: a promising tool combining monoclonal antibodies and photodynamics for treating human bladder cancer.
    Transl Androl Urol. 2019;8:779-780.
    Abstract     Related articles   

  318. LI X, Gheinani AH, Adam RM
    A multi-omics approach to understanding the field effect in bladder cancer.
    Transl Androl Urol. 2019;8:775-778.
    Abstract     Related articles   

  319. BOCHNER BH
    Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care.
    Eur Urol Oncol. 2020 Feb 6. pii: S2588-9311(20)30011.
    Abstract     Related articles   

  320. SOOD R, Sharma H, Sharma B, Parekh S, et al
    A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30003.
    Abstract     Related articles   

  321. GADZINSKI AJ, Psutka SP
    Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments.
    Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30004.
    Abstract     Related articles   

  322. LUZZAGO S, Palumbo C, Rosiello G, Knipper S, et al
    Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30320.
    Abstract     Related articles   

  323. KOTOV SV, Khachatryan AL, Kotova DP, Guspanov RI, et al
    [Analysis of the results of ERAS protocol in real-life clinical practice AFTER radical cystectomy (the first prospective multicenter study in Russia)].
    Urologiia. 2019;:60-66.
    Abstract     Related articles   

  324. PERLIN DV, Alexandrov IV, Zippunnikov VP, Shmanev AO, et al
    [Laparoscopic radical cystectomy: novel technique with late dividing of the ureters].
    Urologiia. 2019;:54-59.
    Abstract     Related articles   

  325. BORGNA V, Vidal I, Castillo OA
    [Open vs Laparoscopic Radical Cystectomy: Comparison of perioperative and Mid-term oncological outcomes.]
    Arch Esp Urol. 2020;73:32-40.
    Abstract     Related articles   

  326. FERREIRA JT, Pina J, Ribeiro CAF, Fernandes R, et al
    Highly Efficient Singlet Oxygen Generators Based on Ruthenium Phthalocyanines: Synthesis, Characterization and in vitro Evaluation for Photodynamic Therapy.
    Chemistry. 2020;26:1697.
    Abstract     Related articles   

  327. TSUI KH, Lin YH, Chang KS, Hou CP, et al
    Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  328. QIN QP, Wang ZF, Huang XL, Tan MX, et al
    Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells.
    Dalton Trans. 2019;48:15247-15254.
    Abstract     Related articles   

  329. LIU W, Sun L, Guan F, Wang F, et al
    Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Dis Markers. 2019;2019:7386140.
    Abstract     Related articles   

  330. HSU WC, Lee YC, Liang PI, Chang LL, et al
    CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas.
    Dis Markers. 2019;2019:2724948.
    Abstract     Related articles   

  331. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Dis Markers. 2019;2019:6702964.
    Abstract     Related articles   

  332. REDKNAP C, Kaitiff D
    Delirium superimposed on dementia precipitated by an unexpected bladder tumour.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  333. ZAJAC M, Scott M, Ratcliffe M, Scorer P, et al
    Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma.
    Diagn Pathol. 2019;14:99.
    Abstract     Related articles   

  334. ALSTON ELJ, Zynger DL
    Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
    Diagn Pathol. 2019;14:91.
    Abstract     Related articles   

  335. WANG X, Wang L, Zong S, Qiu R, et al
    Use of multifunctional composite nanofibers for photothermalchemotherapy to treat cervical cancer in mice.
    Biomater Sci. 2019 Jul 10. doi: 10.1039/c9bm00756.
    Abstract     Related articles   

  336. MISTRETTA FA, Mazzone E, Knipper S, Palumbo C, et al
    Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
    Cancer Epidemiol. 2019;59:135-142.
    Abstract     Related articles   

  337. RENSHAW AA, Gould EW
    Adequacy criteria for voided urine cytology using cytospin preparations.
    Cancer Cytopathol. 2019;127:116-119.
    Abstract     Related articles   

  338. CRISS SD, Weaver DT, Sheehan DF, Lee RJ, et al
    Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States.
    Urol Oncol. 2019;37:180.
    Abstract     Related articles   

  339. MOSCHINI M, Soria F, Mathieu R, Xylinas E, et al
    Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.
    Urol Oncol. 2019;37:179.
    Abstract     Related articles   

  340. BARROS TMB, Lima APB, Almeida TC, da Silva GN, et al
    Inhibition of urinary bladder cancer cell proliferation by silibinin.
    Environ Mol Mutagen. 2020 Feb 20. doi: 10.1002/em.22363.
    Abstract     Related articles   

  341. STACHOWIAK M, Szymanski M, Ornoch A, Jancewicz I, et al
    SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer.
    IUBMB Life. 2020 Feb 19. doi: 10.1002/iub.2254.
    Abstract     Related articles   

  342. KRAJEWSKI W, Rodriguez Faba O, Breda A, Pisano F, et al
    Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer.
    World J Urol. 2020 Feb 18. pii: 10.1007/s00345-020-03130.
    Abstract     Related articles   

  343. HE Q, Yan D, Dong W, Bi J, et al
    circRNA circFUT8 Upregulates Krupple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p.
    Mol Ther Oncolytics. 2020;16:172-187.
    Abstract     Related articles   

  344. MATULEWICZ RS
    Complexities of Contemporary Bladder Cancer Care: NYU Case of the Month, September 2019.
    Rev Urol. 2019;21:172-174.
    Abstract     Related articles   

  345. GOLLA V, Lenis AT, Faiena I, Chamie K, et al
    Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.
    Rev Urol. 2019;21:145-153.
    Abstract     Related articles   

  346. GUPTA A, Bansal N, Mitash N, Kumar D, et al
    NMR-derived targeted serum metabolic biomarkers appraisal of bladder cancer: A pre- and post-operative evaluation.
    J Pharm Biomed Anal. 2020;183:113134.
    Abstract     Related articles   

  347. WANG B, Zhang K, Wang J, Zhao R, et al
    Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Colloids Surf B Biointerfaces. 2020;189:110832.
    Abstract     Related articles   

  348. CHEN D, Guo Y, Chen Y, Guo Q, et al
    LncRNA growth arrest-specific transcript 5 targets miR-21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN.
    Cancer Med. 2020 Feb 18. doi: 10.1002/cam4.2664.
    Abstract     Related articles   

  349. TAO T, Yuan S, Liu J, Shi D, et al
    Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  350. CALO B, Falagario U, Sanguedolce F, Veccia A, et al
    Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin.
    World J Urol. 2020 Feb 15. pii: 10.1007/s00345-020-03108.
    Abstract     Related articles   

  351. OH H, Lee DH, Giovannucci EL, Keum N, et al
    Gastric and duodenal ulcers, periodontal disease, and risk of bladder cancer in the Health Professionals Follow-up Study.
    Cancer Causes Control. 2020 Feb 14. pii: 10.1007/s10552-020-01274.
    Abstract     Related articles   

  352. SUN Y, Zhu D, Xing H, Hou Y, et al
    Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network.
    World J Urol. 2020 Feb 14. pii: 10.1007/s00345-020-03086.
    Abstract     Related articles   

  353. DE KRUIJFF IE, Beije N, Martens JWM, de Wit R, et al
    Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol Oncol. 2020 Feb 11. pii: S2588-9311(20)30010.
    Abstract     Related articles   

  354. SCHREIBER H, Hanze J, Nimphius W, Verburg FA, et al
    Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging.
    J Cancer Res Clin Oncol. 2020;146:305-313.
    Abstract     Related articles   

  355. YIP W, Ashrafi A, Daneshmand S
    High-grade T1 Urothelial Carcinoma: Where Do We Stand?
    Curr Urol Rep. 2019;20:79.
    Abstract     Related articles   

  356. KALAMPOKIS N, Grivas N, Olschlager M, Hassan FN, et al
    Radical Cystectomy in Female Patients - Improving Outcomes.
    Curr Urol Rep. 2019;20:83.
    Abstract     Related articles   

  357. ROHRA P, Yan L, Mir F, Farrell MR, et al
    Follicular cystitis in urine cytology: A clinical and cytopathologic study.
    Diagn Cytopathol. 2019;47:1223-1228.
    Abstract     Related articles   

  358. KVIKSTAD V, Mangrud OM, Gudlaugsson E, Dalen I, et al
    Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.
    Diagn Pathol. 2019;14:90.
    Abstract     Related articles   

  359. MARTIN C, West JM, Palermo S, Patel DP, et al
    Elderly patients undergoing cystectomy, comparing preoperative American Society of Anesthesiology and Eastern Cooperative Oncology Group scores and operative approaches.
    Urologia. 2019;86:183-188.
    Abstract     Related articles   

  360. MCINTIRE P, Khan R, Kilic I, Wojcik EM, et al
    Immunohistochemistry in the workup of bladder biopsies: Frequency, variation and utility of use at an academic center.
    Ann Diagn Pathol. 2019;41:124-128.
    Abstract     Related articles   

  361. IWAMOTO H, Morizane S, Koie T, Shiroki R, et al
    Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan.
    Int J Clin Oncol. 2019;24:1588-1595.
    Abstract     Related articles   

  362. AKAMATSU H, Nakamura K, Ebara T, Inaba K, et al
    Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey.
    J Radiat Res. 2019;60:509-516.
    Abstract     Related articles   

  363. IWATA T, Kimura S, Foerster B, Fossati N, et al
    Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.
    World J Urol. 2019;37:1557-1570.
    Abstract     Related articles   

  364. HUNTER L, Moser J, Sturge C, Barraza G, et al
    First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case report.
    J Oncol Pharm Pract. 2020;26:216-219.
    Abstract     Related articles   

  365. WANG B, Xie S, Bi J, Liu Z, et al
    Elevated pre-existing lymphocytic infiltrates in tumour stroma predict poor prognosis in resectable urothelial carcinoma of the bladder.
    Histopathology. 2019;75:354-364.
    Abstract     Related articles   

  366. TEOH JY, Cho CL, Wei Y, Isotani S, et al
    A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour.
    World J Urol. 2019;37:1879-1887.
    Abstract     Related articles   

  367. GERGELIS KR, Kreofsky CR, Choo CS, Viehman J, et al
    Outcomes and profiles of elderly patients receiving definitive radiotherapy for muscle-invasive bladder cancer at a tertiary medical center.
    Pract Radiat Oncol. 2020 Feb 25. pii: S1879-8500(20)30045.
    Abstract     Related articles   

  368. LI WQ, Zhao WC, Xin J, Niu TL, et al
    MicroRNA-142-3p suppresses cell proliferation and migration in bladder cancer via Rac1.
    J Biol Regul Homeost Agents. 2020;34.
    Abstract     Related articles   

  369. JIANG F, Li C, Han J, Wang L, et al
    Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033819894573.
    Abstract     Related articles   

  370. FAURE WALKER NA, Nair R
    Commentary on "The Top 100 most cited Manuscripts in Bladder cancer: A bibliometric analysis".
    Int J Surg. 2020 Feb 24. pii: S1743-9191(20)30195.
    Abstract     Related articles   

  371. GUALLAR-GARRIDO S, Julian E
    Bacillus Calmette-Guerin (BCG) Therapy for Bladder Cancer: An Update.
    Immunotargets Ther. 2020;9:1-11.
    Abstract     Related articles   

  372. WANG C, Liu Q, Huang M, Zhou Q, et al
    Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer.
    FASEB J. 2020 Feb 26. doi: 10.1096/fj.201903176.
    Abstract     Related articles   

  373. ABOUSHOUSHA T, Hammam O, Aref A, Kamel A, et al
    Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2020;21:547-554.
    Abstract     Related articles   

  374. MONTEIRO-REIS S, Blanca A, Tedim-Moreira J, Carneiro I, et al
    A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  375. CUCCI MA, Grattarola M, Dianzani C, Damia G, et al
    Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Free Radic Biol Med. 2020 Feb 23. pii: S0891-5849(20)30046.
    Abstract     Related articles   

  376. WANG C, Yang S, Jin L, Dai G, et al
    Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
    Onco Targets Ther. 2020;13:945-958.
    Abstract     Related articles   

  377. GAO S, Yin H, Tong H, Zhan K, et al
    Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-beta Signaling Pathway.
    Onco Targets Ther. 2020;13:813-825.
    Abstract     Related articles   

  378. CAI Z, Zhang F, Chen W, Zhang J, et al
    miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.
    Onco Targets Ther. 2019;12:11805-11816.
    Abstract     Related articles   

  379. LIN H, Zhou Q, Wu W, Ma Y, et al
    Midkine Is a Potential Urinary Biomarker for Non-Invasive Detection of Bladder Cancer with Microscopic Hematuria.
    Onco Targets Ther. 2019;12:11765-11775.
    Abstract     Related articles   

  380. HANSON HA, Leiser CL, O'Neil B, Martin C, et al
    Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2020 Feb 25. pii: 1055-9965.EPI-19-0681.
    Abstract     Related articles   

  381. TERAUCHI T, Nakada S, Takenaka M, Mizuguchi S, et al
    Intracytoplasmic Lumen in Urine Cytology Predicts Worse Prognosis in Non-Muscle-Invasive Bladder Cancers.
    Acta Cytol. 2020 Feb 25:1-8. doi: 10.1159/000505955.
    Abstract     Related articles   

  382. ZAVALISHINA LE, Andreeva YY, Olyushina EM, Frank GA, et al
    [Immunohistochemical study of the MSI phenotype of urothelial bladder cancer].
    Arkh Patol. 2020;82:5-14.
    Abstract     Related articles   

  383. JIANG W, Zhu D, Wang C, Zhu Y, et al
    An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
    Cancer Med. 2020 Feb 25. doi: 10.1002/cam4.2942.
    Abstract     Related articles   

  384. HAN CT, Bao QY, Cheng SJ, Liu M, et al
    Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/beta-catenin signaling pathway.
    Eur Rev Med Pharmacol Sci. 2020;24:1081-1087.
    Abstract     Related articles   

  385. MORTADA WI, Awadalla A, Khater S, Ahmed A, et al
    Copper and zinc levels in plasma and cancerous tissues and their relation with expression of VEGF and HIF-1 in the pathogenesis of muscle invasive urothelial bladder cancer: a case-controlled clinical study.
    Environ Sci Pollut Res Int. 2020 Feb 24. pii: 10.1007/s11356-020-08113.
    Abstract     Related articles   

  386. FUMAROLA S, Cecati M, Sartini D, Ferretti G, et al
    Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression.
    Antioxidants (Basel). 2020;9.
    Abstract     Related articles   

  387. WARRICK JI, Knowles MA, Yves A, van der Kwast T, et al
    Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.
    Am J Surg Pathol. 2020 Feb 19. doi: 10.1097/PAS.0000000000001453.
    Abstract     Related articles   

  388. ZHANG N, Li F, Gao J, Zhang S, et al
    Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway.
    Genes Genomics. 2020 Feb 22. pii: 10.1007/s13258-019-00907.
    Abstract     Related articles   

  389. NAKA M, Shuto S, Konishi C, Maekawa K, et al
    High prevalence of airway obstruction and pulmonary emphysema in urothelial (renal pelvis, ureter, and bladder) cancer patients.
    Respir Investig. 2020 Feb 19. pii: S2212-5345(20)30004.
    Abstract     Related articles   

  390. JOHN JB, Varughese MA, Cooper N, Wong K, et al
    Treatment Allocation and Survival in Patients Diagnosed with Nonmetastatic Muscle-invasive Bladder Cancer: An Analysis of a National Patient Cohort in England.
    Eur Urol Focus. 2020 Feb 19. pii: S2405-4569(20)30032.
    Abstract     Related articles   

  391. LUO H, Yang L, Liu C, Wang X, et al
    TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
    Int J Biochem Cell Biol. 2020 Feb 19:105702. doi: 10.1016/j.biocel.2020.105702.
    Abstract     Related articles   

  392. ABDELKADER EL HAKIM B, Caid N, Braneci F, Boudjemaa M, et al
    Epidemiological study of gall bladder cancer.
    Ann Oncol. 2019;30 Suppl 4:iv66.
    Abstract     Related articles   

  393. HAROON N
    An invited commentary on: "The top 100 most cited manuscripts in bladder cancer: A bibliometric analysis" [Int. J. surg. 2020; Epub ahead of print].
    Int J Surg. 2020;76:4.
    Abstract     Related articles   

  394. FENG D, Li A, Hu X, Lin T, et al
    Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis.
    Minerva Urol Nefrol. 2020 Feb 19. pii: S0393-2249.20.03680.
    Abstract     Related articles   

  395. REGNIER P, De Luca V, Brunelle S, Sfumato P, et al
    Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy and post cystectomy complications.
    Minerva Urol Nefrol. 2020 Feb 19. pii: S0393-2249.20.03616.
    Abstract     Related articles   

  396. PANG K, Hao L, Shi Z, Chen B, et al
    Comprehensive gene expression analysis after ERH gene knockdown in human bladder cancer T24 cell lines.
    Gene. 2020 Feb 17:144475. doi: 10.1016/j.gene.2020.144475.
    Abstract     Related articles   

  397. HOSEN MI, Sheikh M, Zvereva M, Scelo G, et al
    Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
    EBioMedicine. 2020 Feb 12:102643. doi: 10.1016/j.ebiom.2020.102643.
    Abstract     Related articles   

  398. HERMANNS T, Savio AJ, Olkhov-Mitsel E, Mari A, et al
    A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
    Urol Oncol. 2020 Feb 18. pii: S1078-1439(20)30008.
    Abstract     Related articles   

  399. MURAMATSU-MAEKAWA Y, Taniguchi T, Ito H, Nakane K, et al
    Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review.
    J Immunother. 2020 Feb 19. doi: 10.1097/CJI.0000000000000311.
    Abstract     Related articles   

  400. KUDELSKI J, Mlynarczyk G, Darewicz B, Bruczko-Goralewska M, et al
    Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity.
    Medicine (Baltimore). 2020;99:e19224.
    Abstract     Related articles   

  401. QAYOOM S, Chakrabarti D, Khan F, Goel MM, et al
    Primary small cell carcinoma of the urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  402. DING Y, Cao Q, Wang C, Duan H, et al
    LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
    Technol Cancer Res Treat. 2019;18:1533033819876601.
    Abstract     Related articles   

  403. LUO X, Lin J, Du L, Wu R, et al
    Ultrasound findings of urachal anomalies. A series of interesting cases.
    Med Ultrason. 2019;21:294-298.
    Abstract     Related articles   

  404. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Pediatr Blood Cancer. 2019;66:e27952.
    Abstract     Related articles   

  405. RASMUSSEN LA, Jensen H, Virgilsen LF, Falborg AZ, et al
    Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.
    Eur J Cancer Care (Engl). 2019;28:e13123.
    Abstract     Related articles   

  406. SHAFIEI S, Kalantari E, Saeednejad Zanjani L, Abolhasani M, et al
    Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
    Exp Mol Pathol. 2019;108:164-172.
    Abstract     Related articles   

  407. HASHEMIAN M, Sinha R, Murphy G, Weinstein SJ, et al
    Coffee and tea drinking and risk of cancer of the urinary tract in male smokers.
    Ann Epidemiol. 2019;34:33-39.
    Abstract     Related articles   

  408. LIU J, Li J
    PKCalpha and Netrin-1/UNC5B positive feedback control in relation with chemical therapy in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:1712-1717.
    Abstract     Related articles   

  409. SU Y, Feng W, Zhong G, Ya Y, et al
    Correction for: ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.
    Aging (Albany NY). 2020 Mar 2. pii: 102885. doi: 10.18632/aging.102885.
    Abstract     Related articles   

  410. STEINBACH D, Kaufmann M, Hippe J, Gajda M, et al
    High Detection Rate for Non-Muscle-Invasive Bladder Cancer Using an Approved DNA Methylation Signature Test.
    Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30311.
    Abstract     Related articles   

  411. ESAWY MM, Abdel-Samd KM
    The diagnostic and prognostic roles of serum irisin in bladder cancer.
    Curr Probl Cancer. 2019 Nov 20:100529.
    Abstract     Related articles   

  412. LUO Y, Fu X, Ru R, Han B, et al
    CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
    Arch Med Res. 2020 Mar 3. pii: S0188-4409(19)30676.
    Abstract     Related articles   

  413. FLAIG TW, Spiess PE, Agarwal N, Bangs R, et al
    Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2020;18:329-354.
    Abstract     Related articles   

  414. ANNELS NE, Simpson GR, Pandha H
    Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response.
    Front Oncol. 2020;10:175.
    Abstract     Related articles   

  415. ZHU S, Huang Z, Nabi G
    Fluorometric optical sensor arrays for the detection of urinary bladder cancer specific volatile organic compounds in the urine of patients with frank hematuria: a prospective case-control study.
    Biomed Opt Express. 2020;11:1175-1185.
    Abstract     Related articles   

  416. OH SS, Lee KW, Madhi H, Jeong JW, et al
    Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  417. MITIN T, Dengina N, Chernykh M, Usychkin S, et al
    Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
    J Cancer Educ. 2020 Mar 4. pii: 10.1007/s13187-020-01728.
    Abstract     Related articles   

  418. YANG Y, Yang X, Liu C, Li J, et al
    Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer.
    World J Urol. 2020 Mar 4. pii: 10.1007/s00345-020-03143.
    Abstract     Related articles   

  419. NAGARAJAN G, Kundalia K
    Should every cholecystectomy specimen be sent for histopathology to identify incidental gall bladder cancer?
    Indian J Cancer. 2020;57:2-3.
    Abstract     Related articles   

  420. NASON GJ, Khaled A, Tan GH, Kulkarni GS, et al
    Bladder-sparing treatment options in localized muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2020 Mar 4. doi: 10.1080/14737140.2020.1736565.
    Abstract     Related articles   

  421. LOH-DOYLE JC, Han J, Ghodoussipour S
    Factors Associated With Patient-Reported Penile Length Loss After Radical Cystoprostatectomy in Male Patients With Bladder Cancer.
    J Sex Med. 2020 Feb 29. pii: S1743-6095(20)30063.
    Abstract     Related articles   

  422. CHOI SJ, Park KJ, Lee G, Kim MH, et al
    Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Eur J Radiol. 2020;126:108902.
    Abstract     Related articles   

  423. XIE H, Li J, Ying Y, Yan H, et al
    METTL3/YTHDF2 m(6) A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.
    J Cell Mol Med. 2020 Mar 3. doi: 10.1111/jcmm.15063.
    Abstract     Related articles   

  424. IKEDA A, Kojima T, Kawai K, Hinotsu S, et al
    Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
    Int J Clin Oncol. 2020 Mar 3. pii: 10.1007/s10147-020-01634.
    Abstract     Related articles   

  425. SU Y, Du Z, Zhong G, Ya Y, et al
    Correction for: circ5912 suppresses cancer progression via inducing MET in bladder cancer.
    Aging (Albany NY). 2020 Feb 27. pii: 102886. doi: 10.18632/aging.102886.
    Abstract     Related articles   

  426. KARSIYAKALI N, Karabay E, Yucetas U
    Predictive value of prognostic nutritional index on tumor stage in patients with primary bladder cancer.
    Arch Esp Urol. 2020;73:132-139.
    Abstract     Related articles   

  427. NAUSEEF JT, Villamar DM, Lebenthal J, Vlachostergios PJ, et al
    An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancer.
    Expert Opin Pharmacother. 2020 Mar 3:1-8. doi: 10.1080/14656566.2020.1736036.
    Abstract     Related articles   

  428. HUANG Z, Wang X, Ma L, Guo Z, et al
    Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
    Arch Toxicol. 2020 Mar 2. pii: 10.1007/s00204-020-02663.
    Abstract     Related articles   

  429. SHIOTA M, Fujimoto N, Yamamoto Y, Takeuchi A, et al
    Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer.
    Cancer Immunol Immunother. 2020 Mar 2. pii: 10.1007/s00262-020-02533.
    Abstract     Related articles   

  430. ABDELHAKAM D, Young PR, Jain MK, Nassar A, et al
    Complete remission with immunotherapy: Case report of a patient with metastatic bladder cancer to the humerus.
    Urol Case Rep. 2020;30:101130.
    Abstract     Related articles   

  431. MOKKAPATI S, Porten SP, Narayan VM, Lim AH, et al
    TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer.
    Mol Cancer Res. 2020 Mar 2. pii: 1541-7786.MCR-19-0766.
    Abstract     Related articles   

  432. COOLEY LF, Glaser AP, Meeks JJ
    Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
    Urol Oncol. 2020 Feb 28. pii: S1078-1439(20)30041.
    Abstract     Related articles   

  433. ECKE TH, Otto T
    Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  434. LIU N, Leng M, Yue T, Dong L, et al
    Simultaneously Quantifying Both Young's Modulus and Specific Membrane Capacitance of Bladder Cancer Cells with Different Metastatic Potential.
    Micromachines (Basel). 2020;11.
    Abstract     Related articles   

  435. GOONEWARDENA SAS, Jayarajah U, de Silva MVC, Kuruppu SN, et al
    Bladder cancer in women: a Sri Lankan study
    Ceylon Med J. 2019;64:98-102.
    Abstract     Related articles   

  436. SCHROECK FR, St Ivany A, Lowrance W, Makarov DV, et al
    Patient Perspectives on the Implementation of Risk-Aligned Bladder Cancer Surveillance: Systematic Evaluation Using the Tailored Implementation for Chronic Diseases Framework.
    JCO Oncol Pract. 2020 Mar 2:JOP1900576. doi: 10.1200/JOP.19.00576.
    Abstract     Related articles   

  437. WU J, Wang M, Chen H, Xu J, et al
    The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population.
    Front Oncol. 2020;10:134.
    Abstract     Related articles   

  438. ZHU S, Yu W, Yang X, Wu C, et al
    Traditional Classification and Novel Subtyping Systems for Bladder Cancer.
    Front Oncol. 2020;10:102.
    Abstract     Related articles   

  439. LIU K, Zhu J, Song YX, Wang X, et al
    Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis.
    Front Oncol. 2020;10:29.
    Abstract     Related articles   

  440. QIU H, Hu X, He C, Yu B, et al
    Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
    Front Genet. 2020;11:12.
    Abstract     Related articles   

  441. JIN H, Ma J, Xu J, Li H, et al
    Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy.
    Autophagy. 2020 Mar 1:1-15. doi: 10.1080/15548627.2020.1733262.
    Abstract     Related articles   

  442. ZHANG M, Du H, Wang L, Yue Y, et al
    Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/beta-catenin signaling pathway.
    Chem Biol Interact. 2020;320:109022.
    Abstract     Related articles   

  443. CAGLIC I, Panebianco V, Vargas HA, Bura V, et al
    MRI of Bladder Cancer: Local and Nodal Staging.
    J Magn Reson Imaging. 2020 Feb 29. doi: 10.1002/jmri.27090.
    Abstract     Related articles   

  444. DANESHMAND S
    Bladder Cancer: Advances and Innovations.
    Eur Urol Focus. 2020 Feb 25. pii: S2405-4569(20)30069.
    Abstract     Related articles   

  445. DAZA J, Charap A, Wiklund PN, Sfakianos JP, et al
    Role of the Innate Immune System in the Development, Progression, and Therapeutic Response of Bladder Cancer.
    Eur Urol Focus. 2020 Feb 25. pii: S2405-4569(20)30070.
    Abstract     Related articles   

  446. WANG Y, Li Q, Wang J, Tong M, et al
    Small cell carcinoma of the bladder: the characteristics of molecular alterations, treatment, and follow-up.
    Med Oncol. 2019;36:98.
    Abstract     Related articles   

  447. JENA R, Sureka SK, Ruidas S, Lal H, et al
    Spontaneous renoalimentary fistula as a complication of upper tract urothelial carcinoma: unknown complication of a rare disease.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  448. SUN J, Wang C, Wang D, Wu J, et al
    Follicular dendritic cell sarcoma (FDCS) of urinary bladder with coexisting urothelial carcinoma-a case report.
    BMC Urol. 2019;19:83.
    Abstract     Related articles   

  449. MOLDAN MM, Stewart TM, Kor TM, Brown MJ, et al
    Bilateral Cavernous Sinus Syndrome, Pituitary Macroadenoma, and Postoperative Loss of Vision: A Case Report.
    A A Pract. 2019;13:350-351.
    Abstract     Related articles   

  450. SHARMA A, Frohlich H, Zhang R, Ebert AK, et al
    Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
    Cancer Genet. 2019;235-236:18-20.
    Abstract     Related articles   

  451. CULIG Z
    Centrosomal Proteins in Urothelial Tumors: New Pathways in Disease Pathogenesis.
    Am J Pathol. 2019;189:1178-1179.
    Abstract     Related articles   

  452. AUDENET F, Attalla K, Giordano M, Pfail J, et al
    Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion.
    Urol Oncol. 2019;37:300.
    Abstract     Related articles   

  453. MATULEWICZ RS, Demzik AL, DeLancey JO, Popescu O, et al
    Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy.
    Urol Oncol. 2019;37:300.
    Abstract     Related articles   

  454. LEE YE, Chan TC, Tian YF, Liang PI, et al
    High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Urol Oncol. 2019;37:299.
    Abstract     Related articles   

  455. BURGESS EF, Livasy C, Hartman A, Robinson MM, et al
    Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions.
    Urol Oncol. 2019;37:299.
    Abstract     Related articles   

  456. MAISH WN, Nguyen LK, Ngu C, Bennett G, et al
    Metastatic Urachus Neoplasia: A Case Report and Review of the Current Literature.
    Clin Genitourin Cancer. 2019;17:e377-e382.
    Abstract     Related articles   

  457. JALANKO T, de Jong JJ, Gibb EA, Seiler R, et al
    Genomic Subtyping in Bladder Cancer.
    Curr Urol Rep. 2020;21:9.
    Abstract     Related articles   

  458. AMIN HAA, Kobaisi MH, Samir RM
    Schistosomiasis and Bladder Cancer in Egypt: Truths and Myths.
    Open Access Maced J Med Sci. 2019;7:4023-4029.
    Abstract     Related articles   

  459. FAHMY UA, Fahmy O
    In vitro evaluation of cytotoxic properties of 5-Aminolevulinic acid (5-ALA) on bladder cancer cells.
    Photodiagnosis Photodyn Ther. 2020 Mar 9:101714.
    Abstract     Related articles   

  460. MIRON B, Hoffman-Censits JH, Anari F, O'Neill J, et al
    Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Mar 10. pii: S2588-9311(20)30028.
    Abstract     Related articles   

  461. ZHOU X, Zhai Y, Liu C, Yang G, et al
    Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin alpha5beta1 interaction and Akt signaling pathway.
    Cell Commun Signal. 2020;18:44.
    Abstract     Related articles   

  462. ILIOU A, Panagiotakis A, Giannopoulou AF, Benaki D, et al
    Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  463. WETTSTEIN MS, Naimark D, Hermanns T, Herrera-Caceres JO, et al
    Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
    Cancer Med. 2020 Mar 12. doi: 10.1002/cam4.2980.
    Abstract     Related articles   

  464. FRAGKOULIS C, Glykas I, Papadopoulos G, Ntoumas K, et al
    Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Br J Radiol. 2020 Mar 11:20200025. doi: 10.1259/bjr.20200025.
    Abstract     Related articles   

  465. ISHIDA M, Ohno N, Sato H, Kitajima T, et al
    [Neoadjuvant Proton Beam Chemoradiotherapy for Locally Advanced Gall Bladder Cancer-A Case Report].
    Gan To Kagaku Ryoho. 2019;46:1975-1977.
    Abstract     Related articles   

  466. EL-GAMAL R, Mokhtar N, Ali-El-Dein B, Baiomy AA, et al
    Netrin-1: A new promising diagnostic marker for muscle invasion in bladder cancer.
    Urol Oncol. 2020 Mar 7. pii: S1078-1439(20)30047.
    Abstract     Related articles   

  467. GEAVLETE BF, Ene CV, Balan GX, Bulai CA, et al
    Bipolar en Bloc Resection - Is it the Future in Non-Muscle Invasive Bladder Cancer?
    Chirurgia (Bucur). 2020;115:89-94.
    Abstract     Related articles   

  468. TAARNHOJ GA, Johansen C, Lindberg H, Basch E, et al
    Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease.
    Cancer Med. 2020 Mar 10. doi: 10.1002/cam4.2958.
    Abstract     Related articles   

  469. YANG Y, Wang X, Bai Y, Feng D, et al
    Programmed death-ligand 2 (PD-L2) expression in bladder cancer.
    Urol Oncol. 2020 Mar 6. pii: S1078-1439(20)30002.
    Abstract     Related articles   

  470. KUMAR R, Kumar R, Tanwar P, Rath GK, et al
    Deciphering the impact of missense mutations on structure and dynamics of SMAD4 protein involved in pathogenesis of gall bladder cancer.
    J Biomol Struct Dyn. 2020 Mar 10:1-27. doi: 10.1080/07391102.2020.1740789.
    Abstract     Related articles   

  471. PENG J, Jiang H, Guo J, Huang J, et al
    CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD.
    Biomed Res Int. 2020;2020:7638975.
    Abstract     Related articles   

  472. ZHANG Z, Chen D, Li Z, Liu Z, et al
    Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.
    Biomed Res Int. 2020;2020:6034670.
    Abstract     Related articles   

  473. SHI C, Sun L, Liu S, Zhang E, et al
    Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
    Med Sci Monit. 2020;26:e921087.
    Abstract     Related articles   

  474. LANGLE YV, Balarino NP, Belgorosky D, Cresta Morgado PD, et al
    Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
    Nitric Oxide. 2020 Mar 5. pii: S1089-8603(20)30004.
    Abstract     Related articles   

  475. EULITT PJ, Altun E, Sheikh A, Wong TZ, et al
    Pilot Study of [(18)F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
    Clin Genitourin Cancer. 2020 Mar 5. pii: S1558-7673(20)30042.
    Abstract     Related articles   

  476. XU QH, Yuan Q, Zhang YQ, Li B, et al
    Ocular Metastasis in Elderly Male Bladder Cancer Patients: Potential Risk Factors.
    Am J Mens Health. 2020;14:1557988320908998.
    Abstract     Related articles   

  477. HECK MM, Koll FJ, Retz M, Autenrieth M, et al
    Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
    Urol Oncol. 2020 Mar 4. pii: S1078-1439(20)30040.
    Abstract     Related articles   

  478. MAHENDRA I, Hanaoka H, Yamaguchi A, Amartuvshin T, et al
    Diagnosis of bladder cancer using (18)F-labeled alpha-methyl-phenylalanine tracers in a mouse model.
    Ann Nucl Med. 2020 Mar 6. pii: 10.1007/s12149-020-01452.
    Abstract     Related articles   

  479. BANDINI M, Pederzoli F, Madison R, Briganti A, et al
    Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.
    Clin Genitourin Cancer. 2020 Feb 8. pii: S1558-7673(20)30033.
    Abstract     Related articles   

  480. COX E, Saramago P, Kelly J, Porta N, et al
    Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial.
    Clin Genitourin Cancer. 2019 Dec 14. pii: S1558-7673(19)30377.
    Abstract     Related articles   

  481. MARTIN JW, Jefferson FA, Huang M, Sung JM, et al
    A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Clin Genitourin Cancer. 2020 Jan 16. pii: S1558-7673(20)30011.
    Abstract     Related articles   

  482. OSSICK MV, Ferrari KL, Nunes-Silva I, Denardi F, et al
    Chorioallantoic urothelial tumor avatar. A clinical tool for phenotype-based therapy.
    Acta Cir Bras. 2020;34:e201901207.
    Abstract     Related articles   

  483. DE JONG JJ, Zwarthoff EC
    Molecular and clinical heterogeneity within the luminal subtype.
    Nat Rev Urol. 2020;17:69-70.
    Abstract     Related articles   

  484. WEN Y, Chen Y, Duan X, Zhu W, et al
    The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Clin Exp Med. 2019;19:407-416.
    Abstract     Related articles   

  485. LI X, Dong P, Wei W, Jiang L, et al
    Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1.
    Am J Pathol. 2019;189:1284-1297.
    Abstract     Related articles   

  486. TAKAI M, Kato D, Iinuma K, Maekawa YM, et al
    Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.
    Urol Case Rep. 2020;31:101145.
    Abstract     Related articles   

  487. LIU D, Qiu X, Xiong X, Chen X, et al
    Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics.
    Clin Transl Oncol. 2020 Mar 18. pii: 10.1007/s12094-020-02330.
    Abstract     Related articles   

  488. ZHOU W, Wang W, Wu W, Yan T, et al
    Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients.
    BMC Urol. 2020;20:30.
    Abstract     Related articles   

  489. KALAN FARMANFARMA K, Mahdavifar N, Salehiniya H
    Bladder Cancer in Iran: An Epidemiological Review.
    Res Rep Urol. 2020;12:91-103.
    Abstract     Related articles   

  490. QIAO Z, Dai H, Zhang Y, Li Q, et al
    LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143.
    Cancer Manag Res. 2020;12:1661-1668.
    Abstract     Related articles   

  491. ZHANG T, Du E, Liu Y, Cheng J, et al
    Anticancer Effects of Zinc Oxide Nanoparticles Through Altering the Methylation Status of Histone on Bladder Cancer Cells.
    Int J Nanomedicine. 2020;15:1457-1468.
    Abstract     Related articles   

  492. FUKUOKAYA W, Kimura T, Miki J, Kimura S, et al
    Red cell distribution width predicts time to recurrence in patients with primary non-muscle-invasive bladder cancer and improves the accuracy of the EORTC scoring system.
    Urol Oncol. 2020 Mar 14. pii: S1078-1439(20)30036.
    Abstract     Related articles   

  493. SAGINALA K, Barsouk A, Aluru JS, Rawla P, et al
    Epidemiology of Bladder Cancer.
    Med Sci (Basel). 2020;8.
    Abstract     Related articles   

  494. LIANG H, Huang H, Li Y, Lu Y, et al
    CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.
    Biosci Rep. 2020 Mar 17. pii: 222397. doi: 10.1042/BSR20193484.
    Abstract     Related articles   

  495. NAZARI A, Ahmadi Z, Hassanshahi G, Abbasifard M, et al
    Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review.
    Oman Med J. 2020;35:e103.
    Abstract     Related articles   

  496. HU C, Jiang D, Wu M, Wang J, et al
    Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer.
    J Cancer Res Clin Oncol. 2020 Mar 16. pii: 10.1007/s00432-020-03160.
    Abstract     Related articles   

  497. MATSUMOTO K, Murakami Y, Shimizu Y, Hirayama T, et al
    Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study.
    Cancer Biomark. 2020 Feb 28. pii: CBM190466. doi: 10.3233/CBM-190466.
    Abstract     Related articles   

  498. JIN L, Yuan F, Dai G, Yao Q, et al
    Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
    Cell Mol Biol Lett. 2020;25:17.
    Abstract     Related articles   

  499. FERRO M, Katalin MO, Buonerba C, Marian R, et al
    Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor.
    Urol Oncol. 2020 Mar 12. pii: S1078-1439(20)30057.
    Abstract     Related articles   

  500. YIN L, Liu Y, Jing H, Yu H, et al
    Corrigendum to "TIS11D can affect bladder cancer cells by regulating epithelial-mesenchymal transition" [Life Sci. 235 (2019) 116832].
    Life Sci. 2020 Mar 12:117516. doi: 10.1016/j.lfs.2020.117516.
    Abstract     Related articles   

  501. SEIDL C
    Targets for Therapy of Bladder Cancer.
    Semin Nucl Med. 2020;50:162-170.
    Abstract     Related articles   

  502. LI X, Shang D, Shen H, Song J, et al
    ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
    Biomed Pharmacother. 2020;126:110066.
    Abstract     Related articles   

  503. KRAJEWSKI W, Poletajew S, Zdrojowy R, Kolodziej A, et al
    Complications after BCG immunotherapy - neither a mountain nor a molehill.
    Scand J Urol. 2019;53:265-266.
    Abstract     Related articles   

  504. KHANDELWAL M, Anand V, Appunni S, Seth A, et al
    RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
    Mol Cell Biochem. 2020;464.
    Abstract     Related articles   

  505. YANG Y, Bai Y, Wang X, Tang Y, et al
    Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis.
    Int J Surg. 2019;72:80-84.
    Abstract     Related articles   

  506. KUMAR L, Narwal A, Kumar M, Kaushal S, et al
    Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  507. STABILE A, Muttin F, Zamboni S, Moschini M, et al
    Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer.
    Expert Rev Anticancer Ther. 2019;19:739-755.
    Abstract     Related articles   

  508. VICUNA L, Fernandez MI, Vial C, Valdebenito P, et al
    Adaptation to Extreme Environments in an Admixed Human Population from the Atacama Desert.
    Genome Biol Evol. 2019;11:2468-2479.
    Abstract     Related articles   

  509. BOCCI F, Tripathi SC, Vilchez Mercedes SA, George JT, et al
    NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
    Integr Biol (Camb). 2019;11:251-263.
    Abstract     Related articles   

  510. HAREMZA C, Baert M, Pascual C, Biet-Hornstein A, et al
    Head and neck squamous cell carcinoma and metachronous second primaries.
    Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:367-372.
    Abstract     Related articles   

  511. FERRERO VT, Oset MM, Masferrer JP, Pardo EH, et al
    Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Clin Transl Oncol. 2019;21:1707-1711.
    Abstract     Related articles   

  512. LU H, Male M, Jiang K, Ye Z, et al
    Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder.
    Urol Oncol. 2019;37:354.
    Abstract     Related articles   

  513. FEUERSTEIN MA, Goldstein L, Reaves B, Sun A, et al
    Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy.
    World J Urol. 2019;37:2401-2407.
    Abstract     Related articles   

  514. JANISCH F, D'Andrea D, Iwata T, Kimura S, et al
    The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC).
    Urol Oncol. 2020 Mar 21. pii: S1078-1439(20)30043.
    Abstract     Related articles   

  515. GONG P, Xu R, Zhuang Q, He X, et al
    A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer.
    Biomed Pharmacother. 2020;126:110059.
    Abstract     Related articles   

  516. GOTO T, Miyamoto H
    Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?
    Expert Rev Anticancer Ther. 2020 Mar 24:1-3. doi: 10.1080/14737140.2020.1744437.
    Abstract     Related articles   

  517. ADAMCZYK P, Juszczak K, Kadlubowski M, Ostrowski A, et al
    Can laparoscopic cystectomy become the method of choice in the treatment of invasive urothelial urinary bladder cancer?
    Adv Clin Exp Med. 2020 Mar 24. doi: 10.17219/acem/115084.
    Abstract     Related articles   

  518. CHEN W, Jiang T, Mao H, Gao R, et al
    SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Hum Cell. 2020 Mar 24. pii: 10.1007/s13577-020-00343.
    Abstract     Related articles   

  519. DE JONG JJ, Boormans JL, van Rhijn BWG, Seiler R, et al
    Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences.
    Eur Urol Oncol. 2020 Mar 20. pii: S2588-9311(20)30035.
    Abstract     Related articles   

  520. ALBAN L, Monteiro WF, Diz FM, Miranda GM, et al
    New quercetin-coated titanate nanotubes and their radiosensitization effect on human bladder cancer.
    Mater Sci Eng C Mater Biol Appl. 2020;110:110662.
    Abstract     Related articles   

  521. MORALES-BARRERA R, Suarez C, Gonzalez M, Valverde C, et al
    The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
    Cancer Treat Rev. 2020;86:102000.
    Abstract     Related articles   

  522. LUO J, Shivappa N, Hebert JR, Xu X, et al
    Dietary inflammatory index and bladder cancer risk: a prospective study.
    Eur J Clin Nutr. 2020 Mar 19. pii: 10.1038/s41430-020-0602.
    Abstract     Related articles   

  523. WU H, Zhang X, Han D, Cao J, et al
    Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8.
    PeerJ. 2020;8:e8721.
    Abstract     Related articles   

  524. FU G, Xu Z, Chen X, Pan H, et al
    CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.
    J Cancer. 2020;11:2408-2420.
    Abstract     Related articles   

  525. KAMAT AM, Lerner SP, O'Donnell M, Georgieva MV, et al
    Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2020 Mar 19. pii: S2588-9311(20)30031.
    Abstract     Related articles   

  526. RUPLIN AT, Spengler AMZ, Montgomery RB, Wright JL, et al
    Downstaging of Muscle-Invasive Bladder Cancer Using Neoadjuvant Gemcitabine and Cisplatin or Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Single Regimens or as Switch Therapy Modalities.
    Clin Genitourin Cancer. 2020 Feb 22. pii: S1558-7673(20)30044.
    Abstract     Related articles   

  527. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Urol Oncol. 2020 Mar 20. pii: S1078-1439(20)30042.
    Abstract     Related articles   

  528. TAKEYAMA Y, Kato M, Tamada S, Azuma Y, et al
    Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.
    Cancer Lett. 2020 Mar 18. pii: S0304-3835(20)30132.
    Abstract     Related articles   

  529. WOO S, Panebianco V, Narumi Y, Del Giudice F, et al
    Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2020 Mar 18. pii: S2588-9311(20)30032.
    Abstract     Related articles   

  530. BENDERSKA-SODER N, Hovanec J, Pesch B, Goebell PJ, et al
    Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
    Urol Oncol. 2020 Mar 18. pii: S1078-1439(20)30007.
    Abstract     Related articles   

  531. WANG Y, Ma DL, Yu CH, Sha KF, et al
    MicroRNA-370 suppresses SOX12 transcription and acts as a tumor suppressor in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:2303-2312.
    Abstract     Related articles   

  532. XIE F, Zhao N, Zhang H, Xie D, et al
    Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer.
    J Cancer. 2020;11:1907-1912.
    Abstract     Related articles   

  533. BORGNA V, Lobos-Gonzalez L, Guevara F, Landerer E, et al
    Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors.
    J Cancer. 2020;11:1780-1791.
    Abstract     Related articles   

  534. YAN X, Fu X, Guo ZX, Liu XP, et al
    Construction and validation of an eight-gene signature with great prognostic value in bladder cancer.
    J Cancer. 2020;11:1768-1779.
    Abstract     Related articles   

  535. XIONG T, Huang C, Li J, Yu S, et al
    LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.
    J Cancer. 2020;11:1751-1760.
    Abstract     Related articles   

  536. WANG Z, Gao W, Li J, Wang T, et al
    Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-Muscle Invasive Bladder Cancer in the Han Chinese Population.
    J Cancer. 2020;11:1668-1678.
    Abstract     Related articles   

  537. YUAN S, Luan X, Chen H, Shi X, et al
    Long non-coding RNA EGFR-AS1 sponges micorRNA-381 to upregulate ROCK2 in bladder cancer.
    Oncol Lett. 2020;19:1899-1905.
    Abstract     Related articles   

  538. WANG X, Meng R, Hu QM
    LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.
    Front Genet. 2020;11:180.
    Abstract     Related articles   

  539. WEI X, Wang B, Wang Q, Yang X, et al
    MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI.
    Front Pharmacol. 2020;11:164.
    Abstract     Related articles   

  540. LI Y, Hendryx MS, Xun P, He K, et al
    The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women.
    Cancer Causes Control. 2020 Mar 19. pii: 10.1007/s10552-020-01294.
    Abstract     Related articles   

  541. BJURLIN MA, Matulewicz RS, Roberts TR, Dearing BA, et al
    Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review.
    Eur Urol Oncol. 2020 Mar 7. pii: S2588-9311(20)30029.
    Abstract     Related articles   

  542. OZCAN Y, Caglar F, Celik S, Demir AB, et al
    The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study.
    Urol Oncol. 2020 Mar 16. pii: S1078-1439(20)30062.
    Abstract     Related articles   

  543. MICHEL C, Robertson HL, Camargo J, Hamilton-Reeves JM, et al
    Nutrition risk and assessment process in patients with bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2020 Mar 16. pii: S1078-1439(20)30060.
    Abstract     Related articles   

  544. ZHANG J, Zhou X, Ding H, Wang L, et al
    The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
    BMC Urol. 2020;20:31.
    Abstract     Related articles   

  545. YANAGIHARA Y, Nishida K, Watanabe R, Koyama K, et al
    Feasibility of Laparoscopic Radical Cystectomy in Elderly Patients: A Comparative Analysis of Clinical Outcomes in a Single Institution.
    Acta Med Okayama. 2019;73:417-418.
    Abstract     Related articles   

  546. BRASSETTI A, Tuderti G, Anceschi U, Ferriero M, et al
    Combined reporting of surgical quality, cancer control and functional outcomes of robot-assisted radical cystectomy with intracorporeal orthotopic neobladder into a novel trifecta.
    Minerva Urol Nefrol. 2019;71:590-596.
    Abstract     Related articles   

  547. ALBISINNI S, Veccia A, Aoun F, Diamand R, et al
    A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy.
    Minerva Urol Nefrol. 2019;71:553-568.
    Abstract     Related articles   

  548. BOUHAJJA L, Farah F, Garbouj N, Rammeh S, et al
    Primary signet-ring cell carcinoma of the urinary bladder: A report of two cases.
    Tunis Med. 2019;97:167-169.
    Abstract     Related articles   

  549. COOK T, Ma Y, Gamagedara S
    Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.
    J Pharm Biomed Anal. 2020;177:112854.
    Abstract     Related articles   

  550. LIN P, Wen DY, Chen L, Li X, et al
    A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma.
    Eur Radiol. 2020;30:547-557.
    Abstract     Related articles   

  551. TOLWIN Y, Gillis R, Agmon IN, Shrem NS, et al
    Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30152.
    Abstract     Related articles   

  552. GELWAN E, Zhang ML, Allison DB, Cowan ML, et al
    Variability among observers utilizing the CellSolutions BestCyte Cell Sorter imaging system for the assessment of urinary tract cytology specimens.
    J Am Soc Cytopathol. 2019;8:18-26.
    Abstract     Related articles   

  553. XU X, Liu K, Jiao B, Luo K, et al
    Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer.
    J Control Release. 2020 Mar 31. pii: S0168-3659(20)30180.
    Abstract     Related articles   

  554. LUO C, Huang B, Wu Y, Chen J, et al
    Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis.
    Eur Radiol. 2020 Apr 2. pii: 10.1007/s00330-020-06802.
    Abstract     Related articles   

  555. SCHULZ WA, Hoffmann MJ, Niegisch G, Fussel S, et al
    [Report from the 9th symposium of the German Association for Bladder Cancer Research].
    Urologe A. 2020 Apr 2. pii: 10.1007/s00120-020-01181.
    Abstract     Related articles   

  556. PEREIRA GLDC, Almeida TC, Seibert JB, Amparo TR, et al
    Antitumor effect of Cymbopogon densiflorus (Linneu) essential oil in bladder cancer cells.
    Nat Prod Res. 2020 Apr 2:1-5. doi: 10.1080/14786419.2020.1747453.
    Abstract     Related articles   

  557. PENG Y, Chen Y, Chen S, Wang J, et al
    JUND-dependent upregulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer.
    J Biochem. 2020 Apr 2. pii: 5815268. doi: 10.1093.
    Abstract     Related articles   

  558. SEMENIUK-WOJTAS A, Lubas A, Cierniak S, Brzoskowska U, et al
    Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2020 Apr 1. pii: 10.1007/s00432-020-03202.
    Abstract     Related articles   

  559. LV J, Zhu Y, Ji A, Zhang Q, et al
    Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Biosci Rep. 2020 Apr 2. pii: 222532. doi: 10.1042/BSR20194337.
    Abstract     Related articles   

  560. MEEKS JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, et al
    Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
    Nat Rev Urol. 2020 Mar 31. pii: 10.1038/s41585-020-0304.
    Abstract     Related articles   

  561. JIANG J, Bi Y, Liu XP, Yu D, et al
    To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    J Cell Mol Med. 2020 Mar 31. doi: 10.1111/jcmm.15193.
    Abstract     Related articles   

  562. MIYAKE M, Matsuyama H, Teramukai S, Kinoshita F, et al
    A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.
    Int J Clin Oncol. 2020 Mar 30. pii: 10.1007/s10147-020-01654.
    Abstract     Related articles   

  563. ABBASTABAR M, Sarfi M, Golestani A, Karimi A, et al
    Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer.
    EXCLI J. 2020;19:301-310.
    Abstract     Related articles   

  564. FANG W, Yang ZY, Chen TY, Shen XF, et al
    Ethnicity and survival in bladder cancer: a population-based study based on the SEER database.
    J Transl Med. 2020;18:145.
    Abstract     Related articles   

  565. WEI X, Bian F, Cai X, Wang Y, et al
    Multiplexed Detection Strategy for Bladder Cancer MicroRNAs Based on Photonic Crystal Barcodes.
    Anal Chem. 2020 Mar 31. doi: 10.1021/acs.analchem.0c00630.
    Abstract     Related articles   

  566. HARSHA BS, Manikandan R, Sreerag KS, Dorairajan LN, et al
    Eosinophilic Leukemoid Reaction with Eosinophilic Tumor Tissue Infiltration as an Extermely Poor Prognostic Factor in Urinary Bladder Cancer- a Known Entity Revisited.
    Pathol Oncol Res. 2020 Mar 29. pii: 10.1007/s12253-020-00807.
    Abstract     Related articles   

  567. TAO W, Sun C, Yao Q, Fu K, et al
    The clinical study of en Bloc transurethral resection with 980 nm Laser for treatment of primary non-muscle invasive bladder cancer.
    J Xray Sci Technol. 2020 Mar 21. pii: XST190616. doi: 10.3233/XST-190616.
    Abstract     Related articles   

  568. CHO JM, Moon KT, Lee HJ, Shin SC, et al
    Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.
    Medicine (Baltimore). 2020;99:e19597.
    Abstract     Related articles   

  569. YANG Y, Jain RK, Glenn ST, Xu B, et al
    Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  570. HONG SB, Lee NK, Kim S, Son IW, et al
    Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    J Magn Reson Imaging. 2020 Mar 27. doi: 10.1002/jmri.27141.
    Abstract     Related articles   

  571. TESCH ME, Pater JA, Vandekerkhove G, Wang G, et al
    Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    NPJ Genom Med. 2020;5:12.
    Abstract     Related articles   

  572. ZHU Z, Chang F, Liu J, Wang J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of circ_100242/miR-145 pathway in bladder cancer.
    Oncol Lett. 2020;19:2971-2978.
    Abstract     Related articles   

  573. WU Z, Zhu K, Liu Q, Liu Y, et al
    Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
    Int J Med Sci. 2020;17:762-772.
    Abstract     Related articles   

  574. JOBCZYK M, Stawiski K, Fendler W, Rozanski W, et al
    Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis.
    Cancer Med. 2020 Mar 26. doi: 10.1002/cam4.3007.
    Abstract     Related articles   

  575. ZIARAN S, Harsanyi S, Bevizova K, Varchulova Novakova Z, et al
    Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence.
    Eur J Histochem. 2020;64.
    Abstract     Related articles   

  576. RKMAN D, Likic R, Bebek M, Gnjidic M, et al
    Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report.
    Croat Med J. 2019;60:552-555.
    Abstract     Related articles   

  577. SAMADDAR S, Mazur J, Boehm D, Thompson DH, et al
    Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules.
    Int J Nanomedicine. 2019;14:9547-9561.
    Abstract     Related articles   

  578. GRIVAS P, DerSarkissian M, Shenolikar R, Laliberte F, et al
    Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA.
    Future Oncol. 2019;15:3809-3818.
    Abstract     Related articles   

  579. NAGUMO Y, Kojima T, Shiga M, Kandori S, et al
    A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.
    Int J Clin Oncol. 2020;25:354-361.
    Abstract     Related articles   

  580. LIU Y, Huang J, Urbanowicz RJ, Chen K, et al
    Embracing study heterogeneity for finding genetic interactions in large-scale research consortia.
    Genet Epidemiol. 2020;44:52-66.
    Abstract     Related articles   

  581. LIU L, Zhao Y, Cui J, Chen S, et al
    Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm.
    Future Oncol. 2019;15:3797-3807.
    Abstract     Related articles   

  582. RODRIGUEZ PENA MDC, Springer SU, Taheri D, Li L, et al
    Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.
    Virchows Arch. 2020;476:423-429.
    Abstract     Related articles   

  583. MORET R, Hellmers L, Zhang X, Gills J, et al
    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    J Vis Exp. 2019;.
    Abstract     Related articles   

  584. AKGUL M, MacLennan GT, Cheng L
    Distinct mutational landscape of inverted urothelial papilloma.
    J Pathol. 2019;249:3-5.
    Abstract     Related articles   

  585. KAO C, McNamara M, Alley C, Spector N, et al
    A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
    Clin Genitourin Cancer. 2019;17:e672-e677.
    Abstract     Related articles   

  586. MAKBOUL R, Hassan HM, Refaiy A, Abdelkawi IF, et al
    A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
    Clin Genitourin Cancer. 2019;17:e712-e719.
    Abstract     Related articles   

  587. KOHADA Y, Goriki A, Yukihiro K, Ohara S, et al
    The risk factors of urinary tract infection after transurethral resection of bladder tumors.
    World J Urol. 2019 Mar 26. pii: 10.1007/s00345-019-02737.
    Abstract     Related articles   

  588. ZAMBONI S, Moschini M, Gallina A, Colombo R, et al
    The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.
    World J Urol. 2019;37:2707-2714.
    Abstract     Related articles   

  589. YANG G, Zhang L, Liu M, Liu Q, et al
    CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder.
    World J Urol. 2019;37:2721-2726.
    Abstract     Related articles   

  590. LI R, Kukreja JEB, Seif MA, Petros FG, et al
    The role of metastatic burden in cytoreductive/consolidative radical cystectomy.
    World J Urol. 2019;37:2691-2698.
    Abstract     Related articles   

  591. LORA V, Haneke E, Scarabello A, Morrone A, et al
    Subungual metastasis: expanding the spectrum.
    J Eur Acad Dermatol Venereol. 2019;33:e282-e284.
    Abstract     Related articles   

  592. ALHALABI O, Rafei H, Shah A, Siefker-Radtke A, et al
    Targeting advanced urothelial carcinoma-developing strategies.
    Curr Opin Oncol. 2019;31:207-215.
    Abstract     Related articles   

  593. THAKER H, Ghodoussipour S, Saffarian M, Ashrafi A, et al
    Extended hospital stay after radical cystectomy with enhanced recovery protocol.
    Can J Urol. 2019;26:9654-9659.
    Abstract     Related articles   

  594. GRIMM T, Grimm J, Buchner A, Schulz G, et al
    Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.
    World J Urol. 2019;37:2385-2392.
    Abstract     Related articles   

  595. YUEN C, Reid P, Zhang Z, Soliven B, et al
    Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study.
    J Immunother. 2019;42:94-96.
    Abstract     Related articles   

  596. STANGL-KREMSER J, D'Andrea D, Vartolomei M, Abufaraj M, et al
    Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
    Urol Oncol. 2019;37:372-379.
    Abstract     Related articles   

  597. QIU JG, Shi DY, Liu X, Zheng XX, et al
    Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
    J Cell Physiol. 2019;234:6976-6982.
    Abstract     Related articles   

  598. DIAO X, Cai J, Zheng J, Kong J, et al
    Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer.
    Cancer Commun (Lond). 2020 Apr 12. doi: 10.1002/cac2.12017.
    Abstract     Related articles   

  599. FUJITA N, Hatakeyama S, Momota M, Kido K, et al
    Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guerin in patients with high-risk non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Apr 9. pii: S1078-1439(20)30093.
    Abstract     Related articles   

  600. LIN YZ, Wu YP, Ke ZB, Cai H, et al
    Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
    Med Sci Monit. 2020;26:e920504.
    Abstract     Related articles   

  601. CELIK S, Sari H, Ugur Mungan M, Yorukoglu K, et al
    Assessment of ex-vivo efficacy (oncogram) of immunotherapeutic and chemotherapeutic agents in bladder cancer: A pilot study of personalized treatment.
    J BUON. 2020;25:295-301.
    Abstract     Related articles   

  602. YE Z, Liang Z, Mi Q, Guo Y, et al
    Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis.
    J BUON. 2020;25:280-285.
    Abstract     Related articles   

  603. XU A, Yang GG, Zhang Y, Zhao ST, et al
    Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of beta-catenin signalling pathway.
    J BUON. 2020;25:274-279.
    Abstract     Related articles   

  604. WANG Y, Liu Q, Men T, Liang Y, et al
    A microfluidic system based on the monoclonal antibody BCMab1 specifically captures circulating tumor cells from bladder cancer patients.
    J Biomater Sci Polym Ed. 2020 Apr 10:1-12. doi: 10.1080/09205063.2020.1748332.
    Abstract     Related articles   

  605. SALEH AA, Gohar SF, Hemida AS, Elgharbawy M, et al
    Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer.
    Biochem Genet. 2020 Apr 9. pii: 10.1007/s10528-020-09962.
    Abstract     Related articles   

  606. WANG X, He H, Rui W, Xie X, et al
    Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.
    Onco Targets Ther. 2020;13:2483-2490.
    Abstract     Related articles   

  607. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells.
    Drug Des Devel Ther. 2020;14:1209-1218.
    Abstract     Related articles   

  608. IYER G, Tully CM, Zabor EC, Bochner BH, et al
    Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience.
    Clin Genitourin Cancer. 2020 Mar 6. pii: S1558-7673(20)30048.
    Abstract     Related articles   

  609. ZHONG XL, Wang L, Yan X, Yang XK, et al
    MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.
    Eur Rev Med Pharmacol Sci. 2020;24:2955-2964.
    Abstract     Related articles   

  610. CUI YP, Xie M, Pan WX, Zhang ZY, et al
    HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Eur Rev Med Pharmacol Sci. 2020;24:2945-2954.
    Abstract     Related articles   

  611. KUNATH F
    [Robotic versus open radical cystectomy for adults with bladder cancer].
    Urologe A. 2020 Apr 8. pii: 10.1007/s00120-020-01185.
    Abstract     Related articles   

  612. GUO J, Zhang J, Yang T, Zhang W, et al
    MiR-22 suppresses the growth and metastasis of bladder cancer cells by targeting E2F3.
    Int J Clin Exp Pathol. 2020;13:587-596.
    Abstract     Related articles   


  613. [Consensus on standardized handling of specimen and pathological diagnosis of bladder cancer].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:305-310.
    Abstract     Related articles   

  614. MARIAPPAN P, Fineron P, O'Donnell M, Gailer RM, et al
    Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.
    World J Urol. 2020 Apr 7. pii: 10.1007/s00345-020-03180.
    Abstract     Related articles   

  615. VAGO R, Ravelli A, Bettiga A, Casati S, et al
    Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  616. AGHAALIKHANI N, Zamani M, Allameh A, Mashayekhi A, et al
    Involvement of haptoglobin phenotypes and genotypes in non-muscle invasive bladder cancer: A possible prognostic marker for risk stratification.
    EXCLI J. 2020;19:351-359.
    Abstract     Related articles   

  617. CAPECE M, Spirito L, La Rocca R, Napolitano L, et al
    Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
    Arch Ital Urol Androl. 2020;92:17-20.
    Abstract     Related articles   

  618. MOJARRAD M, Moghbeli M
    Genetic and molecular biology of bladder cancer among Iranian patients.
    Mol Genet Genomic Med. 2020 Apr 6:e1233. doi: 10.1002/mgg3.1233.
    Abstract     Related articles   

  619. SROUGI V, Reis ST, Viana N, Gallucci FP, et al
    Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder cancer.
    World J Urol. 2020 Apr 6. pii: 10.1007/s00345-020-03188.
    Abstract     Related articles   

  620. HWANG MJ, Kamat AM, Dinney CP, Czerniak B, et al
    Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.
    Am J Clin Pathol. 2020 Apr 7. pii: 5816797. doi: 10.1093.
    Abstract     Related articles   

  621. WANG Z, Shang Y, Luan T, Duan Y, et al
    Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer.
    Cancer Imaging. 2020;20:26.
    Abstract     Related articles   

  622. KURMAN Y, Kiliccioglu I, Dikmen AU, Esendagli G, et al
    Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.
    Exp Biol Med (Maywood). 2020 Apr 6:1535370220917367.
    Abstract     Related articles   

  623. BHASIN A, Sanders EC, Ziegler JM, Briggs JS, et al
    A Virus BioResistor (VBR) for the Detection of the Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute.
    Anal Chem. 2020 Apr 6. doi: 10.1021/acs.analchem.0c00534.
    Abstract     Related articles   

  624. SIKIC D, Eckstein M, Wirtz RM, Jarczyk J, et al
    FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  625. HENTSCHEL AE, Nieuwenhuijzen JA, Bosschieter J, Splunter APV, et al
    Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  626. SHEN C, Wu Z, Wang Y, Gao S, et al
    Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Cancer Med. 2020 Apr 6. doi: 10.1002/cam4.3006.
    Abstract     Related articles   

  627. HILTBRUNNER S, Mints M, Eldh M, Rosenblatt R, et al
    Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.
    Sci Rep. 2020;10:5960.
    Abstract     Related articles   

  628. PAGUIO JA, Yao JS, Reyes MSGL, Lee G, et al
    Bladder Cancer and Google Trends: Associations Between US Search Patterns and Disease Outcomes May Show Need for Improved Awareness Strategies.
    J Cancer Educ. 2020 Apr 5. pii: 10.1007/s13187-020-01739.
    Abstract     Related articles   

  629. POHAR KS
    Blue Light Cystoscopy: Indications and Outcomes.
    Curr Urol Rep. 2020;21:19.
    Abstract     Related articles   

  630. GOMES ATPC, Fernandes R, Ribeiro CF, Tome JPC, et al
    Synthesis, Characterization and Photodynamic Activity against Bladder Cancer Cells of Novel Triazole-Porphyrin Derivatives.
    Molecules. 2020;25.
    Abstract     Related articles   

  631. PISAPIA L, Terreri S, Barba P, Mastroianni M, et al
    Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis.
    Biology (Basel). 2020;9.
    Abstract     Related articles   

  632. YANG C, Li Q, Chen X, Zhang Z, et al
    Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  633. JIN L, Lu MH, Dai GC, Yao Q, et al
    O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.
    Neoplasma. 2020 Apr 16. pii: 191006N1009. doi: 10.4149/neo_2020_191006N1009.
    Abstract     Related articles   

  634. VAN DER HEIJDEN AG, Witjes JA
    Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnostics: The Replacement for Surgery?
    Eur Urol Oncol. 2020 Apr 14. pii: S2588-9311(20)30043.
    Abstract     Related articles   

  635. KRAJEWSKI W, Nowak L, Poletajew S
    A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Apr 14. pii: S1078-1439(20)30133.
    Abstract     Related articles   

  636. SPAGNUOLO M, Costantini M, Ferriero M, Varmi M, et al
    Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
    J Exp Clin Cancer Res. 2020;39:68.
    Abstract     Related articles   

  637. WEN L, Pan X, Yu Y, Yang B, et al
    Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity.
    BMC Urol. 2020;20:39.
    Abstract     Related articles   

  638. AFFERI L, Moschini M, Cumberbatch MG, Catto JW, et al
    Biomarkers predicting oncological outcomes of high-risk non-muscle-invasive bladder cancer.
    Minerva Urol Nefrol. 2020 Apr 16. pii: S0393-2249.20.03786.
    Abstract     Related articles   

  639. RASPOLLINI MR, Montironi R, Mazzucchelli R, Cimadamore A, et al
    pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
    Virchows Arch. 2020 Apr 15. pii: 10.1007/s00428-020-02808.
    Abstract     Related articles   

  640. KIM JW, Ahn ST, Oh MM, Moon DG, et al
    Increased incidence of bladder cancer with metabolically unhealthy status: analysis from the National Health Checkup database in Korea.
    Sci Rep. 2020;10:6476.
    Abstract     Related articles   

  641. ZHOU Z, Cui D, Sun MH, Huang JL, et al
    CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
    FASEB J. 2020 Apr 15. doi: 10.1096/fj.201902659.
    Abstract     Related articles   

  642. MENCUCCI MV, Lapyckyj L, Rosso M, Besso MJ, et al
    Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.
    Front Oncol. 2020;10:283.
    Abstract     Related articles   

  643. PECORARO M, Takeuchi M, Vargas HA, Muglia VF, et al
    Overview of VI-RADS in Bladder Cancer.
    AJR Am J Roentgenol. 2020 Apr 14:1-10. doi: 10.2214/AJR.20.22763.
    Abstract     Related articles   

  644. NING JZ, Yu WM, Cheng F, Rao T, et al
    MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3.
    J Cancer. 2020;11:3424-3432.
    Abstract     Related articles   

  645. LIN YC, Chen MC, Hsieh TH, Liou JP, et al
    CK1delta as a potential therapeutic target to treat bladder cancer.
    Aging (Albany NY). 2020;12:5764-5780.
    Abstract     Related articles   

  646. SHEN J, Lv X, Zhang L
    GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process.
    Onco Targets Ther. 2020;13:2511-2522.
    Abstract     Related articles   

  647. WEI JG, Wang C, Teng XD
    [Pathological diagnosis and differential diagnosis of non-urothelial carcinoma of the bladder].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:386-392.
    Abstract     Related articles   

  648. YIN XN, Zhang Q, He XL, Zhao M, et al
    [Large nested variant of urothelial carcinoma of urinary bladder: a clinicopathological analysis of five cases].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:317-323.
    Abstract     Related articles   

  649. FAN DG, Wu CL, Huang HJ, Wu L, et al
    [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:311-316.
    Abstract     Related articles   

  650. QIN J, Zhou G, Chen X
    Imaging manifestations of bladder paraganglioma.
    Ann Palliat Med. 2020;9:346-351.
    Abstract     Related articles   

  651. TULLY KH, Roghmann F, Noldus J, Chen X, et al
    Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2020 Mar 31. pii: S1558-7673(20)30075.
    Abstract     Related articles   

  652. LI J, Ma W, Cheng X, Zhang X, et al
    Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells.
    Arch Biochem Biophys. 2020 Apr 23:108363. doi: 10.1016/j.abb.2020.108363.
    Abstract     Related articles   

  653. GOEL S, Aggarwal A, Iqbal A, Gupta M, et al
    18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
    Eur J Surg Oncol. 2020 Apr 15. pii: S0748-7983(20)30412.
    Abstract     Related articles   

  654. HARMON SA, Sanford TH, Brown GT, Yang C, et al
    Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
    JCO Clin Cancer Inform. 2020;4:367-382.
    Abstract     Related articles   

  655. LONGDON E, Mistry H, Pratt O, Donnelly A, et al
    Variables associated with survival in patients with invasive bladder cancer with and without surgery.
    Anaesthesia. 2020 Apr 24. doi: 10.1111/anae.15034.
    Abstract     Related articles   

  656. PENG T, Wang G, Cheng S, Xiong Y, et al
    The role and function of PPARgamma in bladder cancer.
    J Cancer. 2020;11:3965-3975.
    Abstract     Related articles   

  657. KIM H, Lee SJ, Lee IK, Min SC, et al
    Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  658. MATSUSHITA Y, Watanabe K, Watanabe H, Tamura K, et al
    Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
    Jpn J Clin Oncol. 2020 Apr 23. pii: 5823898. doi: 10.1093.
    Abstract     Related articles   

  659. MACLENNAN SJ, MacLennan S
    How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
    Front Oncol. 2020;10:465.
    Abstract     Related articles   

  660. BALOGLU IH, Albayrak AT, Gunay KC, Yavuzsan AH, et al
    Regression of the Sweet's syndrome after Bacillus Calmette-Guerin therapy: A bladder cancer case report.
    Urol Case Rep. 2020;31:101202.
    Abstract     Related articles   

  661. BHAKTA PS, Harris EA, Connolly MM
    A patient with history of bladder cancer presenting with an axillary mass: A rare case of supradiaphragmatic cutaneous bladder cancer metastasis.
    Urol Case Rep. 2020;31:101157.
    Abstract     Related articles   

  662. YU EYW, Wesselius A, Sinhart C, Wolk A, et al
    A Data Mining Approach to Investigate Food Groups related to Incidence of Bladder Cancer in the BLadder cancer Epidemiology and Nutritional Determinants International Study.
    Br J Nutr. 2020 Apr 23:1-28. doi: 10.1017/S0007114520001439.
    Abstract     Related articles   

  663. LUO J, Zhou L, Lin S, Yan W, et al
    Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.
    Clinics (Sao Paulo). 2020;75:e1639.
    Abstract     Related articles   

  664. TAN QL, Zhou CY, Cheng L, Luo M, et al
    Immunotherapy of Bacillus CalmetteGuerin by targeting macrophages against bladder cancer in a NOD/scid IL2Rg/ mouse model.
    Mol Med Rep. 2020 Apr 22. doi: 10.3892/mmr.2020.11090.
    Abstract     Related articles   

  665. HEKTOEN HH, Robsahm TE, Andreassen BK, Stenehjem JS, et al
    Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
    Cancer Med. 2020 Apr 21. doi: 10.1002/cam4.3060.
    Abstract     Related articles   

  666. YAO Z, Jiang Y, Zhu X, Wu B, et al
    Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Int J Clin Oncol. 2020 Apr 21. pii: 10.1007/s10147-020-01679.
    Abstract     Related articles   

  667. WANG H, Xu X, Zhang X, Liu Y, et al
    Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06796.
    Abstract     Related articles   

  668. MANI J, Neuberth MT, Fettel J, Senf B, et al
    Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients.
    Oncol Res Treat. 2020 Apr 21:1-8. doi: 10.1159/000507094.
    Abstract     Related articles   

  669. YAO K, He L, Gan Y, Liu J, et al
    HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  670. GUO Y, Wang J, Zhou K, Lv J, et al
    Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC.
    FASEB J. 2020 Apr 21. doi: 10.1096/fj.201903266.
    Abstract     Related articles   

  671. LI W, Zeng J, Luo B, Mao Y, et al
    [High expression of activated CD4(+) memory T cells and CD8(+) T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36:97-103.
    Abstract     Related articles   

  672. MALANGONE-MONACO E, Wilson K, Diakun D, Tayama D, et al
    Cost of cystectomy-related complications in patients with bladder cancer in the United States.
    Curr Med Res Opin. 2020 Apr 21:1. doi: 10.1080/03007995.2020.1758927.
    Abstract     Related articles   

  673. WANG Z, Zhou Q, Zeng H, Zhang H, et al
    Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
    Oncoimmunology. 2020;9:1747332.
    Abstract     Related articles   

  674. SANCHEZ A, Kissel S, Coletta A, Scott J, et al
    Impact of body size and body composition on bladder cancer outcomes: Risk stratification and opportunity for novel interventions.
    Urol Oncol. 2020 Apr 18. pii: S1078-1439(20)30104.
    Abstract     Related articles   

  675. BENLIER N, Solakhan M, Yildirim Z, Kaya V, et al
    A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1.
    Urol Oncol. 2020 Apr 17. pii: S1078-1439(20)30131.
    Abstract     Related articles   

  676. WANG J, Wu Y, He W, Yang B, et al
    Nomogram for predicting overall survival of patients with bladder cancer: A population-based study.
    Int J Biol Markers. 2020 Apr 20:1724600820907605. doi: 10.1177/1724600820907605.
    Abstract     Related articles   

  677. ALBERTO BANDEIRA FERREIRA L, Garcia-Fossa F, Radaic A, Duran N, et al
    Biogenic silver nanoparticles: in vitro and in vivo antitumor activity in bladder cancer.
    Eur J Pharm Biopharm. 2020 Apr 17. pii: S0939-6411(20)30106.
    Abstract     Related articles   

  678. BAHRAMI S, Gheysarzadeh A, Sotoudeh M, Bandehpour M, et al
    The Association Between Gelsolin-like Actin-capping Protein (CapG) Overexpression and Bladder Cancer Prognosis.
    Urol J. 2020 Apr 20. pii: 5664/1466. doi: 10.22037/uj.v0i0.5664.
    Abstract     Related articles   

  679. XUE M, Liu L, Du G, Fu Z, et al
    Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
    Urol J. 2020 Apr 20. pii: 5538/1462. doi: 10.22037/uj.v0i0.5538.
    Abstract     Related articles   

  680. NISHIYAMA H, Yamamoto Y, Sassa N, Nishimura K, et al
    Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
    Int J Clin Oncol. 2020;25:165-174.
    Abstract     Related articles   

  681. TURKBEY B, Czarniecki M, Shih JH, Harmon SA, et al
    Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    AJR Am J Roentgenol. 2020;214:105-113.
    Abstract     Related articles   

  682. MANOCHA U, Kardos J, Selitsky S, Zhou M, et al
    RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
    Am J Pathol. 2020;190:134-144.
    Abstract     Related articles   

  683. AFFERI L, Zamboni S, Karnes RJ, Roghmann F, et al
    The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03205.
    Abstract     Related articles   

  684. TEOH JYC, Roupret M, Shariat SF, Herrmann T, et al
    Intravesical therapy for bladder cancer in the pandemic of Covid-19.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03218.
    Abstract     Related articles   

  685. RADES D, Nguyen T, Schild SE
    The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
    In Vivo. 2020;34:1317-1320.
    Abstract     Related articles   

  686. TAMURA K, Watanabe K, Matsushita Y, Watanabe H, et al
    Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both In Vitro and In Vivo.
    In Vivo. 2020;34:1001-1008.
    Abstract     Related articles   

  687. JAZZAR U, Shan Y, Klaassen Z, Freedland SJ, et al
    Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer.
    J Geriatr Oncol. 2020 Apr 27. pii: S1879-4068(20)30061.
    Abstract     Related articles   

  688. HEYES SM, Bond MJ
    Pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care.
    Eur J Oncol Nurs. 2020;46:101757.
    Abstract     Related articles   

  689. GAO L, Meng J, Zhang M, Fan S, et al
    Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
    DNA Cell Biol. 2020 Apr 29. doi: 10.1089/dna.2019.5224.
    Abstract     Related articles   

  690. THAM SM, Mahendran R, Chiong E, Wu QH, et al
    Gmcsf and Ifnalpha gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer.
    Future Oncol. 2020 Apr 30. doi: 10.2217/fon-2020-0137.
    Abstract     Related articles   

  691. LIU S, Chen L, Zhao H, Li Q, et al
    Integrin beta8 facilitates tumor growth and drug resistance via a YBX1 dependent signaling pathway in bladder cancer.
    Cancer Sci. 2020 Apr 29. doi: 10.1111/cas.14439.
    Abstract     Related articles   

  692. SANDOUGHDARAN S, Razzaghdoust A, Tabibi A, Basiri A, et al
    Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.
    Urol J. 2020 Apr 30. pii: 5719/1477. doi: 10.22037/uj.v0i0.5719.
    Abstract     Related articles   

  693. JAZAYERI MH, Aghaie T, Nedaeinia R, Manian M, et al
    Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
    Cancer Immunol Immunother. 2020 Apr 30. pii: 10.1007/s00262-020-02559.
    Abstract     Related articles   

  694. CUI Y, Xie M, Zhang Z
    LINC00958 Involves in Bladder Cancer Through Sponging miR-378a-3p to Elevate IGF1R.
    Cancer Biother Radiopharm. 2020 Apr 28. doi: 10.1089/cbr.2019.3300.
    Abstract     Related articles   

  695. LIU Q, Zhou Q, Zhong P
    circ_0067934 increases bladder cancer cell proliferation, migration and invasion through suppressing miR-1304 expression and increasing Myc expression levels.
    Exp Ther Med. 2020;19:3751-3759.
    Abstract     Related articles   

  696. PEDERZOLI F, Ferrarese R, Amato V, Locatelli I, et al
    Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients.
    Eur Urol Oncol. 2020 Apr 25. pii: S2588-9311(20)30050.
    Abstract     Related articles   

  697. MONTEIRO-REIS S, Lameirinhas A, Miranda-Goncalves V, Felizardo D, et al
    Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  698. STEFAN-VAN STADEN RI, Gheorghe DC, Jinga V, Sima CS, et al
    Fast Screening of Whole Blood and Tumor Tissue for Bladder Cancer Biomarkers Using Stochastic Needle Sensors.
    Sensors (Basel). 2020;20.
    Abstract     Related articles   

  699. XIANG H, Liu Z, Zhou YB, Yao Q, et al
    [Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells].
    Zhonghua Yi Xue Za Zhi. 2020;100:1249-1254.
    Abstract     Related articles   

  700. DUNST J
    [Organ-preserving treatment of bladder cancer].
    Strahlenther Onkol. 2020 Apr 27. pii: 10.1007/s00066-020-01608.
    Abstract     Related articles   

  701. LOUGHLIN KR
    Commentary on characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 Apr 24. pii: S1078-1439(20)30137.
    Abstract     Related articles   

  702. MASUDA N, Murakami K, Kita Y, Hamada A, et al
    Trp53 mutation in Krt5-expressing basal cells facilitates the development of basal squamous-like invasive bladder cancer in the chemical carcinogenesis of mouse bladder.
    Am J Pathol. 2020 Apr 24. pii: S0002-9440(20)30202.
    Abstract     Related articles   

  703. PEREIRA PMR, Parada B, Ribeiro-Rodrigues TM, Fontes-Ribeiro CA, et al
    Caveolin-1 modulation increases efficacy of a galacto-conjugated phthalocyanine in bladder cancer cells resistant to photodynamic therapy.
    Mol Pharm. 2020 Apr 27. doi: 10.1021/acs.molpharmaceut.0c00298.
    Abstract     Related articles   

  704. GUO Z, Zhu H, Xu W, Wang X, et al
    Alternative splicing related genetic variants contribute to bladder cancer risk.
    Mol Carcinog. 2020 Apr 27. doi: 10.1002/mc.23207.
    Abstract     Related articles   

  705. QUAN X, Qin Q, Chen Y, Wei Y, et al
    Independent risk factors and the potential predictors of bladder cancer-related ischemic stroke.
    J Int Med Res. 2020;48:300060520919227.
    Abstract     Related articles   

  706. KRAJEWSKI W, Nowak L, Poletajew S, Tukiendorf A, et al
    The Impact of Restaging Transurethral Resection of Bladder Tumour on Survival Parameters in T1 Non-Muscle Invasive Bladder Cancer - Systematic Review and Meta-analysis.
    J Endourol. 2020 Apr 25. doi: 10.1089/end.2020.0301.
    Abstract     Related articles   

  707. VAKAR LOPEZ F
    Molecular Subtyping Bladder Cancer: Is it ready for clinical practice?
    Turk J Med Sci. 2020 Apr 27. doi: 10.3906/sag-2004.
    Abstract     Related articles   

  708. LESHNO A, Vishnevskia-Dai V, Barak A, Zur D, et al
    OPTICAL DENSITY RATIO OF THE SUBRETINAL FLUID IN CHOROIDAL MELANOMA AND METASTASIS.
    Retina. 2017 Dec 15. doi: 10.1097/IAE.0000000000001998.
    Abstract     Related articles   

  709. XU C, Lin X, Qian W, Na R, et al
    Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.
    Medicine (Baltimore). 2020;99:e19980.
    Abstract     Related articles   

  710. ZHOU M, Zhang Z, Bao S, Hou P, et al
    Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer.
    Brief Bioinform. 2020 May 8. pii: 5831478. doi: 10.1093.
    Abstract     Related articles   

  711. WANG C, He H, Fang W
    Oncogenic roles of the cholesterol metabolite 25-hydroxycholesterol in bladder cancer.
    Oncol Lett. 2020;19:3671-3676.
    Abstract     Related articles   

  712. DUAN F, Mei C, Yang L, Zheng J, et al
    Vitamin K2 promotes PI3K/AKT/HIF-1alpha-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells.
    Sci Rep. 2020;10:7714.
    Abstract     Related articles   

  713. KIMURA T, Nishiyama H
    [.Topics of Bladder Cancer Treatment of New "Reiwa" Era].
    Gan To Kagaku Ryoho. 2020;47:30-37.
    Abstract     Related articles   

  714. AQUINA CT, Truong M, Justiniano CF, Kaur R, et al
    Variation in Adequate Lymph Node Yield for Gastric, Lung, and Bladder Cancer: Attributable to the Surgeon, Pathologist, or Hospital?
    Ann Surg Oncol. 2020 May 6. pii: 10.1245/s10434-020-08509.
    Abstract     Related articles   

  715. YIP W, Cacciamani G, Bhanvadia SK
    Disparities in Bladder Cancer Outcomes Based on Key Sociodemographic Characteristics.
    Curr Urol Rep. 2020;21:24.
    Abstract     Related articles   

  716. GAO X, Wen X, He H, Zheng L, et al
    Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
    PeerJ. 2020;8:e9078.
    Abstract     Related articles   

  717. OTTLEY EC, Pell R, Brazier B, Hollidge J, et al
    Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
    J Pathol Clin Res. 2020 May 6. doi: 10.1002.
    Abstract     Related articles   

  718. TASKOVSKA M, Kreft ME, Smrkolj T
    Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids.
    Radiol Oncol. 2020.
    Abstract     Related articles   

  719. HUANG Y, Zhu Y, Zhang Z, Li Z, et al
    UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53.
    Cancer Gene Ther. 2020 May 6. pii: 10.1038/s41417-020-0175.
    Abstract     Related articles   

  720. SHI R, Bao X, Rogowski P, Schafer C, et al
    Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  721. SHOU J, Yu C, Zhang D, Zhang Q, et al
    Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer.
    J Cancer. 2020;11:4173-4180.
    Abstract     Related articles   

  722. LIU X, Ke J, Gu L, Tang H, et al
    Long non-coding RNA LINC00675 is associated with bladder cancer metastasis and patient survival.
    J Gene Med. 2020 May 4:e3210. doi: 10.1002/jgm.3210.
    Abstract     Related articles   

  723. WANG T, Zhou Q, Zeng H, Zhang H, et al
    CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2020 May 4. pii: 10.1007/s00262-020-02583.
    Abstract     Related articles   

  724. LI S, Zhao K, Jin Y, Ma Z, et al
    Relapse and Prognosis of Non-Muscle Invasive Bladder Cancer After Combined HOLRBT with Sunitinib and TGC Perfusion Chemotherapy.
    Cancer Biother Radiopharm. 2020 May 1. doi: 10.1089/cbr.2019.3455.
    Abstract     Related articles   

  725. LEPARA Z, Lepara O, Fajkic A, Rebic D, et al
    Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer.
    Rom J Intern Med. 2020.
    Abstract     Related articles   

  726. MAO F, Niu XB, Gu S, Ji L, et al
    Investigation of Leptin G19A polymorphism with bladder cancer risk: A case-control study.
    J Clin Lab Anal. 2020 May 3:e23351. doi: 10.1002/jcla.23351.
    Abstract     Related articles   

  727. RENTSCH CA, Bosshard P, Mayor G, Rieken M, et al
    Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guerin (BCG), in patients with non-muscle invasive bladder cancer and previous failur
    Oncoimmunology. 2020;9:1748981.
    Abstract     Related articles   

  728. CHEN CH, Ho CH, Kuan-Hua Huang S, Shen CH, et al
    Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis.
    Cytokine. 2020;131:155112.
    Abstract     Related articles   

  729. KOBZA-MROCZKOWSKA D, Khot MI
    The current situation of 5-aminolevulinic acid mediated photodynamic therapy in bladder cancer.
    Photodiagnosis Photodyn Ther. 2020 Apr 29:101794.
    Abstract     Related articles   

  730. SHI Z, Pang K, Yang W, Zhou J, et al
    Antitumor mechanism of MAP30 in bladder cancer T24 cells, and its potential toxic effects in mice.
    Cell Mol Biol (Noisy-le-grand). 2020;66:42-48.
    Abstract     Related articles   

  731. LUO Y, Fu X, Han B, Zhang F, et al
    The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells.
    Anticancer Agents Med Chem. 2020 May 1. pii: ACAMC-EPUB-106277.
    Abstract     Related articles   

  732. GRIGNOUX J, Lodde B, Dewitte JD, Larabi L, et al
    [Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].
    Bull Cancer. 2020;107:428-437.
    Abstract     Related articles   

  733. GARCZYK S, Ortiz-Bruchle N, Schneider U, Lurje I, et al
    Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder.
    Am J Pathol. 2020;190:323-332.
    Abstract     Related articles   

  734. CHEN D, Chen J, Gao J, Zhang Y, et al
    LncRNA DDX11-AS1 Promotes Bladder Cancer Occurrence Via Protecting LAMB3 from Downregulation by Sponging miR-2355-5p.
    Cancer Biother Radiopharm. 2020 May 15. doi: 10.1089/cbr.2019.3021.
    Abstract     Related articles   

  735. LAM CJK, Warren JL, Nielsen M, Smith A, et al
    Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries.
    J Natl Cancer Inst Monogr. 2020;2020:31-38.
    Abstract     Related articles   

  736. LUO C, Lei T, Zhao M, Meng Q, et al
    CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer.
    J Oncol. 2020;2020:3676751.
    Abstract     Related articles   

  737. JALANKO T, de Jong JJ, Gibb EA, Seiler R, et al
    Correction to: Genomic Subtyping in Bladder Cancer.
    Curr Urol Rep. 2020;21:25.
    Abstract     Related articles   

  738. XIONG Q, Liu A, Ren Q, Xue Y, et al
    Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer.
    Cell Death Dis. 2020;11:366.
    Abstract     Related articles   

  739. GARG T, Young AJ, O'Keeffe-Rosetti M, McMullen CK, et al
    Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults.
    Urol Oncol. 2020 May 11. pii: S1078-1439(20)30150.
    Abstract     Related articles   

  740. MA J, Qi J, Li S, Zhang C, et al
    Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820926591.
    Abstract     Related articles   

  741. HAN H, Yu F, Wu C, Dai L, et al
    Trends and Utilization of Inpatient Palliative Care Among Patients With Metastatic Bladder Cancer.
    J Palliat Care. 2020 May 14:825859720924936. doi: 10.1177/0825859720924936.
    Abstract     Related articles   

  742. LUO HL, Chen YT, Cheng YT
    Reply to: High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: The first evidence of JC virus as a potential oncovirus in bladder cancer.
    Am J Transplant. 2020 May 14. doi: 10.1111/ajt.16006.
    Abstract     Related articles   

  743. KUTLUHAN MA, Ozsoy E, Baskak F, Urkmez A, et al
    How reliable are imaging techniques in aging males with bladder cancer?
    Aging Male. 2020 May 13:1-7. doi: 10.1080/13685538.2020.1766014.
    Abstract     Related articles   

  744. VOSKAMP MJH, Vermeer M, Molijn GJ, Cornel EB, et al
    The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy.
    Curr Urol. 2020;14:32-37.
    Abstract     Related articles   

  745. CHEN Q, Yin Q, Mao Y, Zhang Z, et al
    Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation.
    Cancer Cell Int. 2020;20:151.
    Abstract     Related articles   

  746. ZHANG J, Duan H, Feng Z, Han X, et al
    Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress.
    Oncogenesis. 2020;9:46.
    Abstract     Related articles   

  747. MATUSZCZAK M, Salagierski M
    Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   


  748. Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer.
    Biosci Rep. 2020;40.
    Abstract     Related articles   

  749. ZHEGALIK AG, Polyakov SL, Rolevich AI, Volkov AN, et al
    Long-term results of a single-center prospective randomized trial assessing efficacy of a shortened course of adjuvant chemotherapy after radical cystectomy in patients with locally advanced bladder cancer.
    Cent European J Urol. 2020;73:26-32.
    Abstract     Related articles   

  750. GRONOSTAJ K, Czech AK, Fronczek J, Wiatr T, et al
    Changes in neoadjuvant chemotherapy utilization in muscle invasive bladder cancer treatment: a tertiary center retrospective study.
    Cent European J Urol. 2020;73:13-18.
    Abstract     Related articles   

  751. LIU YC, Chen VC, Lu ML, Lee MJ, et al
    The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  752. WOLACEWICZ M, Hrynkiewicz R, Grywalska E, Suchojad T, et al
    Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  753. TAN L, Xiao K, Ye Y, Liang H, et al
    High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  754. CAO H, Cheng L, Yu J, Zhang Z, et al
    Identifying the mRNAs associated with Bladder cancer recurrence.
    Cancer Biomark. 2020 Apr 30. pii: CBM190617. doi: 10.3233/CBM-190617.
    Abstract     Related articles   

  755. GUAN H, Li X, Lu J, Meng L, et al
    Aberrant Methylation of Suppressor of Cytokine Signaling 1 (SOCS1) Gene as a Biomarker for Early Prediction and Diagnosis of Bladder Cancer.
    Clin Lab. 2020;66.
    Abstract     Related articles   

  756. SHARMA M, Nagata Y, Yang Z, Miyamoto H, et al
    The impact of routine frozen section analysis during partial cystectomy for bladder cancer on surgical margin status and long-term oncologic outcome.
    Urol Oncol. 2020 May 8. pii: S1078-1439(20)30140.
    Abstract     Related articles   

  757. WU T, Duan X, Hu T, Mu X, et al
    Effect of endostatin on Wnt pathway of stem-like cells in bladder cancer in tumor microenvironment.
    Mol Biol Rep. 2020 May 9. pii: 10.1007/s11033-020-05487.
    Abstract     Related articles   

  758. QI Y, Toyooka T, Nie J, Ohta H, et al
    Comparative gamma-H2AX analysis for assessment of the genotoxicity of six aromatic amines implicated in bladder cancer in human urothelial cell line.
    Toxicol In Vitro. 2020;66:104880.
    Abstract     Related articles   

  759. STAKHOVSKYI OE, Pikul MV, Semko SL, Vitruk IV, et al
    Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy.
    Wiad Lek. 2020;73:988-993.
    Abstract     Related articles   

  760. YOSHINO H, Enokida H, Osako Y, Nohata N, et al
    Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
    Mol Oncol. 2020 May 9. doi: 10.1002/1878-0261.12697.
    Abstract     Related articles   

  761. WANG F, Qin CP, Yang WB, Liu SJ, et al
    [Advances in Pelvic Lymph Node Dissection for Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020;42:263-269.
    Abstract     Related articles   

  762. HAEDICKE K, Agemy L, Omar M, Berezhnoi A, et al
    High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies.
    Nat Biomed Eng. 2020;4:286-297.
    Abstract     Related articles   

  763. LI Y, Li G, Guo X, Yao H, et al
    Non-coding RNA in bladder cancer.
    Cancer Lett. 2020 May 10. pii: S0304-3835(20)30225.
    Abstract     Related articles   

  764. JONES P, Eldakhakhny M, Hawary A
    Haematuria caused by bladder cancer in the paediatric setting.
    Ann R Coll Surg Engl. 2020 May 21:e1-e2. doi: 10.1308/rcsann.2020.0108.
    Abstract     Related articles   

  765. HU Y, Zhang Y, Gao J, Lian X, et al
    The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.
    Bioengineered. 2020;11:572-581.
    Abstract     Related articles   

  766. RINK M
    Electronic cigarettes and bladder cancer - a game-changer?
    Nat Rev Urol. 2020 May 20. pii: 10.1038/s41585-020-0337.
    Abstract     Related articles   

  767. WU JP, Zhang GY, Sun XZ
    LncRNA ZNFX1-AS1 targeting miR-193a-3p/SDC1 regulates cell proliferation, migration and invasion of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2020;24:4719-4728.
    Abstract     Related articles   

  768. WATT J, Maguire DG, Reid CN, Lamont JV, et al
    Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival.
    Res Rep Urol. 2020;12:157-165.
    Abstract     Related articles   

  769. VENA F, Bayle S, Nieto A, Quereda V, et al
    Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase.
    Mol Cancer Ther. 2020 May 19. pii: 1535-7163.MCT-19-0997.
    Abstract     Related articles   

  770. MATULAY JT, Tabayoyong W, Duplisea JJ, Chang C, et al
    Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Urol Oncol. 2020 May 16. pii: S1078-1439(20)30181.
    Abstract     Related articles   

  771. SORENSEN KK, Jensen BW, Thomas PE, Madsen K, et al
    Early life body size and its associations with adult bladder cancer.
    Ann Hum Biol. 2020;47:166-172.
    Abstract     Related articles   

  772. ECKSTEIN M, Epple E, Jung R, Weigelt K, et al
    CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  773. GHASEMI H, Mousavibahar SH, Hashemnia M, Karimi J, et al
    Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection.
    Ann N Y Acad Sci. 2020 May 19. doi: 10.1111/nyas.14358.
    Abstract     Related articles   

  774. CHIU YF, Wu CC, Kuo MH, Miao CC, et al
    Critical role of SOX2-IGF2 signaling in aggressiveness of bladder cancer.
    Sci Rep. 2020;10:8261.
    Abstract     Related articles   

  775. KRAJEWSKI W, Karabon L, Partyka A, Tomkiewicz A, et al
    Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.
    Cent Eur J Immunol. 2020;45:37-47.
    Abstract     Related articles   

  776. LI Q, Wang S, Wu Z, Liu Y, et al
    DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
    Biomed Pharmacother. 2020;127:110164.
    Abstract     Related articles   

  777. TACHIBANA I, Kaimakliotis HZ
    Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy-does it lead to prolonged survival?
    Transl Androl Urol. 2020;9:831-833.
    Abstract     Related articles   

  778. LIU S, Xu F, Xu T, Yan Y, et al
    Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.
    Transl Androl Urol. 2020;9:445-451.
    Abstract     Related articles   

  779. MA W, Mao S, Bao M, Wu Y, et al
    Prognostic significance of red cell distribution width in bladder cancer.
    Transl Androl Urol. 2020;9:295-302.
    Abstract     Related articles   

  780. CAI Q, Chen Y, Xin S, Zhang D, et al
    Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030.
    Transl Androl Urol. 2020;9:153-165.
    Abstract     Related articles   

  781. CAO H, Huang D, Guo L, Gao Y, et al
    Effects of Different Chemical Groups on Behaviors of Bladder Cancer Cells.
    J Biomed Mater Res A. 2020 May 17. doi: 10.1002/jbm.a.36999.
    Abstract     Related articles   

  782. BURASCHI S, Neill T, Xu SQ, Palladino C, et al
    Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer.
    Matrix Biol. 2020 May 14. pii: S0945-053X(20)30038.
    Abstract     Related articles   

  783. NECCHI A, Raggi D, Giannatempo P, Marandino L, et al
    Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study.
    Eur Urol Oncol. 2020 May 13. pii: S2588-9311(20)30053.
    Abstract     Related articles   

  784. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Urol Oncol. 2020 May 14. pii: S1078-1439(20)30178.
    Abstract     Related articles   

  785. CHIPOLLINI J, Wright JR, Nwanosike H, Kepler CY, et al
    Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 May 12. pii: S1078-1439(20)30139.
    Abstract     Related articles   

  786. WU Q, Wong JPC, Kwok HF
    Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment.
    Cells. 2020;9.
    Abstract     Related articles   

  787. LI S, Li P, Ge M, Wang H, et al
    Elucidation of leak-resistance DNA hybridization chain reaction with universality and extensibility.
    Nucleic Acids Res. 2020;48:2220-2231.
    Abstract     Related articles   

  788. LI F, Guo H, Wang Y, Liu B, et al
    Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
    Int Immunopharmacol. 2020;85:106641.
    Abstract     Related articles   

  789. TODENHOFER T, Boegemann M
    [Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments].
    Urologe A. 2020 May 28. pii: 10.1007/s00120-020-01237.
    Abstract     Related articles   

  790. KRAMER MW, Gakis G
    [Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer].
    Urologe A. 2020 May 28. pii: 10.1007/s00120-020-01233.
    Abstract     Related articles   

  791. ZHANG C, Gou X, He W, Yang H, et al
    A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
    Cancer Cell Int. 2020;20:177.
    Abstract     Related articles   

  792. RUTZ J, Janicova A, Woidacki K, Chun FK, et al
    Curcumin-A Viable Agent for Better Bladder Cancer Treatment.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  793. DE RIDDER M, Gerbrandy LC, de Reijke TM, Hinnen KA, et al
    BioXmark(R) liquid fiducial markers for image guided radiotherapy in muscle invasive bladder cancer, a safety and performance trial.
    Br J Radiol. 2020 May 28:20200241. doi: 10.1259/bjr.20200241.
    Abstract     Related articles   

  794. PFISTER D, Niegisch G
    [Bladder cancer - complications related to urinary diversion].
    Aktuelle Urol. 2020 May 27. doi: 10.1055/a-1134-6642.
    Abstract     Related articles   

  795. XIE K, Cao D, Wei Q, Ren Z, et al
    Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials.
    World J Urol. 2020 May 27. pii: 10.1007/s00345-020-03271.
    Abstract     Related articles   

  796. BHUNIA S, Barbhuiya MA, Gupta S, Shrivastava BR, et al
    Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
    Indian J Med Res. 2020;151:311-318.
    Abstract     Related articles   

  797. MITTAL B
    Desmin dysregulation in gall bladder cancer.
    Indian J Med Res. 2020;151:273-274.
    Abstract     Related articles   

  798. CHEN L, Yang X, Zhao J, Xiong M, et al
    Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    J Exp Clin Cancer Res. 2020;39:94.
    Abstract     Related articles   

  799. LEE HW, Chung W, Lee HO, Jeong DE, et al
    Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
    Genome Med. 2020;12:47.
    Abstract     Related articles   

  800. WANG J, Gao Y, Wang X, Gao Y, et al
    Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
    Int J Biol Markers. 2020 May 28:1724600820926685. doi: 10.1177/1724600820926685.
    Abstract     Related articles   

  801. WILSON JL JR, Antoniassi MP, Lopes PI, Azevedo H, et al
    Proteomic research and diagnosis in bladder cancer: state of the art review.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  802. SHI YR, Wu Z, Xiong K, Liao QJ, et al
    Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression.
    Front Pharmacol. 2020;11:605.
    Abstract     Related articles   

  803. WANG T, Liu S, Joseph T, Lyou Y, et al
    Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  804. BLINOVA E, Enikeev D, Roshchin D, Samyshina E, et al
    Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  805. RESZKA E, Lesicka M, Wieczorek E, Jablonska E, et al
    Dysregulation of Redox Status in Urinary Bladder Cancer Patients.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  806. SHEN C, Liu J, Wang J, Yang X, et al
    The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Dis Markers. 2020;2020:4312629.
    Abstract     Related articles   

  807. YAO J, Qian K, Chen C, Liu X, et al
    ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  808. NATALE C, Leinwand G, Zeineddine F, Silberstein JL, et al
    Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Cancer Treat Res Commun. 2020;24:100177.
    Abstract     Related articles   

  809. KASSOUF W, Aprikian A, Saad F, Fleshner N, et al
    Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
    Can Urol Assoc J. 2020;14:E115-E125.
    Abstract     Related articles   

  810. DANESHMAND S, Nazemi A
    Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence.
    Eur Urol Focus. 2020 May 22. pii: S2405-4569(20)30110.
    Abstract     Related articles   

  811. GRIMBERG DC, Shah A, Molinger J, Whittle J, et al
    Assessments of frailty in bladder cancer.
    Urol Oncol. 2020 May 22. pii: S1078-1439(20)30195.
    Abstract     Related articles   

  812. WANG M, Hiraki R, Nakamura N, Hayama T, et al
    Determination of Gemcitabine in Plasma of Bladder Cancer Patients by Hydrophilic Interaction Chromatography with Ultraviolet Detection.
    J Chromatogr Sci. 2020 May 25. pii: 5842359. doi: 10.1093.
    Abstract     Related articles   

  813. ECKSTEIN M, Strissel P, Strick R, Weyerer V, et al
    Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  814. CHIANG CL, Huang HH, Huang TY, Shih YL, et al
    Nonalcoholic Fatty Liver Disease Associated With Bladder Cancer.
    Am J Med Sci. 2020 May 4. pii: S0002-9629(20)30164.
    Abstract     Related articles   

  815. ROPERCH JP, Hennion C
    A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients - Design of the Urodiag(R) PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC).
    BMC Med Genet. 2020;21:112.
    Abstract     Related articles   

  816. LENIS AT, Lec PM, Michel J, Brisbane W, et al
    Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
    Urol Oncol. 2020 May 20. pii: S1078-1439(20)30182.
    Abstract     Related articles   

  817. NARAIN TA, Gautam G, Seth A, Panwar VK, et al
    Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.
    Indian J Cancer. 2020;57:129-138.
    Abstract     Related articles   

  818. SCHNITZLER T, Ortiz-Bruchle N, Schneider U, Lurje I, et al
    Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
    Cell Oncol (Dordr). 2020 May 22. pii: 10.1007/s13402-020-00524.
    Abstract     Related articles   

  819. PRADERE B, Shariat SF
    Exploring the molecular basis of sexual dimorphism in bladder cancer.
    Nat Rev Urol. 2020 May 22. pii: 10.1038/s41585-020-0339.
    Abstract     Related articles   

  820. TANG H, Kan L, Ou T, Chen D, et al
    Development of a Novel Prognostic Signature for Predicting the Overall Survival of Bladder Cancer Patients.
    Biosci Rep. 2020 May 22. pii: 224923. doi: 10.1042/BSR20194432.
    Abstract     Related articles   

  821. SFAKIANOS JP, Daza J, Hu Y, Anastos H, et al
    Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.
    Nat Commun. 2020;11:2540.
    Abstract     Related articles   

  822. CHEN Y, Fu D, Zhao H, Cheng W, et al
    GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  823. KOVACS PT, Juhasz D, Modos O, Kocsmar I, et al
    Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer
    Orv Hetil. 2020;161:881-888.
    Abstract     Related articles   

  824. WANG Z, He Y, Wang N, Zhang T, et al
    Clinical value of texture analysis in differentiation of urothelial carcinoma based on multiphase computed tomography images.
    Medicine (Baltimore). 2020;99:e20093.
    Abstract     Related articles   

  825. TOBIAS-MACHADO M, Pazeto CL, Borges RC
    Robot-assisted transvesical partial cystectomy for leiomyoma of bladder trigone.
    Int Braz J Urol. 2020;46:300.
    Abstract     Related articles   

  826. PARRA LA, Swanson SK, Salomao MA, Yang M, et al
    Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
    Clin Nucl Med. 2020;45:e156-e157.
    Abstract     Related articles   

  827. YOSHIDA T, Shida D
    ASO Author Reflections: Partial versus Total Cystectomy in Bladder-Involving Colorectal Cancer.
    Ann Surg Oncol. 2019 Aug 9. pii: 10.1245/s10434-019-07716.
    Abstract     Related articles   

  828. OH DY, Kwek SS, Raju SS, Li T, et al
    Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.
    Cell. 2020 Jun 3. pii: S0092-8674(20)30612-7. doi: 10.1016/j.cell.2020.
    Abstract     Related articles   

  829. ZHANG L, Liu B, Deng QH, Li JX, et al
    LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
    Eur Rev Med Pharmacol Sci. 2020;24:5320-5328.
    Abstract     Related articles   

  830. FENG F, Chen AP, Wang XL, Wu GL, et al
    Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Eur Rev Med Pharmacol Sci. 2020;24:5310-5319.
    Abstract     Related articles   

  831. GRIVAS N, van den Bergh RCN, Brouwer OR, KleinJan GH, et al
    Pelvic lymph node distribution and metastases of prostate and bladder cancer: a systematic literature review and template proposal.
    World J Urol. 2020 Jun 3. pii: 10.1007/s00345-020-03281.
    Abstract     Related articles   

  832. ZHOU N, Zhu X, Man L
    LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
    Cancer Manag Res. 2020;12:3353-3361.
    Abstract     Related articles   

  833. BESSA A, Martin R, Haggstrom C, Enting D, et al
    Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence.
    BMC Urol. 2020;20:64.
    Abstract     Related articles   

  834. SUAREZ-IBARROLA R, Kriegmair M, Waldbillig F, Grune B, et al
    A novel endoimaging system for endoscopic 3D reconstruction in bladder cancer patients.
    Minim Invasive Ther Allied Technol. 2020.
    Abstract     Related articles   

  835. ZHOU S, Zhao N, Wang J
    Gambogenic Acid Suppresses Bladder Cancer Cells Growth And Metastasis By Regulating NF-kappaB Signaling.
    Chem Biol Drug Des. 2020 Jun 3. doi: 10.1111/cbdd.13737.
    Abstract     Related articles   

  836. SUKAPIRIYA C, Bandidwattanawong C
    Case of renal cell carcinoma associated with synchronous contralateral renal pelvic cancer and bladder cancer.
    Urol Case Rep. 2020;32:101267.
    Abstract     Related articles   

  837. CHEN S, Yang Y, Luo Z, Deng H, et al
    Establishing a prediction model of infection during the intravesical instillation of bladder cancer: a multicenter retrospective study.
    J Cancer. 2020;11:4324-4331.
    Abstract     Related articles   

  838. KIEHL IGA, Riccetto E, Salustiano ACC, Ossick MV, et al
    Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guerin association.
    World J Urol. 2020 Jun 2. pii: 10.1007/s00345-020-03294.
    Abstract     Related articles   

  839. ROH YG, Mun JY, Kim SK, Park W, et al
    Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  840. OLIVEIRA MC, Caires HR, Oliveira MJ, Fraga A, et al
    Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  841. ASHRAFIZADEH M, Zarrabi A, Samarghandian S, Najafi M, et al
    PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?
    Eur J Pharmacol. 2020 May 30:173226. doi: 10.1016/j.ejphar.2020.173226.
    Abstract     Related articles   

  842. HARSANYI S, Ziaran S, Bevizova K, Varchulova Novakova Z, et al
    The prognostic value of E-cadherin and Ki-67 compared to standard histopathologic examination in non-muscle invasive bladder cancer.
    Bratisl Lek Listy. 2020;121:444-449.
    Abstract     Related articles   

  843. LI J, Wang AS, Wang S, Wang CY, et al
    Death-inducer obliterator 1 (DIDO1) silencing suppresses growth of bladder cancer cells through decreasing SAPK/JNK signaling cascades.
    Neoplasma. 2020 Jun 2. pii: 191115N1171. doi: 10.4149/neo_2020_191115N01171.
    Abstract     Related articles   

  844. NABAVIZADEH R, Bobrek K, Master VA
    Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation.
    Urol Oncol. 2020 May 20. pii: S1078-1439(20)30146.
    Abstract     Related articles   

  845. EDEFONTI V, La Vecchia C, Di Maso M, Crispo A, et al
    Association between Nutrient-Based Dietary Patterns and Bladder Cancer in Italy.
    Nutrients. 2020;12.
    Abstract     Related articles   

  846. SUN R, Liu X, Li G, Wang H, et al
    A Photo-Activated H2 Nanogenerator for Enhanced Chemotherapy of Bladder Cancer.
    ACS Nano. 2020 Jun 1. doi: 10.1021/acsnano.0c01300.
    Abstract     Related articles   

  847. LIU Y, Zhu DY, Xing HJ, Hou Y, et al
    A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
    J Biol Res (Thessalon). 2020;27:6.
    Abstract     Related articles   

  848. LIU X, Zhou Z, Wang Y, Zhu K, et al
    Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
    Front Oncol. 2020;10:589.
    Abstract     Related articles   

  849. SONG Q, Seigne JD, Schned AR, Kelsey KT, et al
    A Machine Learning Approach for Long-Term Prognosis of Bladder Cancer based on Clinical and Molecular Features.
    AMIA Jt Summits Transl Sci Proc. 2020;2020:607-616.
    Abstract     Related articles   

  850. SCHMID SC, Koll FJ, Beckert F, Seitz AK, et al
    [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
    Urologe A. 2020 May 29. pii: 10.1007/s00120-020-01234.
    Abstract     Related articles   

  851. ERDMANN K, Salomo K, Klimova A, Heberling U, et al
    Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  852. TATSUMI Y, Miyake M, Shimada K, Fujii T, et al
    Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  853. MAIMAITI M, Sakamoto S, Yamada Y, Sugiura M, et al
    Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
    Sci Rep. 2020;10:1292.
    Abstract     Related articles   

  854. CLAPS M, Stellato M, Zattarin E, Mennitto A, et al
    Current Understanding of Urachal Adenocarcinoma and Management Strategy.
    Curr Oncol Rep. 2020;22:9.
    Abstract     Related articles   

  855. KHOI PN, Li S, Thuan UT, Sah DK, et al
    Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-kappaB Signaling in Bladder Carcinoma Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  856. JOKISCH F, Buchner A, Schulz GB, Grimm T, et al
    Prospective evaluation of 4-D contrast-enhanced-ultrasound (CEUS) imaging in bladder tumors.
    Clin Hemorheol Microcirc. 2020;74:1-12.
    Abstract     Related articles   

  857. SHAN G, Tang T, Xia Y, Qian HJ, et al
    Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1.
    Biomed Pharmacother. 2020;121:109248.
    Abstract     Related articles   

  858. MANZI M, Riquelme G, Zabalegui N, Monge ME, et al
    Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics.
    J Pharm Biomed Anal. 2020;178:112905.
    Abstract     Related articles   

  859. STRACCIA P, Martini M, Sacco E, Bassi PF, et al
    Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
    Diagn Cytopathol. 2020;48:111-117.
    Abstract     Related articles   

  860. CORNEJO KM, Cosar EF, Paner GP, Yang P, et al
    Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
    Int J Surg Pathol. 2020;28:51-59.
    Abstract     Related articles   

  861. MITRA S, Ayyanar P, Kaur G
    Villous Morphology in Urinary Bladder Biopsy: An Approach to Diagnosis.
    Int J Surg Pathol. 2020;28:4-12.
    Abstract     Related articles   

  862. JIANG Q, Han T, Ren H, Aziz AUR, et al
    Bladder cancer hunting: a microfluidic paper-based analytical device.
    Electrophoresis. 2020 Jun 12. doi: 10.1002/elps.202000080.
    Abstract     Related articles   

  863. LILGE L, Wu J, Xu Y, Manalac A, et al
    Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer.
    J Biomed Opt. 2020;25:1-13.
    Abstract     Related articles   

  864. YAN YL, Huang ZN, Zhu Z, Cui YY, et al
    Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1.
    Front Oncol. 2020;10:667.
    Abstract     Related articles   

  865. SALIMIAN J, Baradaran B, Azimzadeh Jamalkandi S, Moridikia A, et al
    MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes.
    Urol Oncol. 2020 Jun 8. pii: S1078-1439(20)30212.
    Abstract     Related articles   

  866. SABO AA, Birolo G, Naccarati A, Dragomir MP, et al
    Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  867. SHARMA G, Tyagi S
    Comment on "Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials".
    World J Urol. 2020 Jun 10. pii: 10.1007/s00345-020-03292.
    Abstract     Related articles   

  868. BARLOW LJ
    Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020.
    Rev Urol. 2020;22:35-36.
    Abstract     Related articles   

  869. ABUGOMAA A, Elbadawy M, Yamanaka M, Goto Y, et al
    Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
    Sci Rep. 2020;10:9393.
    Abstract     Related articles   


  870. Correction to "Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer".
    Mol Pharmacol. 2020;98:23.
    Abstract     Related articles   

  871. YU M, Ozaki T, Sun D, Xing H, et al
    HIF-1alpha-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    J Exp Clin Cancer Res. 2020;39:108.
    Abstract     Related articles   

  872. XIE H, Zhang T, Yang N, Li Z, et al
    Anticancer effects of Mahanimbine alkaloid on the human bladder cancer cells are due to the induction of G0/G1 cell cycle arrest, apoptosis and autophagy.
    J BUON. 2020;25:1166-1171.
    Abstract     Related articles   

  873. CHAN KM, Gleadle J, Li J, Vasilev K, et al
    Shedding Light on Bladder Cancer Diagnosis in Urine.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  874. YANG G, Bondaruk J, Cogdell D, Wang Z, et al
    Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
    iScience. 2020;23:101201.
    Abstract     Related articles   

  875. ELIE-CAILLE C, Lascombe I, Pechery A, Bittard H, et al
    Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
    Mol Cell Biochem. 2020 Jun 9. pii: 10.1007/s11010-020-03771.
    Abstract     Related articles   

  876. ORNAGHI PI, Afferi L, Antonelli A, Cerruto MA, et al
    The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature.
    World J Urol. 2020 Jun 9. pii: 10.1007/s00345-020-03291.
    Abstract     Related articles   

  877. HUANG CS, Ho JY, Chiang JH, Yu CP, et al
    Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
    Cells. 2020;9.
    Abstract     Related articles   

  878. JURI H, Narumi Y, Panebianco V, Osuga K, et al
    Staging of bladder cancer with multiparametric MRI.
    Br J Radiol. 2020 Jun 9:20200116. doi: 10.1259/bjr.20200116.
    Abstract     Related articles   

  879. BANDINI M, Ross JS, Raggi D, Gallina A, et al
    Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
    J Natl Cancer Inst. 2020 Jun 9. pii: 5855139. doi: 10.1093.
    Abstract     Related articles   

  880. BOSTROM PJ, Jensen JB, Jerlstrom T, Arum CJ, et al
    Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review.
    Scand J Urol. 2020 Jun 9:1-10. doi: 10.1080/21681805.2020.1773527.
    Abstract     Related articles   

  881. PAL DK, Agrawal A, Ghosh S, Ghosh A, et al
    Association of arsenic with recurrence of urinary bladder cancer.
    Trop Doct. 2020 Jun 9:49475520930155. doi: 10.1177/0049475520930155.
    Abstract     Related articles   

  882. JUSTIN S, Rutz J, Maxeiner S, Chun FK, et al
    Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  883. SUN S, Liu F, Xian S, Cai D, et al
    miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Med Sci Monit. 2020;26:e920331.
    Abstract     Related articles   

  884. ARIAFAR A, Ghaedi M, Rezaeifard S, Shahriari S, et al
    Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2.
    Mol Immunol. 2020;124:35-41.
    Abstract     Related articles   

  885. HAYASHI Y, Fujita K, Matsuzaki K, Eich ML, et al
    Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
    Front Oncol. 2020;10:755.
    Abstract     Related articles   

  886. BERNARDO C, Santos J, Costa C, Tavares A, et al
    Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation.
    Urol Oncol. 2020 Jun 2. pii: S1078-1439(20)30158.
    Abstract     Related articles   

  887. LONG Q, Ma AH, Zhang H, Cao Z, et al
    Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
    Cancer Immunol Immunother. 2020 Jun 6. pii: 10.1007/s00262-020-02609.
    Abstract     Related articles   

  888. RAMMANT E, Van Wilder L, Van Hemelrijck M, Pauwels NS, et al
    Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.
    Qual Life Res. 2020 Jun 6. pii: 10.1007/s11136-020-02544.
    Abstract     Related articles   

  889. KESSLER ER, Kukreja JB, Geiger CL, Fischer SM, et al
    Treating Elderly Patients With Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2020;18:783-790.
    Abstract     Related articles   

  890. CHEN DY, Cheng L, Dong LX, He WJ, et al
    Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis.
    Medicine (Baltimore). 2020;99:e20415.
    Abstract     Related articles   

  891. TANG Q, Wang L, Jiang X, Li R, et al
    MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation.
    Biosci Rep. 2020 Jun 5. pii: 225167. doi: 10.1042/BSR20193991.
    Abstract     Related articles   

  892. GAKIS G, Hassan FN, Schmid MA, Olschlager M, et al
    Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer.
    Scand J Urol. 2020 Jun 5:1-7. doi: 10.1080/21681805.2020.1773530.
    Abstract     Related articles   

  893. LIU X, Zhang M, Cheng X, Liu X, et al
    LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma.
    Front Oncol. 2020;10:717.
    Abstract     Related articles   

  894. BURKE B, Eden C, Perez C, Belshoff A, et al
    Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction.
    Front Oncol. 2020;10:699.
    Abstract     Related articles   

  895. JIN D, Qiu S, Jin K, Zhou X, et al
    Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.
    Front Oncol. 2020;10:653.
    Abstract     Related articles   

  896. ROSIELLO G, Knipper S, Palumbo C, Pecoraro A, et al
    Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades.
    J Surg Oncol. 2020;121:1329-1336.
    Abstract     Related articles   

  897. PENG L, Li J, Cao D, Ren Z, et al
    Can robotic-assisted radical cystectomy provide patients with a smaller trauma and faster recovery period? A systematic review and meta-analysis of comparative trials.
    J Cancer Res Clin Oncol. 2020;146:1591-1601.
    Abstract     Related articles   

  898. ESPERTO F, Pang KH, Albisinni S, Papalia R, et al
    Bladder Cancer at the time of COVID-19 Outbreak.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  899. HADJIISKI LM, Cha KH, Cohan RH, Chan HP, et al
    Intraobserver Variability in Bladder Cancer Treatment Response Assessment With and Without Computerized Decision Support.
    Tomography. 2020;6:194-202.
    Abstract     Related articles   

  900. LI C, Fu X, He H, Chen C, et al
    The Biogenesis, Functions, and Roles of circRNAs in Bladder Cancer.
    Cancer Manag Res. 2020;12:3673-3689.
    Abstract     Related articles   

  901. MAO S, Wu Y, Wang R, Guo Y, et al
    Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway.
    Onco Targets Ther. 2020;13:4813-4824.
    Abstract     Related articles   

  902. YU C, Wang Y, Liu T, Sha K, et al
    The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells.
    Onco Targets Ther. 2020;13:4157-4168.
    Abstract     Related articles   

  903. CHENG L, Wang H, Wang Z, Huang H, et al
    Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.
    Drug Des Devel Ther. 2020;14:1897-1908.
    Abstract     Related articles   

  904. GUO CC, Bondaruk J, Yao H, Wang Z, et al
    Assessment of Luminal and Basal Phenotypes in Bladder Cancer.
    Sci Rep. 2020;10:9743.
    Abstract     Related articles   

  905. JAIN RK, Sonpavde G
    Neoadjuvant therapy for muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2020 Jun 16. doi: 10.1080/14737140.2020.1784011.
    Abstract     Related articles   

  906. SILIQUINI N, Viola R, Giura MT, Fierro MT, et al
    Case of bladder cancer during Dupilumab therapy: just an incidental event?
    Dermatol Ther. 2020 Jun 16:e13854. doi: 10.1111/dth.13854.
    Abstract     Related articles   

  907. ZENG H, Zhou Q, Wang Z, Zhang H, et al
    Stromal LAG-3(+) cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  908. SONG Y, Jin D, Chen J, Liang W, et al
    Effects of Arsenic (+3 oxidation state) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence From A Systematic Review, Meta-analysis and TCGA dataset.
    Toxicol Sci. 2020 Jun 15. pii: 5857619. doi: 10.1093.
    Abstract     Related articles   

  909. DE LA PENA E, Hernandez V, Guijarro A, Castro A, et al
    [Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.]
    Arch Esp Urol. 2020;73:374-383.
    Abstract     Related articles   

  910. LI XG, Zhang WS, Yan XP
    Piceatannol inhibits proliferation and induces apoptosis of bladder cancer cells through regulation of the PTEN/AKT signal pathway.
    Cell Mol Biol (Noisy-le-grand). 2020;66:181-184.
    Abstract     Related articles   

  911. OOI EH, Popov V, Alfano M, Cheong JKK, et al
    Influence of natural convection on gold nanorods-assisted photothermal treatment of bladder cancer in mice.
    Int J Hyperthermia. 2020;37:634-650.
    Abstract     Related articles   

  912. GLYKAS I, Fragkoulis C, Kapogiannis F, Ntoumas K, et al
    Re: Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. In press. https://d
    Eur Urol Oncol. 2020 Jun 11. pii: S2588-9311(20)30059.
    Abstract     Related articles   

  913. MAO W, Ma B, Wang K, Wu J, et al
    Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population.
    Clin Transl Med. 2020 Jun 14. doi: 10.1002.
    Abstract     Related articles   

  914. PRAYER GALETTI T, Soligo M, Morlacco A, Lami V, et al
    Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer.
    Aging Clin Exp Res. 2020 Jun 13. pii: 10.1007/s40520-020-01613.
    Abstract     Related articles   

  915. HSIEH JJ
    The 2020 Bladder Cancer Discrepancy Issue.
    Clin Genitourin Cancer. 2020;18:161.
    Abstract     Related articles   

  916. JIN D, Zhang R, Chen H, Li C, et al
    Aberrantly glycosylated integrin alpha3beta1 is a unique urinary biomarker for the diagnosis of bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  917. HAYASHI Y, Fujita K, Nojima S, Tomiyama E, et al
    TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
    Mol Oncol. 2020 Jun 13. doi: 10.1002/1878-0261.12746.
    Abstract     Related articles   

  918. SORIA F, D'Andrea D, Abufaraj M, Moschini M, et al
    Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies.
    Eur Urol Focus. 2020 Jun 9. pii: S2405-4569(20)30115.
    Abstract     Related articles   

  919. HAROON UM, Galvin DJ
    Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors".
    World J Urol. 2020;38:1343.
    Abstract     Related articles   

  920. HASEGAWA M, Hasegawa G, Ikeda Y, Hara N, et al
    Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report.
    SAGE Open Med Case Rep. 2020;8:2050313X20932694.
    Abstract     Related articles   

  921. ROUDNICKY F, Poyet C, Buser L, Saba K, et al
    Characterization of tumor blood vasculature expression of human invasive bladder cancer by laser capture microdissection and transcriptional profiling.
    Am J Pathol. 2020 Jun 22. pii: S0002-9440(20)30296.
    Abstract     Related articles   

  922. ERIKSON MS, Petersen AC, Andersen KK, Jacobsen FK, et al
    Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study.
    Scand J Urol. 2020 Jun 25:1-9. doi: 10.1080/21681805.2020.1782978.
    Abstract     Related articles   

  923. FUKUSHIMA H, Nakanishi Y, Kataoka M, Tobisu KI, et al
    Clinically node-positive micropapillary bladder cancer in a young female desiring to spare functional bladder and fertility.
    Int Cancer Conf J. 2020;9:151-154.
    Abstract     Related articles   

  924. SONG Y, Jin D, Chen J, Luo Z, et al
    Identification of an immune-relatedlLong non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  925. TORAB P, Yan Y, Yamashita H, Warrick JI, et al
    Three-Dimensional Microtumors for Probing Heterogeneity of Invasive Bladder Cancer.
    Anal Chem. 2020 Jun 24. doi: 10.1021/acs.analchem.0c00057.
    Abstract     Related articles   

  926. XU X, Shivappa N
    Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study.
    Eur J Nutr. 2020 Jun 23. pii: 10.1007/s00394-020-02313.
    Abstract     Related articles   

  927. BAJRAMOVIC S, Alic J, Skopljak E, Chikha A, et al
    Renal Tuberculosis Following Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Med Arch. 2020;74:146-150.
    Abstract     Related articles   

  928. OKAJIMA E, Tomizawa M, Shimada K, Negishi T, et al
    D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
    Urol Oncol. 2020 Jun 20. pii: S1078-1439(20)30247.
    Abstract     Related articles   

  929. HUO W, Tan D, Chen Q
    CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
    Nephron. 2020 Jun 22:1-12. doi: 10.1159/000507828.
    Abstract     Related articles   

  930. LIU L, Hu J, Wang Y, Sun T, et al
    Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  931. AJIB K, Tjong MC, Tan GH, Nason G, et al
    Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2020 Jun 16. pii: cuaj.6459. doi: 10.5489/cuaj.6459.
    Abstract     Related articles   

  932. JANG JH, Sung EG, Song IH, Lee TJ, et al
    Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells.
    Anticancer Drugs. 2020 Jun 19. doi: 10.1097/CAD.0000000000000966.
    Abstract     Related articles   

  933. KIKUCHI K, Nakamura R, Segawa T, Oikawa H, et al
    Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
    J Radiat Res. 2020 Jun 22. pii: 5860602. doi: 10.1093.
    Abstract     Related articles   

  934. TYAGI A, Kolluru V, Chandrasekaran B, Saran U, et al
    ASR488, a novel small molecule, activates an mRNA binding protein, CPEB1, and inhibits the growth of bladder cancer.
    Oncol Lett. 2020;20:850-860.
    Abstract     Related articles   

  935. OUYANG S, Liu JH, Ni Z, Ding GF, et al
    Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
    Oncol Lett. 2020;20:828-840.
    Abstract     Related articles   

  936. MUKAE Y, Miyata Y, Nakamura Y, Araki K, et al
    Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1.
    Oncol Lett. 2020;20:135-144.
    Abstract     Related articles   

  937. JALLOH M, Cassell A, Diallo T, Gaye O, et al
    Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts.
    J Trop Med. 2020;2020:8270810.
    Abstract     Related articles   

  938. TIAN Z, Meng L, Long X, Diao T, et al
    DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups.
    Cancer Cell Int. 2020;20:255.
    Abstract     Related articles   

  939. GUPTA NK, Sarkar D, Pal DK
    Monthly maintenance protocol Bacillus Calmette-Guerin as a viable alternative to Southwest Oncology Group maintenance protocol in nonmuscle-invasive bladder cancer: A prospective randomized study.
    Urol Ann. 2020;12:116-121.
    Abstract     Related articles   

  940. ANASTASI E, Maggi M, Tartaglione S, Angeloni A, et al
    Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
    Diagn Cytopathol. 2020 Jun 20. doi: 10.1002/dc.24530.
    Abstract     Related articles   

  941. HAN J, Gu X, Li Y, Wu Q, et al
    Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.
    Biomed Pharmacother. 2020;129:110393.
    Abstract     Related articles   

  942. KIM TJ, Yu YD, Hwang SI, Lee HJ, et al
    Analysis of risk factors for post-bacillus Calmette-Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer.
    Sci Rep. 2020;10:9763.
    Abstract     Related articles   

  943. WANG Y, Sun Q, Ji L, Wang G, et al
    lncRNA MORT Regulates Bladder Cancer Behaviors by Downregulating MicroRNA-146a-5p.
    Nephron. 2020;144:351-357.
    Abstract     Related articles   

  944. VETTERLEIN MW, Witjes JA, Loriot Y, Giannarini G, et al
    Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future.
    Eur Urol Oncol. 2020 Jun 15. pii: S2588-9311(20)30078.
    Abstract     Related articles   

  945. MASTERSON AN, Liyanage T, Berman C, Kaimakliotis H, et al
    A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.
    Analyst. 2020;145:4173-4180.
    Abstract     Related articles   

  946. DIRIX P, Strijbos M, Van den Mooter T, Vandeursen H, et al
    Palliative bladder radiotherapy: caveats in a changing landscape.
    Ann Palliat Med. 2020;9:1269-1271.
    Abstract     Related articles   

  947. LEVY DR, Cheng L
    The expanding molecular and mutational landscape of nested variant of urothelial carcinoma.
    Histopathology. 2020;76:638-639.
    Abstract     Related articles   

  948. HANNA KS
    Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma.
    Drugs. 2020;80:1-7.
    Abstract     Related articles   

  949. LI Y, Qiao L, Zang Y, Ni W, et al
    Circular RNA FOXO3 Suppresses Bladder Cancer Progression and Metastasis by Regulating MiR-9-5p/TGFBR2.
    Cancer Manag Res. 2020;12:5049-5056.
    Abstract     Related articles   

  950. KIM HJ, Gong MK, Yoon CY, Kang J, et al
    Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
    Yonsei Med J. 2020;61:587-596.
    Abstract     Related articles   

  951. SHAIKH MO, Huang TC, Wu TF, Chuang CH, et al
    Label free Impedimetric Immunosensor for effective bladder Cancer detection in clinical urine samples.
    Biomed Microdevices. 2020;22:45.
    Abstract     Related articles   

  952. CAO R, Yuan L, Ma B, Wang G, et al
    Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA).
    Cancer Cell Int. 2020;20:276.
    Abstract     Related articles   

  953. BANDINI M, Calareso G, Raggi D, Marandino L, et al
    The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Jun 27. pii: S2588-9311(20)30082.
    Abstract     Related articles   

  954. ZHANG G, Xu L, Zhao L, Mao L, et al
    CT-based radiomics to predict the pathological grade of bladder cancer.
    Eur Radiol. 2020 Jun 29. pii: 10.1007/s00330-020-06893.
    Abstract     Related articles   

  955. BOTHIG R, Golka K, Tiburtius C, Balzer O, et al
    Incidental bladder cancer at initial urological workup of spinal cord injury patients.
    Spinal Cord Ser Cases. 2020;6:55.
    Abstract     Related articles   

  956. PSUTKA SP
    Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of risk.
    Urol Oncol. 2020 Jun 27. pii: S1078-1439(20)30257.
    Abstract     Related articles   

  957. FERRAN-CARPINTERO A, Dominguez-Garcia A, Munoz-Rodriguez J, Barquero-Lopez M, et al
    Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer.
    Actas Urol Esp. 2020 Jun 26. pii: S0210-4806(20)30097.
    Abstract     Related articles   

  958. BILSKI K, Dobruch J, Kozikowski M, Skrzypczyk MA, et al
    Urobiome in Gender-Related Diversities of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  959. ARORA A, Pugliesi FG, Zugail AS, Moschini M, et al
    Comparing peri-operative complications between laparoscopic and robotic radical cystectomy for bladder cancer.
    J Endourol. 2020 Jun 27. doi: 10.1089/end.2020.0112.
    Abstract     Related articles   

  960. DAI G, Huang C, Yang J, Jin L, et al
    LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    J Cell Mol Med. 2020 Jun 28. doi: 10.1111/jcmm.15564.
    Abstract     Related articles   

  961. WANG T, Yang Y, Wang Z, Zhang X, et al
    A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings.
    J Cell Mol Med. 2020 Jun 28. doi: 10.1111/jcmm.15480.
    Abstract     Related articles   

  962. JIAN Y, Xu Z, Xu C, Zhang L, et al
    The Roles of Glycans in Bladder Cancer.
    Front Oncol. 2020;10:957.
    Abstract     Related articles   

  963. BHAMBHVANI HP, Zamora A, Shkolyar E, Prado K, et al
    Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
    Urol Oncol. 2020 Jun 24. pii: S1078-1439(20)30213.
    Abstract     Related articles   

  964. NAKAYAMA T, Nozawa N, Kawada C, Yamamoto S, et al
    Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
    Photodiagnosis Photodyn Ther. 2020 Jun 24:101893.
    Abstract     Related articles   

  965. LILGE L, Wu J, Xu Y, Manalac A, et al
    Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer (Erratum).
    J Biomed Opt. 2020;25:1.
    Abstract     Related articles   

  966. ERDEM GU, Dogan M, Aytekin A, Sahin S, et al
    Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder.
    Ir J Med Sci. 2020;189:431-438.
    Abstract     Related articles   

  967. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    Abstract     Related articles   

  968. LEE MY, Shi CS, Hsu YC, Huang KJ, et al
    Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
    Anticancer Res. 2019;39:6555-6565.
    Abstract     Related articles   

  969. CHEN M, Chang WS, Shen TC, Gong CL, et al
    Association of Nijmegen Breakage Syndrome 1 Genotypes With Bladder Cancer Risk.
    Anticancer Res. 2020;40:2011-2017.
    Abstract     Related articles   

  970. YU J, Lu Y, Muto S, Ide H, et al
    The Dual Function of Aryl Hydrocarbon Receptor in Bladder Carcinogenesis.
    Anticancer Res. 2020;40:1345-1357.
    Abstract     Related articles   

  971. ADACHI A, Kawamura H, Yoshida D, Kawahara M, et al
    Whole-bladder Radiation Therapy for Lymph Node-negative Bladder Cancer With Muscle Invasion in Elderly Patients.
    Anticancer Res. 2020;40:2905-2909.
    Abstract     Related articles   

  972. HUANG CP, Liu LX, Shyr CR
    Tumor-associated Macrophages Facilitate Bladder Cancer Progression by Increasing Cell Growth, Migration, Invasion and Cytokine Expression.
    Anticancer Res. 2020;40:2715-2724.
    Abstract     Related articles   

  973. MOSSANEN M, Chang SL
    Beyond bladder cancer surveillance: building a survivorship clinic.
    BJU Int. 2020;125:2-3.
    Abstract     Related articles   

  974. MATULAY JT, Soloway M, Witjes JA, Buckley R, et al
    Risk Adapted Management of Low-Grade Bladder Tumors: Recommendations from the International Bladder Cancer Group.
    BJU Int. 2020 Jan 16. doi: 10.1111/bju.14995.
    Abstract     Related articles   

  975. CHUNG J, Maganti M, Kulkarni GS, Morash R, et al
    Modifiable Lifestyle Behaviours Impact the Health-Related Quality of Life of Bladder Cancer Survivors.
    BJU Int. 2020 Jan 24. doi: 10.1111/bju.15007.
    Abstract     Related articles   

  976. TAN WS, Teo CH, Chan D, Ang KM, et al
    Exploring patients' experience and perception of being diagnosed with bladder cancer: A mixed methods approach.
    BJU Int. 2020 Jan 23. doi: 10.1111/bju.15008.
    Abstract     Related articles   

  977. JANISCH F, Rink M, Shariat SF
    The promise and challenges of neoadjuvant immunotherapy in the management of non-metastatic muscle-invasive bladder cancer.
    BJU Int. 2020 Feb 3. doi: 10.1111/bju.15025.
    Abstract     Related articles   

  978. HAMPSON A, Vincent A, Dasgupta P, Vasdev N, et al
    Radical cystectomy complications and perioperative mortality.
    BJU Int. 2019;124:3-4.
    Abstract     Related articles   

  979. DOYLE E, Crew J, Mostafid H, Tuthill M, et al
    Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive disease.
    BJU Int. 2019;123:947-958.
    Abstract     Related articles   

  980. MOSTAFID AH, Porta N, Cresswell J, Griffiths T, et al
    CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer.
    BJU Int. 2020 Mar 3. doi: 10.1111/bju.15038.
    Abstract     Related articles   

  981. MANNION L, Bosco C, Nair R, Mullassery V, et al
    Overall survival, disease specific survival and local recurrence outcomes in patients with muscle invasive bladder cancer treated with external beam radiotherapy and brachytherapy: A systematic review.
    BJU Int. 2020 Mar 7. doi: 10.1111/bju.15047.
    Abstract     Related articles   

  982. MCCLOSKEY H, Hamad J, Smith AB
    How can we motivate patients with bladder cancer to help themselves?
    BJU Int. 2020;125:751-752.
    Abstract     Related articles   

  983. MAZZONE E, Mistretta FA, Knipper S, Palumbo C, et al
    Long-Term Incidence of Secondary Bladder, Rectal Cancer in Patients Treated with Brachytherapy for Localized Prostate Cancer: A Large-Scale Population-Based Analysis.
    BJU Int. 2019 May 30. doi: 10.1111/bju.14841.
    Abstract     Related articles   

  984. HENTSCHEL AE, van EE, der Toom, Vis AN, et al
    A Systematic Review on Mutation Markers for Bladder Cancer Diagnosis in Urine.
    BJU Int. 2020 Jun 15. doi: 10.1111/bju.15137.
    Abstract     Related articles   

  985. GAKIS G, Karl A, Bertz S, Burger M, et al
    Transurethral en bloc submucosal hydrodissection versus conventional resection for resection of non-muscle invasive bladder cancer (HYBRIDBLUE): a randomized, multicentre trial.
    BJU Int. 2020 Jun 23. doi: 10.1111/bju.15150.
    Abstract     Related articles   

  986. IHIRA H, Sawada N, Yamaji T, Goto A, et al
    Physical activity and subsequent risk of kidney, bladder and upper urinary tract cancer in the Japanese population: the Japan Public Health Centre-based Prospective Study.
    Br J Cancer. 2019;120:571-574.
    Abstract     Related articles   

  987. BERG S, D'Andrea D, Vetterlein MW, Cole AP, et al
    Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Cancer. 2019;125:1449-1458.
    Abstract     Related articles   

  988. O'DONNELL PH, Arkenau HT, Sridhar SS, Ong M, et al
    Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
    Cancer. 2020;126:432-443.
    Abstract     Related articles   

  989. HU B, Wang Z, Zeng H, Qi Y, et al
    Blockade of DC-SIGN+ tumor-associated macrophages reactivates anti-tumor immunity and improves immunotherapy in muscle-invasive bladder cancer.
    Cancer Res. 2020 Feb 14. pii: 0008-5472.CAN-19-2254.
    Abstract     Related articles   

  990. LOH XY, Sun QY, Ding LW, Mayakonda A, et al
    RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling.
    Cancer Res. 2020;80:219-233.
    Abstract     Related articles   

  991. LUO J, Xu X
    Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort.
    Carcinogenesis. 2019 Nov 18. pii: 5628148. doi: 10.1093.
    Abstract     Related articles   

  992. KOBATAKE K, Ikeda K, Nakata Y, Yamasaki N, et al
    Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction.
    Clin Cancer Res. 2020 Feb 11. pii: 1078-0432.CCR-19-2230.
    Abstract     Related articles   

  993. LOKESHWAR VB, Morera DS, Hasanali SL, Yates TJ, et al
    A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.
    Clin Cancer Res. 2020 Feb 24. pii: 1078-0432.CCR-19-2912.
    Abstract     Related articles   


  994. Bacillus Calmette-Guerin (BCG) treatment of bladder cancer: a systematic review and commentary on recent publications: Erratum.
    Curr Opin Urol. 2020;30:281.
    Abstract     Related articles   

  995. BANDINI M, Fossati N, Briganti A
    Nomograms in urologic oncology, advantages and disadvantages.
    Curr Opin Urol. 2019;29:42-51.
    Abstract     Related articles   

  996. FANKHAUSER CD, Teoh JY, Mostafid H
    Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guerin shortage.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000739.
    Abstract     Related articles   

  997. WITJES JA
    Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn the last 24 months: a critical review.
    Curr Opin Urol. 2020 Feb 25. doi: 10.1097/MOU.0000000000000741.
    Abstract     Related articles   

  998. LENFANT L, Aminsharifi A, Seisen T, Roupret M, et al
    Current status and future directions of the use of novel immunotherapeutic agents in bladder cancer.
    Curr Opin Urol. 2020 Mar 5. doi: 10.1097/MOU.0000000000000740.
    Abstract     Related articles   

  999. CIPOLLARI S, Carnicelli G, Bicchetti M, Campa R, et al
    Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Curr Opin Urol. 2020 Mar 9. doi: 10.1097/MOU.0000000000000743.
    Abstract     Related articles   

  1000. POZO C, Shariat SF, D'Andrea D, Fajkovic H, et al
    Enhanced Recovery after Radical Cystectomy.
    Curr Opin Urol. 2019;29:227-238.
    Abstract     Related articles   

  1001. BURG ML, Daneshmand S
    Frailty and preoperative risk assessment before radical cystectomy.
    Curr Opin Urol. 2019;29:216-219.
    Abstract     Related articles   

  1002. HASSLER MR, Shariat SF, Soria F
    Salvage therapeutic strategies for bacillus Calmette-Guerin failure.
    Curr Opin Urol. 2019;29:239-246.
    Abstract     Related articles   

  1003. CACCIAMANI GE, Rajarubendra N, Artibani W, Gill IS, et al
    Robotic intracorporeal urinary diversion: state of the art.
    Curr Opin Urol. 2019;29:293-300.
    Abstract     Related articles   

  1004. FABA OR, Palou J
    Emerging approaches and future perspectives in nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000766.
    Abstract     Related articles   

  1005. SUNG HH, Lerner SP
    Utility of lymphadenectomy in bladder cancer: where do we stand?
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000750.
    Abstract     Related articles   

  1006. SARI MOTLAGH R, Pradere B, Mori K, Miura N, et al
    Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?
    Curr Opin Urol. 2020 Apr 16. doi: 10.1097/MOU.0000000000000769.
    Abstract     Related articles   

  1007. SORIA F, Giordano A, Shariat SF, Gontero P, et al
    Bladder sparing landscape for bacillus Calmette-Guerin unresponsive bladder cancer.
    Curr Opin Urol. 2020 May 13. doi: 10.1097/MOU.0000000000000789.
    Abstract     Related articles   

  1008. GUST KM, Rebhan K, Resch I, Shariat SF, et al
    Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer.
    Curr Opin Urol. 2020;30:547-556.
    Abstract     Related articles   

  1009. NECCHI A, Bandini M, Calareso G, Raggi D, et al
    Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
    Eur Urol. 2019 Dec 24. pii: S0302-2838(19)30960.
    Abstract     Related articles   

  1010. HUDDART RA, Hall E, Lewis R, Porta N, et al
    Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy +/- Chemotherapy in the BC2001 Phase III Randomised Controlled Trial.
    Eur Urol. 2019 Dec 13. pii: S0302-2838(19)30840.
    Abstract     Related articles   

  1011. SUNDAHL N, Vandekerkhove G, Decaestecker K, Meireson A, et al
    Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
    Eur Urol. 2019;75:707-711.
    Abstract     Related articles   

  1012. BRIGANTI A, Gandaglia G, Scuderi S, Gallina A, et al
    Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial.
    Eur Urol. 2020 Jan 3. pii: S0302-2838(19)30963.
    Abstract     Related articles   

  1013. FRAGKOULIS C, Papadopoulos G, Ntoumas K
    Re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patient
    Eur Urol. 2020 Jan 21. pii: S0302-2838(20)30053.
    Abstract     Related articles   

  1014. DEL GIUDICE F, Catto JWF, Panebianco V
    Reply to Charalampos Fragkoulis, Georgios Papadopoulos, and Konstantinos Ntoumas's Letter to the Editor re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI
    Eur Urol. 2020 Jan 28. pii: S0302-2838(20)30056.
    Abstract     Related articles   

  1015. KAMOUN A, de Reynies A, Allory Y, Sjodahl G, et al
    Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press.
    Eur Urol. 2020 Feb 6. pii: S0302-2838(19)30958.
    Abstract     Related articles   

  1016. LIU W, Liu X, Li S
    Re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy +/- Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol.
    Eur Urol. 2020 Feb 26. pii: S0302-2838(20)30120.
    Abstract     Related articles   

  1017. NECCHI A, Raggi D, Gallina A, Ross JS, et al
    Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
    Eur Urol. 2020 Mar 9. pii: S0302-2838(20)30138.
    Abstract     Related articles   

  1018. LI R, Sundi D, Zhang J, Kim Y, et al
    Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guerin.
    Eur Urol. 2020 Mar 3. pii: S0302-2838(20)30118.
    Abstract     Related articles   

  1019. BANDINI M, Necchi A
    Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Mus
    Eur Urol. 2020 Mar 14. pii: S0302-2838(20)30150.
    Abstract     Related articles   

  1020. HUDDART R, Hall E, Lewis R, Porta N, et al
    Reply to Wei Liu, Xiaoping Liu, Sheng Li's Letter to the Editor, re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy +/- Chemotherap
    Eur Urol. 2020 Mar 10. pii: S0302-2838(20)30119.
    Abstract     Related articles   

  1021. BAI Y, Yang Y, Tang Y
    Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-0
    Eur Urol. 2020 Mar 18. pii: S0302-2838(20)30149.
    Abstract     Related articles   

  1022. NECCHI A, Gallina A, Dyrskjot L, Roupret M, et al
    Converging Roads to Early Bladder Cancer.
    Eur Urol. 2020 Mar 17. pii: S0302-2838(20)30141.
    Abstract     Related articles   

  1023. MOSTAFID H, Babjuk M, Bochner B, Lerner SP, et al
    Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer.
    Eur Urol. 2020 Mar 16. pii: S0302-2838(20)30146.
    Abstract     Related articles   

  1024. SHAH A, Grimberg DC, Inman BA
    From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guerin Trials in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2020 Apr 14. pii: S0302-2838(20)30197.
    Abstract     Related articles   

  1025. WOERL AC, Eckstein M, Geiger J, Wagner DC, et al
    Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
    Eur Urol. 2020 Apr 27. pii: S0302-2838(20)30255.
    Abstract     Related articles   

  1026. LOUIS L, Thomas S, Yohann L, Morgan R, et al
    Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic.
    Eur Urol. 2020 Apr 24. pii: S0302-2838(20)30302.
    Abstract     Related articles   

  1027. VETTERLEIN MW, Gild P, Fisch M, Rink M, et al
    Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of U
    Eur Urol. 2020 May 3. pii: S0302-2838(20)30314.
    Abstract     Related articles   

  1028. BABJUK M
    Re: Multi-institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.
    Eur Urol. 2020 May 3. pii: S0302-2838(20)30252.
    Abstract     Related articles   

  1029. WITJES JA, Bruins HM, Cathomas R, Comperat EM, et al
    European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
    Eur Urol. 2020 Apr 29. pii: S0302-2838(20)30230.
    Abstract     Related articles   

  1030. KAMAT AM
    Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease.
    Eur Urol. 2020 Apr 27. pii: S0302-2838(20)30322.
    Abstract     Related articles   

  1031. PANEBIANCO V, Del Giudice F, Leonardo C, Sciarra A, et al
    VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic.
    Eur Urol. 2020 Apr 27. pii: S0302-2838(20)30306.
    Abstract     Related articles   

  1032. WITJES JA, Babjuk M, Bellmunt J, Bruins HM, et al
    Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250
    Eur Urol. 2020 May 20. pii: S0302-2838(20)30192.
    Abstract     Related articles   

  1033. MARIAPPAN P
    Propensity for Quality: No Longer a Tenuous Proposition in Bladder Cancer.
    Eur Urol. 2020 May 19. pii: S0302-2838(20)30218.
    Abstract     Related articles   

  1034. POTTEGARD A, Kristensen KB, Friis S, Hallas J, et al
    Urinary tract infections and risk of squamous cell carcinoma bladder cancer: A Danish nationwide case-control study.
    Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32842.
    Abstract     Related articles   

  1035. VRIELING A, Bueno-De-Mesquita HB, Ros MM, Kampman E, et al
    One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
    Int J Cancer. 2019;145:2349-2359.
    Abstract     Related articles   

  1036. JOCHEMS SHJ, Reulen RC, van Osch FHM, Witlox WJA, et al
    Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33008.
    Abstract     Related articles   

  1037. HIEN TT, Ambite I, Butler D, Wan MLY, et al
    Bladder cancer therapy without toxicity - A dose-escalation study of alpha1-oleate.
    Int J Cancer. 2020 Apr 22. doi: 10.1002/ijc.33019.
    Abstract     Related articles   

  1038. LI Y, Hendryx MS, Xun P, He K, et al
    Physical activity and risk of bladder cancer among postmenopausal women.
    Int J Cancer. 2020 May 10. doi: 10.1002/ijc.33042.
    Abstract     Related articles   

  1039. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Adherence to a Western dietary pattern and risk of bladder cancer: a pooled analysis of 13 Cohort Studies of the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Study.
    Int J Cancer. 2020 Jun 24. doi: 10.1002/ijc.33173.
    Abstract     Related articles   

  1040. SJODAHL G, Eriksson P, Patschan O, Marzouka NA, et al
    Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
    Int J Cancer. 2020;146:2636-2647.
    Abstract     Related articles   

  1041. PATEL R, Islam SA, Bommareddy RR, Smalley T, et al
    Simultaneous inhibition of atypical protein kinaseC and mTOR impedes bladder cancer cell progression.
    Int J Oncol. 2020 Mar 20. doi: 10.3892/ijo.2020.5021.
    Abstract     Related articles   

  1042. ZHANG HH, Huang ZX, Zhong SQ, Fei KL, et al
    miR21 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line.
    Int J Oncol. 2020 Feb 13. doi: 10.3892/ijo.2020.4984.
    Abstract     Related articles   

  1043. KANNO T, Inoue T, Ito K, Okumura K, et al
    Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Jan 16. doi: 10.1111/iju.14182.
    Abstract     Related articles   

  1044. TANAKA H, Fukushima H, Kijima T, Nakamura Y, et al
    Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jan 19. doi: 10.1111/iju.14179.
    Abstract     Related articles   

  1045. ABE T
    Editorial Comment from Dr Abe to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Feb 5. doi: 10.1111/iju.14193.
    Abstract     Related articles   

  1046. TANAKA H, Fujii Y
    Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.
    Int J Urol. 2020 Feb 5. doi: 10.1111/iju.14194.
    Abstract     Related articles   

  1047. MATSUMOTO H, Shiraishi K, Azuma H, Inoue K, et al
    Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper.
    Int J Urol. 2020 Mar 14. doi: 10.1111/iju.14210.
    Abstract     Related articles   

  1048. OKITA K, Hatakeyama S, Momota M, Soma O, et al
    Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 May 25. doi: 10.1111/iju.14263.
    Abstract     Related articles   

  1049. SHIN T
    Editorial Comment from Dr Shin to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jun 4. doi: 10.1111/iju.14282.
    Abstract     Related articles   

  1050. ADOMI S, Fujita K, Yoshimura K, Uemura H, et al
    Editorial Comment from Dr Adomi et al. to Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
    Int J Urol. 2020 Jun 4. doi: 10.1111/iju.14284.
    Abstract     Related articles   

  1051. WEINER AB, Pham MN, Isaacson DS, Ko OS, et al
    Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort.
    Int J Urol. 2020 Jun 26. doi: 10.1111/iju.14288.
    Abstract     Related articles   

  1052. MATSUMOTO H, Shiraishi K, Azuma H, Inoue K, et al
    Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.
    Int J Urol. 2020 Jun 21. doi: 10.1111/iju.14281.
    Abstract     Related articles   

  1053. TSATURYAN A, Sahakyan S, Muradyan A, Fanarjyan S, et al
    A new modification of tubeless cutaneous ureterostomy following radical cystectomy.
    Int Urol Nephrol. 2019;51:959-967.
    Abstract     Related articles   

  1054. FENG D, Liu S, Tang Y, Yang Y, et al
    Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis.
    Int Urol Nephrol. 2020 Feb 20. pii: 10.1007/s11255-020-02406.
    Abstract     Related articles   

  1055. MCFERRIN C, Raza SJ, May A, Davaro F, et al
    Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
    Int Urol Nephrol. 2019;51:1755-1762.
    Abstract     Related articles   

  1056. PARIKH N, Sharma P
    Frailty as a prognostic indicator in the radical cystectomy population: a review.
    Int Urol Nephrol. 2019;51:1281-1290.
    Abstract     Related articles   

  1057. MAZDAK H, Tolou Ghamari Z, Gholampour M
    Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E.
    Int Urol Nephrol. 2020 Feb 22. pii: 10.1007/s11255-020-02411.
    Abstract     Related articles   

  1058. KHALIL MI, Alliston JT, Bauer-Erickson JJ, Davis R, et al
    Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Int Urol Nephrol. 2019;51:1903-1911.
    Abstract     Related articles   

  1059. ANDRADE DL, Moretti TBC, Neto WA, Benedetti J, et al
    Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2020 Mar 10. pii: 10.1007/s11255-020-02438.
    Abstract     Related articles   

  1060. EL-HEFNAWY AS, Rizk EMAEA, Al Demerdash Khamis NM, Barakat MAA, et al
    Urinary hyaluronic acid: a versatile marker of bladder cancer.
    Int Urol Nephrol. 2020 May 1. pii: 10.1007/s11255-020-02480.
    Abstract     Related articles   

  1061. DE VERE WHITE R, Lara PN Jr, Black PC, Evans CP, et al
    Framing Pragmatic Strategies to Reduce Mortality From Bladder Cancer: An Endorsement From the Society of Urologic Oncology.
    J Clin Oncol. 2020 Jan 17:JCO1901731. doi: 10.1200/JCO.19.01731.
    Abstract     Related articles   

  1062. WINQUIST E, Booth CM
    Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough.
    J Clin Oncol. 2020 May 27:JCO1902959. doi: 10.1200/JCO.19.02959.
    Abstract     Related articles   

  1063. GRIEBLING TL
    Re: Frailty as a Predictor of Complications after Radical Cystectomy: A Prospective Study of Various Preoperative Assessments.
    J Urol. 2020;203:9.
    Abstract     Related articles   

  1064. ALDHAAM NA, Elsayed AS, Jing Z, Richstone L, et al
    Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC.
    J Urol. 2020;203:57-61.
    Abstract     Related articles   

  1065. CHECK DK, Leo MC, Banegas MP, Bulkley JE, et al
    Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy.
    J Urol. 2020;203:159-163.
    Abstract     Related articles   

  1066. PEYTON CC, Reich RR, Tang D, Alford B, et al
    Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes, and Clinical Chart Review.
    J Urol. 2019;202:913-919.
    Abstract     Related articles   

  1067. HUSSEIN AA, Elsayed AS, Aldhaam NA, Jing Z, et al
    Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
    J Urol. 2019;202:927-935.
    Abstract     Related articles   

  1068. MCALPINE K, Lavallee LT, Stacey D, Moodley P, et al
    Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.
    J Urol. 2019;202:1001-1007.
    Abstract     Related articles   

  1069. SIEGEL C
    Re: Delayed (18)F FDG PET/CT Imaging in the Assessment of Residual Tumors after Transurethral Resection of Bladder Cancer.
    J Urol. 2020 Jan 7:101097JU0000000000000718. doi: 10.1097/JU.0000000000000718.
    Abstract     Related articles   

  1070. ATALA A
    Re: Epigenetic Loss of AOX1 Expression via EZH2 Leads to Metabolic Deregulations and Promotes Bladder Cancer Progression.
    J Urol. 2020 Jan 13:101097JU000000000000073202.
    Abstract     Related articles   

  1071. CHANG SS
    Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Jan 13:101097JU0000000000000729. doi: 10.1097/JU.0000000000000729.
    Abstract     Related articles   

  1072. CHANG SS
    Re: Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Jan 13:101097JU000000000000072902.
    Abstract     Related articles   

  1073. WEINER AB, Kundu SD
    Editorial Comment.
    J Urol. 2020;203:290-291.
    Abstract     Related articles   

  1074. CHANG SS
    Re: Effectiveness of Adjuvant Chemotherapy after Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-Invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    J Urol. 2020;203:250.
    Abstract     Related articles   

  1075. ATALA A
    Re: 5-Methylcytosine Promotes Pathogenesis of Bladder Cancer through Stabilizing mRNAs.
    J Urol. 2020 Feb 12:101097JU0000000000000781. doi: 10.1097/JU.0000000000000781.
    Abstract     Related articles   

  1076. ATALA A
    Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression.
    J Urol. 2020 Feb 12:101097JU000000000000078101.
    Abstract     Related articles   

  1077. NABAVIZADEH R, Joshi SS
    Editorial Comment.
    J Urol. 2020;203:511.
    Abstract     Related articles   

  1078. MONTORSI F, Moschini M, Gallina A, Briganti A, et al
    Re: Ten-Year Oncologic Outcomes following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
    J Urol. 2020;203:624.
    Abstract     Related articles   

  1079. SHARMA V, Wymer KM, Borah BJ, Saigal CS, et al
    Cost-Effectiveness of Maintenance BCG for Intermediate and High Risk Non-Muscle Invasive Bladder Cancer.
    J Urol. 2020 Mar 19:101097JU0000000000001023. doi: 10.1097/JU.0000000000001023.
    Abstract     Related articles   

  1080. CHANG SS
    Re: The Challenges of Bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients.
    J Urol. 2020 Mar 17:101097JU000000000000099902.
    Abstract     Related articles   

  1081. MULLER G, Butea-Bocu M, Brock O, Hanske J, et al
    Association between Development of Metabolic Acidosis and Improvement of Urinary Continence after Ileal Neobladder Creation.
    J Urol. 2020;203:585-590.
    Abstract     Related articles   

  1082. ZHANG JH, Ericson KJ, Thomas LJ, Knorr J, et al
    Large Single Institution Comparison of Perioperative Outcomes and Complications of Open Radical Cystectomy, Intracorporeal Robot-Assisted Radical Cystectomy and Robotic Extracorporeal Approach.
    J Urol. 2020;203:512-521.
    Abstract     Related articles   

  1083. VENKATRAMANI V, Reis IM, Castle EP, Gonzalgo ML, et al
    Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup.
    J Urol. 2020;203:522-529.
    Abstract     Related articles   

  1084. ATALA A
    Re: Hypermethylation of FOXA1 and Allelic Loss of PTEN Drive Squamous Differentiation and Promote Heterogeneity in Bladder Cancer.
    J Urol. 2020 Apr 9:101097JU0000000000001058. doi: 10.1097/JU.0000000000001058.
    Abstract     Related articles   

  1085. CHANG SS
    Re: Bladder Preservation with Twice-a-Day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    J Urol. 2020 Apr 9:101097JU0000000000001055. doi: 10.1097/JU.0000000000001055.
    Abstract     Related articles   

  1086. BECERRA MF, Venkatramani V, Reis IM, Soodana-Prakash N, et al
    Health-Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial - A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy.
    J Urol. 2020 Apr 9:101097JU0000000000001029. doi: 10.1097/JU.0000000000001029.
    Abstract     Related articles   

  1087. CHANG SS
    Re: PD-L1 Expression in Tumor Cells and the Immunologic Milieu of Bladder Carcinomas: A Pathologic Review of 165 Cases.
    J Urol. 2020;203:880.
    Abstract     Related articles   

  1088. WITJES JA
    Editorial Comment.
    J Urol. 2020;203:908-909.
    Abstract     Related articles   

  1089. CHANG SS
    Re: Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery after Surgery Protocol.
    J Urol. 2020;203:660.
    Abstract     Related articles   

  1090. ROUPRET M, Gontero P, McCracken SRC, Dudderidge T, et al
    Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Non Muscle Invasive Bladder Cancer Follow up: A Blinded, Prospective Cohort, Multicentric European Study.
    J Urol. 2020 Apr 21:101097JU0000000000001084. doi: 10.1097/JU.0000000000001084.
    Abstract     Related articles   

  1091. GRIEBLING TL
    Re: Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis.
    J Urol. 2020 May 13:101097JU000000000000110204.
    Abstract     Related articles   

  1092. CHANG SS
    Re: Assessment of Quality of Life, Information, and Supportive Care Needs in Patients with Muscle and Non-Muscle Invasive Bladder Cancer across the Illness Trajectory.
    J Urol. 2020 May 12:101097JU000000000000111402.
    Abstract     Related articles   

  1093. ATALA A
    Re: A Genetically Defined Disease Model Reveals that Urothelial Cells Can Initiate Divergent Bladder Cancer Phenotypes.
    J Urol. 2020 May 12:101097JU0000000000001117. doi: 10.1097/JU.0000000000001117.
    Abstract     Related articles   

  1094. CHANG SS
    Re: Association between Treatment of Superficial Bladder Cancer and 10-Year Mortality in Older Adults with Multiple Chronic Conditions.
    J Urol. 2020 May 12:101097JU000000000000111401.
    Abstract     Related articles   

  1095. CHANG SS
    Re: The Impact of Non-Urothelial Variant Histology on Oncological Outcomes following Radical Cystectomy.
    J Urol. 2020;203:1060.
    Abstract     Related articles   

  1096. ATALA A
    Re: Therapeutically Actionable PAK4 is Amplified, Overexpressed, and Involved in Bladder Cancer Progression.
    J Urol. 2020 Jun 18:101097JU000000000000117901.
    Abstract     Related articles   

  1097. CHANG SS
    Re: National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.
    J Urol. 2020 Jun 30:101097JU0000000000001175. doi: 10.1097/JU.0000000000001175.
    Abstract     Related articles   

  1098. CHANG SS
    Re: Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Jun 30:101097JU000000000000117501.
    Abstract     Related articles   

  1099. LIU X, Cui J, Gong L, Tian F, et al
    The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.
    Oncogene. 2020 Mar 3. pii: 10.1038/s41388-020-1236.
    Abstract     Related articles   

  1100. LIU HJ, Lam HC, Baglini CV, Nijmeh J, et al
    Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor beta (RARbeta).
    Oncogene. 2019;38:7367-7383.
    Abstract     Related articles   

  1101. CHANDRASHEKAR DS, Chakravarthi BVSK, Robinson AD, Anderson JC, et al
    Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
    Oncogene. 2020 Mar 30. pii: 10.1038/s41388-020-1275.
    Abstract     Related articles   

  1102. YIN H, Zhang C, Gou X, He W, et al
    Identification of a 13mRNA signature for predicting disease progression and prognosis in patients with bladder cancer.
    Oncol Rep. 2019 Dec 12. doi: 10.3892/or.2019.7429.
    Abstract     Related articles   

  1103. JOU YC, Wang SC, Dai YC, Chen SY, et al
    Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Oncol Rep. 2019;42:1005-1016.
    Abstract     Related articles   

  1104. DOISY L, Walz J, Fakhfakh S, Rybikowski S, et al
    [Is a routine second transurethral resection of the bladder still necessary after hexaminolevulinate photodynamic diagnosis-assisted TURBT?]
    Prog Urol. 2019;29:332-339.
    Abstract     Related articles   

  1105. ANRACT J, Duquesne I, Montagne P, Sibony M, et al
    [Optical coherence tomography of bladder resection specimen].
    Prog Urol. 2019;29.
    Abstract     Related articles   

  1106. KHAN W, Zugail AS, Blanc E, Neuziller Y, et al
    Reasons for intravesical instillation postponement during adjuvant treatment of non-muscle-invasive bladder cancer: A prospective study.
    Prog Urol. 2020 Jan 14. pii: S1166-7087(19)30642.
    Abstract     Related articles   

  1107. YANG T, Fan J, Liang H, He D, et al
    Reduced E-cadherin expression as a prognostic factor in non-muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Prog Urol. 2020 Feb 12. pii: S1166-7087(19)30651.
    Abstract     Related articles   

  1108. ROUPRET M, Neuzillet Y, Pignot G, Comperat E, et al
    French ccAFU guidelines - Update 2018-2020: Bladder cancer
    Prog Urol. 2019;28.
    Abstract     Related articles   

  1109. CARANDO R, Pradere B, Afferi L, Marra G, et al
    The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review.
    Prog Urol. 2020 Apr 9. pii: S1166-7087(20)30097.
    Abstract     Related articles   

  1110. SHIGEMURA K, Tanaka K, Hamasuna R, Ishikawa K, et al
    Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study.
    Urol Int. 2019;102:293-298.
    Abstract     Related articles   

  1111. YANG H, Lin J, Gao P, He Z, et al
    Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jan 7:1-8. doi: 10.1159/000503734.
    Abstract     Related articles   

  1112. URBINA-LIMA AD, Roman-Martin AA, Crespo-Santos A, Martinez-Rodriguez A, et al
    Solitary Fibrous Tumor of the Urinary Bladder Associated with Hypoglycemia: An Unusual Case of Doege-Potter Syndrome.
    Urol Int. 2019;103:120-124.
    Abstract     Related articles   

  1113. SCHULZ GB, Grimm T, Buchner A, Kretschmer A, et al
    Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction.
    Urol Int. 2019;103:350-356.
    Abstract     Related articles   

  1114. AZNAR MARTINEZ L, Lopez Cubillana P, Lopez Abad A, Vidal Crespo N, et al
    Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma.
    Urol Int. 2019;103:242-244.
    Abstract     Related articles   

  1115. SUAREZ-IBARROLA R, Hein S, Farin E, Waldbillig F, et al
    Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.
    Urol Int. 2020 Mar 25:1-7. doi: 10.1159/000506653.
    Abstract     Related articles   

  1116. SERRETTA V, Di Maida F, Baiamonte D, Vella M, et al
    Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.
    Urol Int. 2020 May 5:1-6. doi: 10.1159/000507122.
    Abstract     Related articles   

  1117. XU J, Wang C, Ouyang J, Sun J, et al
    Efficacy and Safety of Transurethral Laser Surgery Versus Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis and Systematic Review.
    Urol Int. 2020 May 27:1-14. doi: 10.1159/000506655.
    Abstract     Related articles   

  1118. BUSETTO GM, Porreca A, Del Giudice F, Maggi M, et al
    SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
    Urol Int. 2020 Jun 9:1-13. doi: 10.1159/000509065.
    Abstract     Related articles   

  1119. NAKANE K, Enomoto T, Hishida S, Tomioka M, et al
    The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution.
    Urol Int. 2020 Jun 17:1-7. doi: 10.1159/000508192.
    Abstract     Related articles   

  1120. WU J, Wang YC, Luo WJ, Dai B, et al
    Diagnostic Performance of Confocal Laser Endomicroscopy for the Detection of Bladder Cancer: Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jun 18:1-10. doi: 10.1159/000508417.
    Abstract     Related articles   

  1121. CHEN G, Yang T, Shao Q, Zhang M, et al
    Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jul 1:1-7. doi: 10.1159/000506238.
    Abstract     Related articles   

  1122. RIOS EM, Parma MA, Fernandez RA, Clinton TN, et al
    Urinary diversion disparity following radical cystectomy for bladder cancer in the Hispanic population.
    Urology. 2019 Dec 26. pii: S0090-4295(19)31119.
    Abstract     Related articles   

  1123. ANDERSON AG, Murray KS
    EDITORIAL COMMENT.
    Urology. 2019;134:160-161.
    Abstract     Related articles   

  1124. SOLANKI AA, Efstathiou JA
    EDITORIAL COMMENT.
    Urology. 2019;133:171-172.
    Abstract     Related articles   

  1125. LEE BH
    EDITORIAL COMMENT.
    Urology. 2019;133:161-162.
    Abstract     Related articles   

  1126. GURUNG PMS, Messing EE, Joseph JV
    EDITORIAL COMMENT.
    Urology. 2019;131:118-119.
    Abstract     Related articles   

  1127. SCHROECK FR
    EDITORIAL COMMENT.
    Urology. 2019;131:102.
    Abstract     Related articles   

  1128. HERR H
    EDITORIAL COMMENT.
    Urology. 2019;128:60.
    Abstract     Related articles   

  1129. HAYWOOD SC, Long Roche K, Bochner BH
    A Thoughtful Pause for Sparing Oophorectomy.
    Urology. 2019;129:237.
    Abstract     Related articles   

  1130. BERTOLO R, Agudelo J, Garisto J, Armanyous S, et al
    Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study.
    Urology. 2019;129:98-105.
    Abstract     Related articles   

  1131. MYRGA JM, Ayyash OM, Bandari J, Fam MM, et al
    The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy.
    Urology. 2020;135:106-110.
    Abstract     Related articles   

  1132. GOH AC, Belarmino A, Patel NA, Sun T, et al
    A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy.
    Urology. 2020;135:57-65.
    Abstract     Related articles   

  1133. TULLY KH, Krimphove MJ, Reese SW, Kibel AS, et al
    Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy.
    Urology. 2020;135:44-49.
    Abstract     Related articles   

  1134. OTTA-OSHIRO RJ, Lista-Mateos F, Encinas-Garcia S, Morales-Garcia S, et al
    Metachronous Signet Ring Cell Bladder Metastasis as First Sing of Cancer Recurrence.
    Urology. 2019;134:e1-e2.
    Abstract     Related articles   

  1135. LIN FC, Medendorp A, Van Kuiken M, Mills SA, et al
    Vaginal Dehiscence and Evisceration After Robotic-assisted Radical Cystectomy: A Case Series and Review of the Literature.
    Urology. 2019;134:90-96.
    Abstract     Related articles   

  1136. BADIN J, Abello A, Gupta M, Das AK, et al
    UROTHELIAL CARCINOMA OF THE BLADDER WITH A RARE SOLITARY METASTASIS TO THE OVARY.
    Urology. 2019 Aug 7. pii: S0090-4295(19)30700.
    Abstract     Related articles   

  1137. MICHEL J, Goel AN, Golla V, Lenis AT, et al
    Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty.
    Urology. 2019;133:25-33.
    Abstract     Related articles   

  1138. LEINWAND GZ, Greenberg JW, Sholl AB, Krane LS, et al
    Synchronous Urothelial Bladder and Renal Malignancies. Case Report and Review of Urologic Cancers in Patients With Familial Rb Mutations.
    Urology. 2019;131:89-92.
    Abstract     Related articles   

  1139. PENTICUFF J, McDermott S, Carrasco A, Bowlin P, et al
    Second Reported Case of Pediatric Bladder Alveolar Soft Part Sarcoma as Secondary Malignancy After Prior Cytotoxic Chemotherapy.
    Urology. 2019;130:148-150.
    Abstract     Related articles   

  1140. MUKHERJEE P, George AJP, Yadav BK, Jeyaseelan L, et al
    The Impact of Narrow Band Imaging in the Detection and Resection of Bladder Tumor in Transitional Cell Carcinoma of the Bladder: A Prospective, Blinded, Sequential Intervention Randomized Controlled Trial.
    Urology. 2019;128:55-61.
    Abstract     Related articles   

  1141. NASSIRI N, Maas M, Asanad K, Daneshmand S, et al
    Detecting Invisible Bladder Cancers with Blue Light Cystoscopy.
    Urology. 2020 Feb 19. pii: S0090-4295(20)30182.
    Abstract     Related articles   

  1142. DAS H, Rodriguez R
    Health Care Disparities in Urologic Oncology: A Systematic Review.
    Urology. 2020;136:9-18.
    Abstract     Related articles   

  1143. AGARD H, Clark C, Massanyi E, Steele M, et al
    Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
    Urology. 2020;137:173-177.
    Abstract     Related articles   

  1144. DREJER D, Moltke AL, Nielsen AM, Lam GW, et al
    DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence.
    Urology. 2020;137:91-96.
    Abstract     Related articles   

  1145. HALSTEAD NV, Cost NG, Hecht SL, Walker JP, et al
    Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence.
    Urology. 2020;137:168-172.
    Abstract     Related articles   

  1146. HECHT SL, Walker JP, Treece AL, Cost NG, et al
    Isolated Pure Malignant Rhabdoid Tumor (MRT) of the Bladder: Case Report and Lessons Learned.
    Urology. 2020;137:164-167.
    Abstract     Related articles   

  1147. YONG C, Steinberg RL, O'Donnell MA
    Severe Infectious Complications of Intravesical Bacillus Calmette-Guerin: A Case Series of 10 Patients.
    Urology. 2020;137:79-83.
    Abstract     Related articles   

  1148. PEARD L, Stark T, Ziada A, Saltzman AF, et al
    Recurrent Bladder Cancer in a Teenage Male.
    Urology. 2020 Apr 22. pii: S0090-4295(20)30411.
    Abstract     Related articles   

  1149. KOCH GE, Luckenbaugh AN, Chang SS
    High-Risk Non-Muscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.
    Urology. 2020 May 20. pii: S0090-4295(20)30573.
    Abstract     Related articles   

  1150. SCHMID SC, Koll FJ, Rodel C, Maisch P, et al
    Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
    BMC Cancer. 2020;20:8.
    Abstract     Related articles   

  1151. SASSENBERG M, Droop J, Schulz WA, Dietrich D, et al
    Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    BMC Cancer. 2019;19:806.
    Abstract     Related articles   

  1152. FIORENTINO V, Pierconti F, Lenci N, Calicchia M, et al
    Urinary bladder leiomyosarcoma with osteoclast-like multinucleated giant cells: a case report.
    BMC Cancer. 2019;19:763.
    Abstract     Related articles   

  1153. LATIFOVIC L, Villeneuve PJ, Parent ME, Kachuri L, et al
    Silica and asbestos exposure at work and the risk of bladder cancer in Canadian men: a population-based case-control study.
    BMC Cancer. 2020;20:171.
    Abstract     Related articles   

  1154. MORSCH R, Rose M, Maurer A, Cassataro MA, et al
    Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
    BMC Cancer. 2020;20:230.
    Abstract     Related articles   

  1155. ZHANG Y, Ou DH, Zhuang DW, Zheng ZF, et al
    In silico analysis of the immune microenvironment in bladder cancer.
    BMC Cancer. 2020;20:265.
    Abstract     Related articles   

  1156. RIPPING TM, Kiemeney LA, van Hoogstraten LMC, Witjes JA, et al
    Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB).
    BMC Cancer. 2020;20:455.
    Abstract     Related articles   

  1157. RYTLEWSKI J, Deng S, Xie T, Davis C, et al
    Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood.
    PLoS One. 2019;14:e0213684.
    Abstract     Related articles   

  1158. CHEN Q, Fu L
    Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    PLoS One. 2020;15:e0227568.
    Abstract     Related articles   

  1159. ETO S, Saeki K, Yoshitake R, Yoshimoto S, et al
    Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells.
    PLoS One. 2019;14:e0218382.
    Abstract     Related articles   

  1160. ABECASSIS J, Hamy AS, Laurent C, Sadacca B, et al
    Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    PLoS One. 2019;14:e0224143.
    Abstract     Related articles   

  1161. EVERS J, Grotenhuis AJ, Aben KKH, Kiemeney LALM, et al
    No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    PLoS One. 2020;15:e0229384.
    Abstract     Related articles   

  1162. REZAEE ME, Lynch KE, Li Z, MacKenzie TA, et al
    The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).
    PLoS One. 2020;15:e0230417.
    Abstract     Related articles   

  1163. LILLESAND M, Kvikstad V, Mangrud OM, Gudlaugsson E, et al
    Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer.
    PLoS One. 2020;15:e0233676.
    Abstract     Related articles   

  1164. PACKEISER EM, Hewicker-Trautwein M, Thiemeyer H, Mohr A, et al
    Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
    PLoS One. 2020;15:e0230272.
    Abstract     Related articles   

  1165. HANKE M, Dubois J, Kausch I, Petkovic S, et al
    Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA.
    PLoS One. 2020;15:e0229193.
    Abstract     Related articles   

  1166. WANG L, Smith BA, Balanis NG, Tsai BL, et al
    A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Proc Natl Acad Sci U S A. 2019 Dec 23. pii: 1915770117.
    Abstract     Related articles   

  1167. KHAN Z, Di Nucci F, Kwan A, Hammer C, et al
    Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer.
    Proc Natl Acad Sci U S A. 2020 May 19. pii: 1922867117.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;